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Do Humans Possess the Capability to Regenerate? 
Chasha Wuensch 
A Chasha Wuensch graduated in May 2018 with a Bachelor of Science degree in Biology and will be attending 
pharmacy school. 
Abstract 
Urodele amphibians, including newts and salamanders, are amongst the most commonly studied research models for regenera-
tion.The ability to regenerate, however, is not limited to amphibians, and the regenerative process has been observed in mammals 
as well.This paper discusses methods by which amphibians and mammals regenerate to lend insights into human regenerative 
mechanisms and regenerative potential.A focus is placed on the urodele and  murine digit tip models, both of which share critical 
regenerative stages including wound healing, histolysis, and blastema formation. Formation of the blastema proved to be a crucial 
process necessary for regeneration, and is responsible for dedifferentiation and pattern formation. Additionally, the necessity of 
nerves, macrophages, and upregulation of several genes are discussed.The use of cellular therapy and development of extracel-
lular templates shows promising opportunities in the fields of regenerative medicine and tissue engineering for the stimulation of 
endogenous repair. 
Introduction 
Organ deterioration can be caused by disease, damage, or aging. 
The shortage of viable organs for transplantation has grown 
severe; an average of twenty people die each day waiting for an 
organ. (www.unos.org) Additionally, there are nearly 2 million 
people with amputations in the United States alone, with limb 
loss caused by various reasons including vascular disease, trau-
ma, and cancer. (www.amputee-coaliton.org) If a human organ 
or limb could be stimulated to regenerate it would radically 
change the quality of life and prognosis of many people. 
There are two major classes of regeneration. Regular replen-
ishment of a specific cell type or various types of cells within a 
tissue is defined as homeostatic regeneration.The mammalian 
epidermis is continuously undergoing homeostatic regeneration 
by the shedding and renewal of the epidermal cells. However, 
when complex tissue is replaced due to a wound this is re-
ferred to as reparative regeneration. Differentiation between 
these two types of regeneration is necessary; it expresses that 
regeneration requires coordination between multiple cell types, 
and that single cell level regeneration does not mean regenera-
tion for complex tissue. For example, if an injury causes the loss 
of the epidermis and the underlying dermis, the skin will replace 
the lost tissue, but hair follicles derived from the epidermis fail 
to regenerate.( Simkin, Seifert, 2017) Using other models of re-
parative regeneration as a guideline, the mechanism by which 
humans may regenerate can be better understood. 
Methods 
This study was completed through the use of databases such 
as Touro College Library and Google Scholar. The National 
Institute of Health and NCBI were also used to find peer re-
viewed articles related to both amphibian and mammalian re-
generation and regenerative mechanisms. 
Urodele Limb Regeneration 
Amphibians of the order Urodela, which include salamanders 
and newts, are the only tetrapod vertebrates capable of repeat-
edly undergoing regeneration of entire limbs. (Stocum, 2017) 
The mechanism by which they regenerate has been studied for 
over a century, with original studies focused on the histology 
and morphology of a regenerating limb, and more recent work 
on manipulating the regenerative process. The mechanisms by 
which they regenerate have been divided into several phases: 
Wound Healing 
Within a few hours after sustaining an injury, an enzyme cata-
lyzed blood clot forms, sealing the open wound. Cells from the 
basal layer of the epidermis detach from the basement mem-
brane and begin to travel towards the injury site.The basal cells 
relocate in thin sheets which begin to proliferate only once the 
wound is fully covered, forming a protective layer called the 
wound epidermis. The wound epidermis (WE) insulates the 
wound, protecting it from further external damage as well as 
providing a regenerative microenvironment.WE can grow up to 
15 cell layers thick, ultimately forming the apical epithelial cap 
(AEC). (Campbell, Crews, 2008) 
The breakdown of the extracellular matrix of the stump tissue 
through matrix metalloproteinases (MMP) and other hydrolytic 
enzymes is called histolysis. Degradation of the extracellular 
matrix by MMP is directly correlated with the rapid produc-
tion and release of cells from the limb tissue. The significance 
of MMP’s role was noted when an amputated limb was treated 
with the matrix metalloproteinase inhibitor GM6001 and the 
blastema failed to form. In addition to ECM remodeling, MMPs 
ensure that the basement membrane does not reform.This al-
lows the wound epidermis and the tissues below to be in direct 
contact, which is necessary for the successful establishment of 
apical epithelial cap. Matrix metalloproteinases are released up 
until the developing limb bud is about medium sized, slowing 
only once inhibitory molecules such as TIMP1 are upregulated. 
(Vinarsky et.al. 2005) 
Blastema 
Two to five days post-amputation, cells from the internal tissues 
adjacent to the limb stump undergo dedifferentiation, forming 
a heterogeneous mixture of multipotent stem cells and limit-
ed progenitor cells. (Wallace et al., 1974) This accumulation of 
cells is called the blastema, one of the most fundamental stag-
es in the regenerative response. Dedifferentiation is a nuclear 
reprogramming which prevents transcription of differentiation 
genes, and reverts cells into an embryonic-like state with great-









































blastema formation, they retain a form of cell memory, and are 
predominately restricted to the original cell phenotype. For ex-
ample, cartilage and muscle tissue originating from the blastema 
are generally derived from cells with chondrocyte and myocyte 
lineage, respectively. Dermal cells were the exception, since they 
possess the ability to form other tissues in addition to the ex-
pected dermal tissue. (Tweedel, 2010) The cells are also known 
to possess a positional memory, specifically found in fibroblast 
derived blastema cells. Cells adjacent to neighboring cells with 
disparate positional identities are detected and then stimulated 
to regenerate the missing cells specific to the amputated struc-
ture. (McCusker et. al., 2015) 
Macrophage count is significantly higher during blastema 
formation. Enriched numbers of macrophages reduce inflam-
mation and clear cellular debris while stimulating angiogenesis, 
fibroblast migration, and production of MMPs.Amputated limbs 
depleted of macrophages during blastema formation led to scar-
ring of the limb stump. On the other hand, depletion of mac-
rophages after the blastema already entered the growth phase 
only caused regenerative delay. Dermal scar tissue separates the 
WE from the tissues below, so while the wound can close , 
the AEC is unable to form, thereby preventing the regenerative 
process from occurring. Macrophages are therefore essential in 
the early stages of blastema formation and influence the final 
outcome of a regenerating limb. (Godwin et. al., 2013) 
The gene activity present in a regenerating limb is only par-
tially known. Several genes upregulated during blastema forma-
tion include Msx1, Msx2, Nrad, Rfrng, and Notch.These genes 
have been linked to myogenesis inhibition, reduction of muscle 
regulatory proteins, muscle dedifferentiation, and stem cell 
self‐renewal. Two of these genes, Msx1 and Msx2 , are specif-
ically known to be expressed in the apical mesenchyme of all 
tetrapod vertebrates. Following amputation or a simple wound, 
Msx2 is expressed in the damaged epidermis and the surround-
ing tissue, while Msx1 is limited to the blastemal cells. Studies 
show that MSX genes affect the early regenerative stages, and in 
the absence of these genes tissue growth and differentiation is 
reduced. (Stocum, 2017) 
Patterning 
There are currently two major models for the study of pattern 
formation of a developing limb.The polar coordinate model is 
a one which presents a view on tissue regrowth and how pat-
terning is induced. Cells are thought to have different tissue re-
growth patterns based on their positional information or their 
particular anterior- posterior and proximal- distal sequence. 
This model also predicts that supernumeraries will only be in-
duced when an ipsilateral graft is performed at angles of 180º. 
(Maden, Turner, 1978) 
Cells with a specific differentiated phenotype may not be 
equivalent in terms of positional identity.This fact was proven 
through several studies where skin taken from the anterior por-
tion of the same limb was grafted in strips, and the homotopic 
skin grafting led to regeneration. Heterotopic grafting, however, 
resulted in supernumerary body parts or regeneration failure. 
(Holder, 1981) Studies involving marked grafts provide direct 
evidence for the contribution of different tissues to limb tissue 
regrowth. Cells were proposed to possess the property of in-
tercalation, in which growth is specific to their position.When 
two cells which are typically non-adjacent come in contact due 
to causes such as an injury or grafting, the cells will begin to 
divide. Division begins to replace all intermediary cells, and will 
terminate once all positional disparities between the two cells 
are resolved.When there is more than one possible route, in-
tercalation will occur via the shortest path. (Bryant, Gardiner , 
1987) This model was tested by placing two typically non-adja-
cent cells within a limb in contact with each other. Both cells 
acted via the intercalation response predicted by the polar co-
ordinate model, proving these cells do indeed possess positional 
information. After the initial cells began pattern formation, the 
surrounding cells react secondarily to these cells, not necessari-
ly through intercalation. (Holder, 1981) While cells of the regen-
erating limb were proven to possess positional information, the 
specific tissue containing this information was unknown. It was 
known, however, that the blastemal cells are derived from the 
tissues adjacent to the wound epidermis. Experiments involved 
with repositioning of the epidermis relative to other tissues 
of the limb did not have any effect on formation of the limb, 
nor lead to supernumerary structures. Similar studies done on 
nerve sheaths and skeletal muscle had the same results, leading 
to the conclusion that the epidermis, nerve sheaths, and skele-
tal muscle are not directly related to limb pattering. However, 
when even small grafts of skin was reoriented in the stump it 
led to supernumerary structures. Two of the tissue layers of 
the skin are the dermis and the epidermis. Since the epidermis 
was proven not to possess positional information, the dermis 
was determined to be the tissue layer containing the cells re-
sponsible for patterning in limbs.The dermis consists of mainly 
pigment cells and fibroblasts , and since tissue regrowth can 
occur in limbs without pigmented cells, fibroblasts were deter-
mined to be the cells possessing the positional information. It is 
thought that these fibroblasts form the patterned template for 
the limb, and the endothelium, myoblasts, nerves, and other cells 
use this information secondarily to complete limb regeneration. 
(Bryant, Gardiner, 1987) The polar coordinate model helps ex-
plain the way cells interact before and during regeneration, as 
well as how a specific pattern in a regenerating limb is induced.
However, later experiments could not be explained fully with 
the polar coordinate model. For example, a supernumerary limb 
developed after an ipsilateral 90º rotation. (Maden,Turner, 1978) 
The second model, the Boundary model, states that pattern-
ing in secondary embryonic fields is triggered by the boundaries 
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of cells of different determination. This model proposes test-
able predictions of the handedness, or the specific asymmetry 
in relation to the central axes, of supernumeraries with ipsi-
lateral rotation. One prediction states that a supernumerary 
growing out of the anterior region of the host will possess the 
handedness of the host, while a supernumerary growing from 
the posterior side will have the opposite of the host. However, 
when the dorsoventral polarity of a supernumerary changes, 
(with normal anterior-posterior polarity) the posterior region 
will also have the handedness of the host. 
A comprehensive study on supernumerary limbs found that 
the predictions proposed by the boundary model were ac-
curate, with one exception. A single supernumerary growing 
from the posterior region of a host (possessing non-changing 
DV polarity) developed host handiness, instead of the oppo-
site handiness that was predicted. The opposite handedness 
proposed only occurs when a supernumerary is one of a pair. 
(Meinhardt,1983) The PCM and Boundary models together give 
an encompassing understanding of pattern formation occurs in 
regenerating limbs. 
Retinoic Acid 
Retinoic acid , also known as Tretinoin, is a lipophilic molecule
possessing the capability to regenerate tissues and entire limbs
of urodele amphibians. Retinoic acid (RA) is derived from Vitamin
A, and is synthesized in the cell through several enzymes. Once
formed, it functions to influence gene expression. RA binds to
one of the two classes of ligand activated nuclear transcription
factors, either the retinoid X receptors (RXR’s) or the retinoic
acid receptors (RARs).These receptors act as heterodimers on
upstream DNA sequences of RA responsive- genes. 
The effect of retinoic acid on regeneration varies based on con-
centration. In several clinical studies, transection done through
the radius and ulna of axolotls caused the radius, ulna, carpals,
and digits to regenerate. (Fig. 1,A) However, when a low dosage
of retinoids was applied to the amputation, an entire radius and
ulna regrew in tandem with the original. (Fig. 1, B) Raising the
dosage further led to regeneration of an extra elbow joint (Fig. 1,
C), and with a higher concentration still, the limb was completely
regenerated. (Fig. 1, D, E)  ( Maden, Hind, 2003) 
Additional regeneration effects were found in a study done 
on the common frog, Rana Temporaria.When treated with high 
concentrations of retinoids, not only did the complete foot re-
generate , (Fig. 1, F, G) but sets of limbs-including the bony pelvis, 
were regenerated as well. (Fig. 1, H) The first studies done show 
how retinoids, including retinoic acid, reduplicated the proxi-
modistal axis. Since the pairs of limbs were mirror images of 
each other, it is clear the dorsoventral and anteroposterior axes 
had been reduplicated as well. In addition to regenerating limbs 
from preexisting cells, RA can alter the course of lineage spe-
cific cells, and form different structures entirely. For example,
Figure 1 Treatment of an amputated limb with a high retinoid
concentration regenerated the complete limb, and in some cases even
pairs of limbs, from the amputation plane.  (Maden, Hind, 2003) 
the tail of a tadpole from the species Uperdon systoma and 
Rana temporaria can regenerate completely after amputation. 
(Fig. 1, I). However, treatment with RA led to the development 
of multiple hindlimbs, instead of the expected tail. (Fig. 1, J) In 
addition to retinoic acid’s direct relationship with regeneration 
in amphibian limbs, it has a strong effect on mammalian regener-
ation, which will be discussed later in this text. 
Mouse Digit Tip Regeneration: Mammalian Model 
Mice have the capability to regrow epidermis, nail, bone, and 
other structures of the digit. (Simkin, et. al., 2013) The process 
by which regeneration occurs for the murine digit is similar to 
the human response, and has become a primary resource for 
the study of human regenerative potential. 
The response in mice is dependent on the region of amputa-
tion. If a wound occurs at the outermost tip of the third pha-
lanx bone (P3) the wound will heal in a regenerative manner. 
However, if an amputation take place at the proximal region 
of the P3 bone, or the second phalanx bone (P2), the wound 




































    
   
 
 
guideline for understanding the different processes of scar for-
mation and epimorphic regeneration. 
Wound Healing 
The immediate response to an injury at the digit tip is similar for 
both the P2 and P3 bone regions. In the initial stage, inflamma-
tion, a blood clot is formed and the blood vessels dilate, allowing 
inflammatory cells, neutrophils, and other necessary molecules 
to pass to the wound site. Wound closing time ranges from a 
few hours to over a week, with fetal mice recovering the fastest. 
This wound healing process is distinctly longer than the wound 
healing process occurring for amphibians. In the second stage, 
histolysis, the divergence between the regenerative-competent 
and regenerative incompetent region becomes apparent. In the 
regenerative region, the breakdown of tissue from histolysis 
causes the bone to completely detach about one week post 
amputation.The detached bone will fall off due to the accumu-
lation of epidermal cells beneath it, thereby effectively sealing 
the wound.Amputations at the P2 and the proximal P3 regions 
undergo histolysis as well, but to a lesser extent and generally 
the digit remains attached. Unlike the P3 bone, in the regener-
ative-incompetent region collagen deposits between the tissue 
layers, inhibiting communication and ultimately leading to the 
development of a scar. (Quijano et. al., 2016) 
The developmental genes Msx1 and Msx2 are found in re-
generating digits and are believed to regulate the expression 
of bone morphogenetic proteins (BMPs). These proteins are 
necessary for cartilage and bone repair and have been identified 
as powerful proliferative molecules. Amputated digits treated 
with the BMP-inhibitor noggin did not only lose their ability to 
proliferate, but were unable to regenerate as well. (Manjong et. 
al., 2003) Several of these proteins including Bm7, Bmp2, Bmp4, 
and their receptors, Bmpr1a and Bmpr1 b, are expressed in spe-
cific regions of the phalanx and communicate via signaling.The 
regenerative failure seen at the proximal region of the P3 bone 
has been linked to an absence of BMP signaling.The bone stump 
of a control digit amputated at the proximal level elongated 
slightly but ultimately failed to regenerate. However, treating 
amputations at the proximal P3 region with one BMP bead led 
to a regenerative response. Specifically, signaling by BMP7 stim-
ulated the greatest elongation of the terminal phalangeal, and 
caused an overall skeletal elongation of 58%. Two weeks post 
injury a regenerated digit was integrated within the stump bone. 
While the bone formed is histologically distinct from the stump 
bone, the terminal phalanx is still successfully restored. 
A small hole connecting the marrow region with the dermis 
is formed at the ventrolateral area of the P3 bone when there is 
a severance at the more proximal region of the bone. However, 
digits regenerated from implanted BMP beads do not complete-
ly seal this hole. This can serve as a marker that amputation 
did occur at the proximal level and not from discrepancies of 
severance level. Introduction of one BMP bead caused entire 
tissues to regenerate at a typically non-regenerative region. 
This data indicates that the cells necessary for a regenerative 
response are present, it is the microenvironment which is re-
sponsible for regenerative failure. ( Yu et. al., 2010) 
Neural Requirement and the AEC 
Nerves play a key role in the regenerative process,and often rely 
on neurotrophic factors for their maintenance. Neurotrophic 
factors are biomolecules which encourage neural survival and 
growth, and have been found necessary for both immature and 
fully developed nerves. One of these biomolecules, the Nerve 
Growth Factor (NGF), discovered in the early 1950s, has 
proved particularly important in regeneration of the peripheral 
nervous system. Several experiments found that NGF-treated 
nerves were able to regrow damaged nerve cells that would 
have otherwise been lost. (Rich et. al., 1989) Once a blastema 
has reached the medium bud stage it no longer requires nerves 
for differentiation or morphogenesis, but remains nerve depen-
dent for proliferation. Nerves are also involved with transcrip-
tion; denervation led to a decrease in RNA production by over 
73%. (Stocum, 2017) 
The AEC plays an equally important role in regeneration. Scar 
tissue forms on an amputated limb of a urodele when the AEC 
is taken out multiple times.When the apical epithelial cap was 
removed from the distal portion of newt’s forelimbs, both DNA 
synthetic activity and overall mitotic index decreased, suggest-
ing the AEC plays a mitogenic role in the regenerating wound. 
(Globus, 1980)  
Nerves and the apical epithelial cap both play fundamental 
roles in regeneration, suggesting some relationship between the 
two. One hypothesis is that the nerves and AEC play separate 
yet synergistic roles in the cell cycle.This idea was formed from 
the study of labeled blastema cells within an amputation. If ei-
ther the nerves or wound epidermis were removed, the cells 
were apprehended in the second growth phase of the cell cycle, 
ultimately undergoing apoptosis or removal through macro-
phages. However, if the AEC was re-innervated, mitosis in the 
blastema increased as much as 10-fold. (Mescher et. al., 2000)
This mitotic increase only occurred if both nerves and wound 
epidermis were present. It is thought that the blastema cells 
are stimulated by a wound to enter the cell cycle, and nerves 
send mitogenic signals to the undifferentiated cells maintained 
by the AEC. (Stocum, 2017) Furthermore, the AEC is believed 
to contain all factors for the cell cycle, yet depends on nerves 
to express them. It was found that any neural requirements for 
regeneration are only acquired during late regenerative stages, 
and with aneurogenic limbs of urodeles, in which the neural 
tube was extracted during embryogenesis, there is no neural 
dependency developed at all. (Brockes, 1987) 
A final relationship between nerves and the AEC is that they 
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both possess the same mitogen, neuregulin 1 (NRG1). Studies 
show that transcripts of neuregulin 1 are expressed by over half 
of the blastema mesenchyme cells and by the basal cells of the 
AEC, while immunostaining techniques revealed the presence 
of neuregulin 1 in both peripheral limb nerves and dorsal root 
ganglia.Amputated innervated limbs treated with mubritinib, an 
inhibitor which prevents signaling by neuregulin 1, were unable 
to form the blastema.When 16-day innervated blastemas were 
treated with mubritinib it resulted in the formation of minia-
ture regenerates, identical to the regenerates observed when 
denervation of a blastema is postponed until a stable quantity 
of cells have formed.The nerves present were enough to stim-
ulate a partial regenerative response. However, the blastema is 
also stimulated when NRG1-soaked beads were placed 7 days 
post-amputation under the wound epithelium of denervated 
limbs. Implanting beads every four days starting from about 3 to 
5 weeks post-amputation allowed some regeneration, however 
not as much as limbs which were innervated. (Stocum, 2017) 
These studies indicate the blastema cells produce neuregulin 
1 independently of nerves, but in a quantity not great enough 
to initiate mitosis. Sensory and motors neurons act by inducing 
both the basal cells and the blastema cells of the apical epithelial 
cap to increase production of neuregulin 1 to levels required 
for mitosis.This finding also explains the previously mentioned 
10-fold increase of blastema cell production when the AEC is 
re-innervated.
 Blastema Formation 
The blastema formed during mouse digit tip regeneration has 
similarities to the blastema formed in the regenerating urodele. 
Beginning from 12 hours post amputation for fetal mice to 12 
days post amputation in the adult model, cells begin to aggregate 
at the outer portion of the amputation stump.The cells of the 
blastema stem from neighboring tissue, are avascular, and prolif-
erate at a significantly faster rate than cells in nonregenerating 
tissue. Studies show that the cells of the blastema are lineage 
restricted. It was found that mesodermal cells will form tissues 
of the dermis, blood vessels, tendons, and the mesenchyme of 
the digit, but will not participate in the formation of ectodermal 
cells such as the epidermis, sweat glands, and nail plate. Likewise, 
ectodermal cells were found to contribute solely to the forma-
tion of ectodermal tissue. (Quijano et. al., 2016) 
Similar to the urodele model, retinoic acid has regenerative 
effects on mammals as well. The most advanced clinical study 
to date was the use of retinoic acid to induce alveolar regen-
eration in rats and mice. RALDH1, an enzyme responsible for 
the synthesis of RA, is present in a specific spatial arrangement 
from postnatal day 1 (PND1) to PND4 in a manner correlat-
ing with the patterning of alveolar proliferation.This enzyme is 
expressed in alveolar parenchyma from PND4, where there is a 
sharp increase of cell proliferation.When an inhibitor was used 
to prevent RA production, air spaces began to develop, the di-
ameter of the alveoli increased, and their overall formation was 
delayed. RA receptors (RARs) and its isoforms were present 
in initial alveolar formation, with specific isoforms (RARγ) act-
ing as stimulants for alveolar development and others (RARβ) 
serving as negative regulators. Based on these findings it was 
hypothesized that RA is needed for the primary stages of alve-
olar development, and can stimulate a regenerative response. 
A study on the lungs of adult rats with induced alveolar loss 
proved this indeed was the case.Treatment of these lungs with 
retinoic acid restored all normal lung parameters within 12 days. 
A similar test on mice treated with RA from PND30 to PN42 
and then grown to PN90 showed complete regeneration of 
alveolar tissue. From this data, it was it was deduced that RA 
reactivates the gene pathways used during embryonic alveolar 
formation. ( Maden, Hind, 2003) 
Tissue Remodeling 
During the tissue regrowth process, the new tissues of the re-
generate are formed. The deposition of soft connective tissue 
also takes place during the scar forming process and therefore 
cannot be used as a definitive indicator for the beginning of 
regeneration. Regeneration of bone, however, is unique to the 
regenerative process and serves as an indication that regener-
ation has begun. 
Differentiation of regenerated bone begins at the area closest 
to the body and progresses outwards until the digit tip.As the 
digit tip lengthens, new bone is added through direct ossifica-
tion, forming woven or fibrous bone.The regenerated bone is 
porous, less dense, and therefore weaker than cortical bone. 
Furthermore, the woven bone will have a significantly larger 
volume than the original cortical bone, while still retaining a 
constant length. Eventually, the pores of the regenerated bone 
will shrink in size, and the density will increase, yet the regen-
erate will still remain histologically distinct.( Simkin et. al. 2015) 
While the microarchitecture of the original and regenerated 
digit may differ, many qualities of the original is retained. For 
example, in several studies the dorsal bend of the nail, the area 
the ventral fat was situated, and the tapering formation of the 
digit were restored. 
Human Regeneration 
Regular cell turnover and renewal occurs in many organs and
tissues of the human body, including the cells of the intestinal
epithelium, stomach, and epidermis. (Miguel et. al. 2017) While
complete regeneration of complex tissue is unusual, reports
of distal phalanx regeneration have been documented for both
children and adults. In one early case, an infected adult fingertip
was amputated and then treated with frequent dressing changes.
Three months later,X-ray imaging showed the fingertip had com-













   
 
 




















numerous clinical reports on fingertip regeneration, all sealed
with tight bandaging or direct suturing, which is thought to create
a microenvironment conducive to a regenerative response. 
Tissue Engineering and Regenerative Medicine 
The fields of tissue engineering and regenerative medicine are 
dedicated to finding methods to restore both the structure and 
functions of damaged organs and limbs. (Shieh, Cheng , 2015) 
There are two central strategies used to obtain this goal.The 
first is the use of cellular therapies, such as iPSCs and MSCs. For 
example, a recent study made the use of bone marrow-derived 
mesenchymal stem cells (MSC-CM) in attempt to regenerate 
bone. MSC-CM contains cytokines such as IGF-1, transforming 
growth factor (TGF-β1), and vascular endothelial growth fac-
tor, and was found to increase the development of new blood 
vessels and cell proliferation and mobilization. In a clinical study 
done to test the effectiveness and safety of these stem cells, a 
cavity in the mouth of patients requiring sinus floor elevation 
surgery or guided bone regeneration surgery was filled with 
MSC-CM. Six months post-surgery, new bone was present for 
all the participants. 
The typical method for repairing extensive bone damage 
is through a bone graft. Autogenous bone grafting is oste-
oinductive, osteoconductive, and osteogenic and is therefore 
considered the highest standard available when grafting bone. 
However, the procedure requires retrieving bone directly from 
the patient, and is painful, expensive, and associated with higher 
rates of morbidity. (Katagiri et al. 2016) MSC-M is currently 
undergoing more comprehensive clinical studies and may prove 
to be a better alternative. 
A second a major goal is to transition damaged tissue into a 
blastema in attempt to promote differentiation and regenera-
tion. Some tissues, including the epidermis, heart, and lung, do 
not require formation of a blastema to regenerate. However, 
their microenvironment controls the cellular response to a 
wound and can therefore also initiate differentiation. One 
method used to help regulate this microenvironment and fa-
cilitate regeneration is the creation of biologic and synthetic 
scaffolds. One such scaffold, called the ECM scaffold, is formed 
by decellularization of an organ or tissue, thereby creating a 
meshwork of proteins in tissue-specific structure.The scaffold’s 
composition will vary based on its source, since the ECM scaf-
fold is composed of the molecules released by the resident 
stem cells of an individual organ.This biologic scaffold serves as 
a biochemical signaling platform and a template for the regener-
ating tissue, and provides both a macro and microenvironment 
which promotes functional tissue repair.The environment and 
the processes that occur in the presence of an ECM scaffold are 
similar to that of a normally developing tissue but are typically 
absent in the default repair process of an injured tissue.Work 
is currently being done to regenerate the pancreas, kidneys, 
and the muscles of the heart, with the greatest amount of suc-
cess seen in regeneration of the bladder, skin, airway, and bone. 
(O’Brien, 2011) Studies on the effectiveness of engineered tis-
sues have been promising; however, some of the testing done 
for scaffolds efficacy were not standardized processes. (Moreno 
et. al., 2016) and there is a need for a greater amount of clinical 
research with more consistent testing methods. 
Conclusion 
The challenge of stimulating regeneration is to create an envi-
ronment which permits a regenerative rather than a fibrotic re-
sponse to a wound.The fact that BMP signaling induced regen-
eration of the proximal P3 bone in mice shows this endeavor is 
already a possibility.The regenerative pathways of the urodele 
limb and murine digit tip serve as a solid basis for achieving 
this goal in humans.While their regenerative pathways were not 
identical, both culminate in the formation of the blastema and 
to complete tissue renewal.A focus in the fields of regenerative 
medicine and tissue engineering is to create a microenviron-
ment that parallels the blastema, with the purpose of creating 
integrated multi-tissues for organ and limb formation.The use 
of synthetic and biologic scaffolds, as well as manipulation of 
stem cells already made significant steps in generating endog-
enous repair. Human regeneration once seemed an impossible 
goal, but current advancements and the regenerative success 
seen in human fingertips gives hope for regeneration of com-
plete organs and limbs in the future. 
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.Abstract 
Stem cell research is currently advancing in every area of medicine. New information about regenerating stem cells is being 
uncovered on a daily basis.An area of stem cells that has not been focused on until recently is the use of dental stem cells.The 
objective of this paper is to elucidate the most current research about dental stem cells. Much of what is discussed in this paper 
has not been implemented yet, and is still in clinical trials. Dental stem cells are important because they could be an alternative 
way of treating caries, performing root canals, and other traumas to teeth instead of the non-biomaterial currently used. Present 
research involving dental stem cells includes analyzing the differences between the five dental stem cells, testing out optimal in 
vitro conditions of dental stem cell proliferation, and implementing lasers in regeneration. 
Introduction 
For many people, the word dentist brings up memories of fear 
and pain. Although dentist visits may be traumatic for some 
people, they are quite necessary. However, there may be a way 
to help patients with dental caries and trauma to avoid this 
unpleasantness. By expanding modern technology through on-
going research, regeneration of teeth and neighboring tissue 
without drills, tools, and cement may very well be the next ad-
vancement in dentistry. 
The term ‘stem cell’ was first coined by Haeckel, a German bi-
ologist, in 1868. In 1908,Alexander Maksimov, a Russian histolo-
gist, suggested the existence of hematopoietic stem cells. Dental 
stem cells were not acknowledged until 1932, when Feldman, a 
stomatologist, was able to prove that dental pulp stem cells did 
grow under certain biological conditions. After this discovery, 
dentists were able to implement tooth therapy for dental pulp 
regeneration by using a dentine filling which stimulated pulp. In 
2000, Gronthos et el. discovered and isolated the first dental 
pulp stem cells (DPSCs) (Bansal, Jain, 2015). 
Stem cells are undifferentiated cells that can continuously re-
generate and differentiate into mature cells.Further research may
prove stem cells can be an alternative method of regeneration
and repair in lieu of traditional medical procedures (Park, et al.,
2016). There are two types of stem cells both based upon the
stage of growth in which they are isolated.The first type of stem
cells is embryonic stem cells (ESCs).These stem cells are totipo-
tent, capable of giving rise to an embryo or any cell type.They
are derived from the embryonic blastocyst. Embryonic stem cells
would be the preferred stem cells for regeneration because they
have the greatest differentiation ability, but there are ethical con-
cerns about destroying the blastocyst embryo to isolate the stem
cells. Therefore, ESC’s are no longer being used to regenerate
damaged tissues. The second type of stem cells are adult stem
cells, such as bone marrow stem cells.These adult stem cells do
not pose ethical questions because they are taken from postnatal,
matured tissue. However, they do have limited differentiation po-
tential compared with embryonic stem cells (Sunil, 2016). 
A big step in stem cell research was the discovery of induced 
pluripotent stem cells (iPSCs). Induced pluripotent stem cells 
are made by “recreating” cells by putting new genes that resem-
ble those genes of ESCs into iPSCs. Induced pluripotent stem 
cells are useful because scientists have reprogrammed them 
from their original somatic cell-like state into an embryonic-like 
state.The use of iPSCs eliminates the limitations that adult stem 
cells have, such as lifespan and differentiation, without causing 
any ethical problems. Also, while cells from other parts of the 
body may cause the body to reject adult stem cells,  iPSCs are 
not rejected because of their embryonic state. Induced pluripo-
tent cells look the same, have the same differentiation potential, 
and have the same formation as the cells they are programmed 
to become. Induced pluripotent cells can react with and be-
come neuron, pancreas, cardiac myocytes, and renal lineage cells 
(Yun-Jong, et al., 2016). 
Methods 
This document was written by researching peer reviewed schol-
arly articles and medical journals to assess the newest research 
and methods used in tooth regeneration.The research question 
was analyzed and reviewed from many different perspectives. 
Proquest, Ebsco, and Medline databases were accessed through 
Touro College Library online and Pubmed. Only research arti-
cles published within the last five years were referenced.
Discussion 
Studies in the differentiation of dental epithelial cells conclude 
that iPSCs can differentiate into oral- related cells for genera-
tive purposes. Induced pluripotent stem cell technology needs 
suitable cells for the implementation of genes. Dental pulp cells 
have been shown to be able to help with the reprogramming of 
iPSCs.An advantage that dental pulp stem cells have over other 
cells used in reprogramming is their efficiency, multipotency,
and accessibility (Yun-Jong, et al., 2016). During reprogramming, 
iPSCs are able to form colonies faster than mesenchymal stem 
cells and bone marrow stem cells (Sunil, 2016). However, iPSCs 
have recently been connected with tumor formation while adult 
stem cells have not been, so they may not be as beneficial in re-
generation as originally proposed. Nonetheless, no conclusions 
can be drawn yet as these matters are still undergoing investiga-
tion in clinical trials (Takebe, et al., 2017). 
Bone marrow is the most common tissue to retrieve adult 
stem cells from. However, the number of stem cells in bone 
marrow decreases with age, requiring an alternative place from 
which to recruit them (Newaskar, 2013).The use of dental stem 
cells may be the solution in response to the limitations bone 
marrow stem cells possess. Because dental stem cells are easily 
accessible and are often removed at some point in one’s life, 
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they make a good alternative ot bone marrow stem cells.These 
teeth contain dental pulp that have stem cells which have similar 
characteristics to bone marrow stem cells but the amount of 
cells do not decrease with age (Sunil, 2016). 
Dental-tissue-derived stem cells are used because they can
differentiate into other odontogenic cells.  Since their discovery,
dental stem cells have shown the ability to multi-differentiate into
specifically osteogenic, odontogenic, adipogenic, and neurogenic
cells.Although bone marrow cells do have the same differentia-
tion ability, differences have been noted between the dental cells
and bone marrow multipotent stem cells. It was found that dental
stem cells appear to be more prone to odontogenic development,
while stem cells derived from bone marrow are more prone to
osteogenic development, making dental stem cells a more viable
option for repair of dental trauma (Yun-Jong, et al., 2016). 
Recently, researchers have been encouraging people to save 
dental stem cells from extracted teeth, and store them in a cell 
bank in case a need for regeneration does arise (Newaskar, 
2013).When it comes to storing these cells in the US however, 
there are rules and regulations regarding isolation and storage. 
Dental pulp stem cells are separated into two categories. The 
first category produces products that are “minimally manipulat-
ed.” This means that the cells are used in a homologous man-
ner in clinical trials. The second category of DPSC, produces 
products that are used in a non-homologous way, significantly 
altering the biological functions of the cell by using certain en-
zymes. The FDA does not approve the use of many enzymes 
to extract cells. Therefore, cells are isolated using the explant 
culture, which is a technique that cultures cells from tissues 
or organs which will eventually migrate to the top of the dish 
which will then be isolated and stored (Ducret et el., 2015). 
Human stem cells are removed from either deciduous teeth 
or third molars. The tooth germ is put in sterile physiological 
saline and is placed in the lab within two hours of extraction. 
The success of the stem cells implantation is based upon time 
and temperature, so everything must be done accurately. The 
tooth is cleaned by washing with buffered saline (Dulbecco’s 
Phosphate Buffered Saline without Ca++ and Mg++). Povidine 
iodine and PBSA are used to disinfect the tooth. Once the 
tooth is disinfected, the pulp tissue is removed with forceps 
or a dental excavator.The tissue is digested and the cells that 
are distinct are isolated and filtered. The filtration allows for 
single cell suspensions (Bansal, 2015).The cells are placed onto 
growth plates, and tissue pieces are placed onto plates contain-
ing more growth medium.The stem cells are then incubated in 
a humidified atmosphere with carbon dioxide. These cells are 
left to incubate for ten to fifteen days. Cells are dissociated with 
trypsin, an enzyme that breaks down proteins so that the cells 
can stick to walls in which they are being held, and are incubat-
ed with antibodies such as CD34, CD35, CD73, CD90, CD105, 
CD133, CD166 for a total of 45 minutes.After 45 minutes, the 
cells are washed and placed with more conjugated antibodies 
(Newaskar, 2013). 
The stem cells from this medium can be preserved by cryo-
preservation which cools the cells or tissues at subzero tem-
peratures. This causes all biological activity to stop, but pulp 
death does not occur because that process is stopped as well 
due to the subzero temperature conditions (Newaskar, 2013). 
The best cells for cryopreservation are cells harvested near the 
end of log phase growth (Bansal, Jain, 2015).  Magnetic freezing 
is another method, which allows the cell to remain intact by 
forcing the temperature to drop below freezing point so that 
the cell does not have time to freeze and expand and therefore 
remains intact. Through this process, dental stem cells can be 
isolated and preserved until they are needed  (Newaskar, 2013). 
This cell banking process used is time consuming and costly. 
The cultures used also have the ability to get contaminated by 
microorganisms in the lab because they are left out for a while. 
It has been suggested to shorten cell processing before the 
cryopreservation step to avoid the time wasted and contam-
ination that may occur. Taking dental pulp and cryopreserving 
it without culture would be the quickest way to go about this 
process. However, the percent recovery of cells would be very 
low and only a small amount of healthy cells would be left in 
the tissue.This would occur because without sitting in culture, 
the cryopreservation agent wouldn’t infiltrate to the center of 
the tissue. Instead, letting the cells sit in culture (along with the 
cryopreservation agent) for 5 days allows the agent to infiltrate 
into the middle of the culture and around 90% of cells would 
be recovered.These cells would also able to be easily isolated 
because they would migrate toward the edges even after five 
days (Takebe, et al., 2017). 
Tooth-derived stem cells are named according to the part of 
the tooth from which they are isolated (Park, et al., 2016).There 
are five known types of tooth-derived stem cells: dental pulp 
stem cells (DPSC), periodontal ligament stem cells (PDLSC), 
stem cells from apical papilla (SCAPs), dental follicle progenitor 
cells (DFPC) and stem cells from human exfoliated deciduous 
teeth (SHEDS),.These stem cells come from the tooth but are 
slightly different depending on which place in the tooth they 
originate (Benavides, et al., 2018). 
Dental mesenchyme is also known as ‘ectomesenchyme’ be-
cause of its early interaction with neural crest. Dental tissues 
are specialized and are more restricted in their differentiation 
and do not undergo remodeling the same way that bone mar-
row tissue does. 
Dental pulp cells can easily differentiate into odontoblasts. 
Odontoblasts are cells that have neural crest origin. Dental pulp 
cells can be transported in vitro to help regenerate other cells 
in the mouth.As reported for bone marrow mesenchymal stem 
cells (BMMSC) the DPSC also have different morphology and 






















   
  



















cell growth and size can be observed. If DPSCs are placed on 
dentin, some of them will convert into odontoblasts. DPSCs, 
however, are not limited to oral-related issues. In vitro, they can 
multi-differentiate into adipose-like and neurogenic-like cells. 
They also have the potential to differentiate into osteogenic, 
myogenic, and chondrogenic cells.Their multipotency and rate 
at which they divide is greater than that of BMSCs.This makes 
them a better candidate for mineralized tissue regeneration 
(Yun-Jong, et al., 2016). 
The second type of dental stem cells, PDLSCs, are found in 
the periodontal ligament. The periodontal ligament is located 
between the tooth and alveolar bone (Lymperi, 2013). These 
cells have the ability to differentiate into osteoblasts, cemento-
blasts, adipocytes, and chondrocytes. Because of their location, 
they can be used for periodontal ligament and cementum tissue 
inside the mouth (Park, et al., 2016). 
After PDLSC’s are isolated, they display spindle shapes and 
have microtubule cytoskeleton. PDLSCs were analyzed in depth 
and were found to have 3235 proteins. The majority of pro-
teins were mainly part of the cellular metabolism network and 
showed high proliferation ability (Taraslia, 2018). 
The third type of cells, SCAPs, are located in the upper dental 
papilla.They are usually isolated from third molars and the apex 
of the tooth (Lymperi, 2013).They are also able to be isolated 
while the tooth is developing, when the tooth still has imma-
ture roots.These cells could produce dentin in vivo.The SCAPs 
survive pulp necrosis (pulp death) because they are close to 
the periapical tissue vasculature.This means that after an end-
odontic disinfection, SCAPs can still give rise to primary odon-
toblasts which would help in the completion of root formation 
(Bansal, Jain,2015). 
The fourth type of dental stem cell, DFPCs, are located in the
dental follicle surrounding tooth germ in early tooth formation.
In vitro, these cells have a fibroblast and plastic-like appearance. In
comparison to DPSC, DFPC had higher pluripotent reprogram-
ming factors and developmental factors.This allows DFPC to have
greater regeneration of pulp than DPSC.However,more research
still needs to be conducted to help assess which dental stem cells
are the best for oral regeneration (Karamzadeh, et al., 2017). 
The fifth type of dental stem cell, SHEDs, come from ex-
foliated teeth. It has a faster and higher growth rate and can 
differentiate into BMSCs and DPSCs  (Park, et al., 2016).They 
can also differentiate into a greater variety of cell types than 
DPSCs (Gabiec, et al., 2017). SHEDs have the same morphol-
ogy as PDLSCs, but are larger in size.There are 2032 proteins 
that were found in SHEDs, with the majority functioning during 
cell adhesion, motility, regulation of localization and migration 
(Taraslia, 2018). SHEDs can be good candidates for regeneration 
purposes and specifically for the enhancement of orofacial bone 
regeneration in which these characteristics are greatly required 
(Bansal, et al., 2015). 
The table below (Table 1) summarizes the different abilities 
of each dental cell in vivo and in vitro, along with bone marrow 
mesenchymal stem cells (BMMSC) for comparative measure. 
The main differences in DPSC and BMMSC are in their pro-
liferative ability and how they develop in vitro. Both are limited 
to dividing into other stem cells according to where they were 
in vivo. For example, the neurogenicity of dental stem cells is 
better than that of BMMSC because they come from the neural 
crest, while BMMSC does not (Yun-Jong, 2015). 





Neurogenic (Kim B, et al., 2012) 
Dentin pulp like complex 
Odontoblast-like cells 
Bone-like tissue (Lymperi, 




Neurogenic (Kim B, et al., 2012) 
Osteo-induction, and uniquely the ability 
to recruit bone forming cells and tissue 
formation (Gabiec, et al., 2017) 
Dentin pulp like tissue 
Odontoblast like cells 
No dentin pulp like 
formation 
Bone formation (Lymperi, 





Neurogenic (Kim B, et al., 2012) 
Dentin pulp like complex 
Odontoblast-like cells 




Neurogenic (Kim B, et al., 2012) 
Differentiate into cells 
that have the properties of 
cementoblasts, osteocytes, 












formation and osteoblast 






Neurogenic (Yun-Jong, 2015) 
BMMSC’s have both ectopic
and orthotopic tissue
formation. 
Bone and bone marrow
like, cartilage, muscle,
and neuronal cell tissue
formation (Yun-Jong, 2015) 
Table 1 
The above chart is of vital importance because in many re-
search centers, biological flipper teeth as well as implementing 
of a new tooth are trying to be successfully formed in vitro. So 
far the experiments have been able to be carried out in animals, 
but the formation of a tooth still needs much improvement 
(Gabiec, et al., 2017). 
Clinical Trials: 
The five dental stem cells have been discovered relatively re-
cently, and now further researchers can study alternative ways 
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to use them.All of the following studies are currently in clinical 
trials and have not yet been implemented in dental clinics and 
private practices. 
A study was done last year to determine if dentin repair could 
become biologically more enhanced if the formation of natural 
dentin could be stimulated by mobilizing the resident stem cells 
that are in the pulp of the tooth.The study was done in vitro 
and in vivo with the molars of mice. 
When one loses a tooth due to dental caries or other trau-
ma, the most commonly used treatment is placing cement in the
empty space.The cement which is usually made up of calcium or
silicon, never fully disintegrates. Due to this lack of regeneration,
the normal tooth mineral level will never be like it once was. In
general, when the soft dentin-like tissue gets exposed, a natu-
ral repair process starts to take place. Mesenchymal stem cells
that are already there move and differentiate into new odonto-
blast-like cells that create new dentin, called tertiary dentin.When
the dentin repairs itself, it creates a new, thin layer of dentin which
is then able to protect the pulp from the surroundings.The prob-
lem is that this only works for small injuries. Large injuries cannot
be fixed with reparative dentin (Neves, et al., 2017).
This restoration process takes place by the Wnt/B-catenin 
pathway.Wnt/B – cat (a signaling molecule) is an early response 
for stimulating cellular repair in all tissues. Axin-2, a repressor 
protein, inhibits Wnt/B pathway. Glycogen synthase kinase 3 
(GSK – 3), a component of the Wnt/B transduction pathway, 
phosphorylates B- catenin and axin, in the absence of the Wnt 
ligand/receptor binding.This leads to degradation and death of 
the protein (Neves, et al., 2017).Therefore when the tooth is still 
developing, and B- catenin is not working, the development of 
the tooth stops (Han, et al., 2014). In the presence of the ligands, 
GSK does not work.Because it does not function, the B- catenin 
does not get phosphorylated, but enters the nucleus, where it 
interacts with Lef,/ Tcf transcription factors. One of these tran-
scription factors is Runx2, which helps reform the tissue into 
odontoblastic formation (Han, et al., 2014).These transcription 
factors are able to regulate expression of target genes, including 
Axin -2.  Studies done showed that, following tooth damage, the 
number of receptors on Axin 2, and therefore Wnt/B signaling, 
is increased. It is theorized that if a Wnt signaling agonist were 
added to the stem cells, it may help the formation of reparative 
dentin. In this way, dentine can be restored following removal of 
a cavity (Neves, et al., 2017). 
Recently, a study was done with the use of Tideglusib, a small 
molecule that inhibits GSK3 and upregulates Wnt activity, which 
is currently in clinical trials for the treatment of neurological 
disorders.This could help with Alzheimer’s disease by upregulat-
ing Wnt activity (Boutajangout,Wisniewski, 2014). Other small 
molecules that inhibit GSK3 were also used in experimentation 
and upregulated WNT activity as well. In this study, three GSK3 
inhibitors – BIO, CHIR9902, and Tideglusib were used to arouse 
tertiary dentin formation after inducing with pulp exposure 
(Neves, et al., 2017). 
Mouse dental cells were incubated with the three inhibitors. 
The results showed that BIO induction of Axin 2 was much 
greater than CHIR99021 and Tideglusib levels. To protect the 
tooth, a glass piece was placed on top of the sponge in the 
enamel part because enamel does not regrow from these drugs, 
only the dentin part does.As part of this experiment, a sponge 
was soaked with these three inhibitors and placed into holes in 
mice molars. Sponges were left in the teeth (they were able to 
dissolve) and the teeth were analyzed at 4 and 6 weeks. Treated 
teeth and the controls were compared. 
It was discovered that mineralization did indeed, increase 
with all three agonists.When controls were analyzed, there was 
no obvious mineralization detected. Compared to controls con-
taining collagen sponge and MTA, more reparative dentin was 
formed with GSK-3 inhibitors and the newly formed odonto-
blast-like cells expressed high levels of axin -2. 
This method can be a very effective way of replacing fillings on
teeth.A great way of implanting this procedure would be by using
biomaterial, such as Kolspon (collagen sponge), which is soaked
in the GSK-3 inhibitors.Wnt agonists elevate Wnt activity which
is an immediate response to tooth damage. If Wnt is upregulated
with a sponge, mineralization happens much faster and complete-
ly finishes the tissue formation (Neves, et al., 2017).
Another ongoing study is testing for the optimal conditions in 
vitro for stem cell formation.The past few years have brought 
about much new insight into hypoxia-based response. Hypoxia 
is a deficiency in the amount of oxygen in a biotic environment.
Oxygen has been known for quite a few years to have a variety 
of effects on adult stem cells. Because of this knowledge, new 
regenerative ideas can be implemented to help enhance the use 
of stem cells in vitro, especially with the targeting of cellular 
oxygen sensors (Janji, et el., 2017). 
When stem cells are used in vitro, their differentiation fate 
is determined by transcription factors and cell cycle regulators 
such as Oct-4, Sox2, c-Myc, and downstream signaling pathways 
(Zhou, et al., 2014). It has been shown, although not yet imple-
mented, that low oxygen levels can activate Oct-4 to help main-
tain stem cell properties (Ratajczak, et al., 2016). Also, ongoing 
research has shown that hypoxia may induce the expression of 
hypoxia-inducible factor (HIF-1). HIF-1 regulates the expression 
of target genes that affect cell proliferation, differentiation, apop-
tosis, and embryonic development (Zhou, et al., 2014).Through 
HIF-1, angiogenin is able to work (Ratajczak, et al., 2016). 
Based on the effects of hypoxia transcription factors in other 
stem cells, an experiment was done to try and ascertain if hy-
poxia stimulates production of angiogenin in the pulp (Janji, et 
al., 2017). Angiogenin (ANG), a growth factor contained in tis-
sues, causes angiogenesis, the generation of new blood vessels. 

















































is a secreted protein that regulates cell proliferation and differ-
entiation in other cell models during angiogenesis. Angiogenin 
binds to endothelial and smooth muscle cells. This causes cell 
migration, invasion, proliferation of the endothelial cells. They 
can also cause tube like structures to form. Because of these 
abilities, angiogenin can be used in regenerative techniques. 
In vivo, small amounts of angiogenin are found relatively early 
on during hard and soft tissue regeneration.There are several 
pro-angiogenic factors, including vascular endothelial growth 
factor, fibroblast growth factor, and endothelial growth factor,
which stimulate the growth of angiogenin. The transcription 
factor HIF-1 helps induce angiogenin as well (Janji, et al., 2017). 
Angiogenin is found in other mesenchymal stem cells, such 
as those derived from the umbilical cord.This has been shown 
to help with the function and growth of the tissue which could 
help with infertility due to its ability to create blood vessels 
(Zhang, et al., 2017). 
The results obtained are relevant to preconditioning ap-
proaches for cell therapy and tissue engineering.The goal is to 
improve the pro-angiogenic capacity of transplanted cells (Janji, 
et al., 2017). In this experiment, human dental pulp cells (DPC) 
were extracted from third molars.Three different cultures were 
set up. First, a monolayer culture of DPC was collected and 
incubated overnight.Then, a spheroid culture of DPC was col-
lected and lastly, a tooth slice organ culture was used.All these 
samples were rendered hypoxic. The degree of hypoxia used 
was based on previous studies done with stem cells and hypoxia 
(Janji, et al., 2017). 
Angiogenin was increased in the monolayer culture of DPC 
when rendered with hypoxia. When angiogenin was first ex-
pressed in normoxic conditions, the increase of angiogenin did 
not reach significant levels at the mRNA level. However, at the 
protein level, angiogenin was increased after the hypoxia was 
added compared to the normoxic control. Inhibitor studies 
were also done with echinomycin, which inhibits HIF-1 function. 
Echinomycin is a peptide antibiotic that blocks the binding of 
HIF-1a (subunit of HIF-1). This study was done to help figure 
out the role of HIF-1 mechanism. mRNA production of angio-
genin was reduced in the presence of hypoxia and echinomycin. 
Protein production after hypoxia was implemented was also re-
duced in the presence of echinomycin. It was deduced from this 
data that under hypoxic conditions, HIF-1 activity is needed for 
the angiogenin to be increased on monolayer cultures of DPC. 
In order to make the sample more like the dental pulp matrix, 
in addition to the monolayer used, a spherical culture model 
(3D model) was also used.At the mRNA level, no significant in-
crease of angiogenin occurred.The same was found at the pro-
tein level. It was concluded that the effects of hypoxia and the 
hypoxia mimetic agents that were used did not have the same 
effect on 3D cultures as it did in the monolayer culture. Cells 
from the 3D model in different environments are possibly less 
sensitive to hypoxia than those of the monolayer.This would be 
due to the possibility that the cells which are deep within the 
3D sphere have already reached low levels of oxygen.The third 
culture of the tooth sliced organ culture model was then tested. 
Angiogenin was produced in the dental pulp before and even 
more so after hypoxia was added. 
Overall, when comparing the response at the mRNA levels 
compared to that of the protein level especially in the tooth 
slice model, angiogenin did in fact increase in response to hy-
poxia.The kinetics of angiogenin has yet to be determined be-
cause the amount of time left for the effect of hypoxia in other 
stem cells to take place was not consistent with the time frame 
of the oral stem cells (Janji, et al., 2017). 
The reason why this is a promising technique in the future 
of regenerative endodontics is targeting cellular oxygen sen-
sors with hypoxia did in fact increase pro-angiogenic activity. 
In conclusion, this current research is the first of its kind to 
apply hypoxia and hypoxia mimetic agents in creating a greater 
scope of angiogenin in dental pulp cells.This specific experiment 
concluded that although successful, the results depend on the 
in vitro model and the HIF-1a activity. Knowing how to mod-
ulate angiogenin in dental pulp stem cells is a stepping stone 
for future studies which will research the role of angiogenin in 
pulp regeneration.This study will also be very important for un-
derstanding cell therapy and tissue engineering in regenerative 
endodontics (Hong, et al., 2018). 
Table 2 contains a list of just some of the factors contained 
in dental stem cells that help with angiogenesis stimulation 
(Ratajczak, et al., 2016). Although not yet tested with hypoxia, 
if any of these are somehow stimulated, angiogenesis may very 
well be increased. 
The use of laser for stem cell regeneration is also being re-
searched. Studies previously conducted have shown that lasers 
can help in the differentiation of stem cells.The lasers used in 
these studies were high powered lasers and the effects of low 
power laser (LPL) were never fully studied in dental stem cells. 
LPL had previously been used for therapy to help osteoarthritis, 
inflammation, and soft tissue injuries.When DPSCs were placed 
in vitro, the light from LPL (810 nm light- infrared light) did not 
enhance the growth of DPSC.  However, when LPL was used to 
treat a culture for 21 days under optimal conditions, dentino-
genesis did occur. 
The success of LPL depends on both the biological conditions 
and the way in which it is applied.There are two ways to apply 
the laser.The first method uses the laser in a continuous motion 
and the second way is applying it in pulsed waves. Pulsed waves 
were shown to be more efficient due to the time in between 
pulses that allowed the light to penetrate. 
Non-ionizing LPL does not affect the stem cells directly but 
affects the growth factors that regenerate the teeth. The light 
from the laser hits water, gets excited, absorbs the energy, and 
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Factor Function Population 




activation of smooth 
muscle cells 
indirect degradation of 
basement membrane. 
Angiopoietin -1(ANGPT1) Endothelial survival, 
migration, and matrix 
adhesion. 
DPSCs, SCAPs, and 
FSCs. 
endothelial sprouting and 
vessel stabilization 
Angiopoietin-2 (ANGPT2) Endothelial proliferation, PDLSC 
migration, and sprouting 
in the presence of VEGF 





DPSC, SCAP, SHED, 
and PDLSCs 
induction of proteolytic 
enzyme release 






of proteolytic enzyme 
release 
CXC chemokines, for Endothelial survival, DPSCs 
example, interleukin-8 proliferation, migration, 
(IL-8) and tube formation. 
Induction of MMP 
production 
Hepatocye growth factor 
(HGF) 
Endothelial proliferation, 
migration, and tube 
formation, proliferation 
of vascular smooth 
SCAP, SHED 
muscle cells. stimulation 
of VEGF and PIGF 
Insulin-like growth factor-1 
(IGF-1) 
Endothelial proliferation, 
migration and tube 
formation. stimulation of 
PDLSC 










stimulation of VEGF 
expression 
proliferation of vascular 




transfers energy to dissolved oxygen. This results in the for-
mation of a mild amount of radical oxygen species (ROS). ROS 
then activate TGFB-1 which cause dentiogenic differentiation. 
The low levels of ROS are around when the cell is still a stem 
cell but when ROS is present in mild amounts it helps with 
differentiation, proliferation, and migration of the stem cells 
(Hong, et al., 2018). 
All the methods mentioned in this paper have not yet been
used aside from trials in the laboratory. Last year, a study was
done to assess the awareness of dental pulp cells to those whom
it matters most, the dental professionals. Around one hundred
eighty-nine dental professionals were involved in this study and
over 90% of them had heard of dental stem cells. Only 81% were
aware of the use of dental stem cells through the internet or
journals. Some, however, were aware due to their undergraduate
training. (This would probably be referring to the younger gen-
eration). Not everyone knew about banking dental stem cells,
and the prospective uses that dentists may be able to apply to
improve the restoration of teeth.Those who knew about dental
stem cells thought that the main obstacles with implementing
dental stem cells were the costs as well as lack of full knowledge
about the procedures (most are still in clinical trials). Further
awareness can be created by introducing seminars and lectures
discussing this topic (Chitroda, et al., 2017). 
Conclusions 
Dental stem cells are definitely the future in dentistry. There 
are so many experiments being done that may very well change 
the future in how a yearly trip to the dentist may look like. 
Researchers are optimistic about tooth regeneration and re-
generation of other traumas in the mouth using stem cells. 
However, before regeneration using dental stem cells becomes 
reality, trials need to be conducted on humans. As of 2018, 
many trials have only successfully been experimented on ani-
mals (Benavides, et al., 2018). Although there may still be a long 
way to go, dental stem cells are becoming more and more of 
a reality and may very well be our children’s only association 
with cavities. 
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Abstract 
Capsaicin is the active compound responsible for the pungency of hot chilli. Research has discovered its ability to desensitize periph-
eral nociceptive fibers which is useful in treating chronic pain disorders, specifically neuropathic pain syndromes. Capsaicin treatment
comes in a variety of mediums including patches and creams and has been clinically proven to bring relief to patients with disorders
such as post herpetic neuralgia, chronic regional pain syndrome and HIV related neuralgia. Exciting new forms of treatment are also
in development and promise breakthroughs in the near future in this relatively young field of capsaicin-based analgesia.
Introduction 
Chronic pain syndromes are debilitating, robbing many of their 
quality of life and productivity while putting them at additional 
risk of mental health disorders. Many do not find relief despite 
extensive treatments.This has prompted research into finding 
a compound that will present a viable alternative to traditional 
analgesics, especially opiates which carry an additional risk of 
addiction. Capsaicin, the compound responsible for the pungen-
cy of the capsicum family and an example of a vanilloid, has 
been used as an analgesic agent for thousands of years. Recent 
research has proven just how well suited it is as a treatment for 
a subset of chronic pain disorders especially neuropathic pain. 
This paper will look at the mechanisms of nociception that 
are targeted by this treatment, the properties of capsaicin and 
its receptor,TRPV1, that make it so effective. Its clinical applica-
tions and limitations will also be examined to give a glimpse of 
what research has discovered and where it is taking us. 
Mechanisms of Subcutaneous Primary Nociception 
Nociception is the sensation of noxious stimuli perceived by no-
ciceptive receptors which are usually found in the skin (Caterina 
& Julius, 2001), although they can also be found viscerally. It is 
the first step toward the sensation of pain which is the result 
of a complicated multilayered process including central gating 
controls and peripheral activity (Hunt, 2009). Nociception itself 
is a complex process with aspects that take place in both the 
central (CNS) and peripheral nervous systems (PNS). 
There are two general categories of subcutaneous nociceptive 
primary afferent neurons, myelinated A-fibers and unmyelinated 
C-fibers. Not all A-fibers are sensitive to nociceptive stimuli,Aβ
fibers are large rapidly conducting fibers responsible for touch 
and proprioception, and only Aδ fibers which are smaller and 
slower conductors are involved in nociception (Khalid & Tubbs, 
2017). Lightly-myelinated Aδ fibers are associated with acute 
pain or first pain which is characterized by lancinating, stabbing,
or pricking pain that is felt immediately after exposure a nox-
ious stimulus. Unmyelinated C-fibers are very slow conductors 
and are responsible for second pain which is characterized by 
the more global sensations of throbbing, burning or cramping 
pain (Hunt, 2009; Dubin & Patapoutian, 2010). 
Noxious stimuli are usually categorized as either heat (H), cold
(C), or mechanical (M). Primary nociceptive afferent fibers are fur-
ther classified according to the type of stimuli that they respond to,
for example C-MH,A- MH.The most common C fibers are poly-
modal, meaning they respond to multiple types of stimulation such
as C-MC,C-MH and C-MHC.There is also a subgroup of C-fibers
known as silent C-MiHi that only become sensitive to noxious me-
chanical or thermal stimuli after he area has become sensitized by
inflammation. Most A-fibers are heat- or mechano- sensitive (A-H,
A-M,A-HM) (Dubin & Patapoutian, 2010). 
Nociceptors have a variety of voltage gated channels that en-
code the intensity of the stimulus (Dubin & Patapoutian, 2010). 
They also release neuropeptides that transmit input further up 
the neural axis. For example, when C-fibers are triggered they 
release glutamate and substance P (Hanpaa & Treede, 2012). 
When the skin is injured it undergoes physiological changes
that protect it from further damage and promote healing, known
as inflammation. There are two subgroups of C-fibers. One of
them expresses the trkA receptor which binds to nerve growth
factor (NGF) and synthesizes neuropeptides such as CGRP
and substance P. When they are triggered they contribute to
inflammation and healing at the site of the injury (Hunt, 2009).
Symptoms of the inflammatory state include flare or reddening of
the immediate area and increased sensitivity to both innocuous
and noxious stimul,i both in the immediate and surrounding area.
The increased sensitivity is due to a reduced threshold of exci-
tation in the C-fibers (Dubin & Patapoutian, 2010) and increased
receptor expression and excitation (Lebovitz, et al., 2012). 
There is a second subgroup of C-fibers that do not have a role 
in inflammation, instead they display the Ret receptor that binds 
to GDNF and express PAP that breaks down ATP to produce 
adenosine that, in turn, binds to the A1 receptor and reduces 
nociception. In fact, intrathecal application of GDNF has been 
shown to reduce neuropathic pain symptoms (Hunt, 2009). 
C-fibers that are constantly in a state of excitation, such as 
those in a chronic pain state, will release a constant flow of glu-
tamate known as a glutamate barrage.This barrage may result 
in physiological changes to the dorsal root ganglion and higher 
pain areas of the brain that increases their sensitivity and excit-
ability which is known as central sensitization. Descending con-
trols may also have an impact on determining the sensitization 
of dorsal root neurons (Hunt, 2009). Central sensitization may 
also impact the sensitivity of A-fiber neurons, which don’t usual-
ly become sensitized, causing even innocuous stimuli to register 
as painful (Baron, 2006). This may be a result of synapses that 
they form with neurons that have been sensitized by C-fiber 
barrage (Hunt, 2009). 
Peripheral sensitization may also occur post-injury as a result of
physiological changes which may contribute to the development











































The role that C-fibers and Aδ- fibers play in the process of 
nociception is definitely an important one which makes them a 
worthwhile target in the field of analgesia.These afferent neu-
rons share a receptor TRPV1 which is expressed on all C-fibers 
and a subset of Aδ fibers (Hunt, 2009; (Lebovitz, et al., 2012),
this means that if it can be shut off of blocked then peripheral 
nociceptive input can be greatly minimized or even neutralized. 
Targeting TRPV1 is especially prized because it allows a two-
pronged strategy against pain. Not only does targeting it , target 
the beginning of the pain pathway (Trevisani & Szallasi, 2011; 
Wagner, Roth-Daniek, Sell, England, & Kern, 2012), but it also 
blocks the glutamate barrage which allows the body to break 
the pain cycle common in chronic pain patients. 
TRPV1 
In 1990, the study of a more potent capsaicin analog, resinifer-
atoxin (RTX), led to the discovery of a new receptor known as
TRPV1. It’s name comes from the amino acid sequence that des-
ignates it’s membership in a family of receptors first identified in
fruit flies. In 1969 a mutation was identified on a visual receptor
of a fruit fly, instead of a sustained depolarizing after exposure
to light, these mutated receptors showed only transient depo-
larizing response to light, giving the family of receptors the name
transient receptor potential or TRP.The second part of its name,
V1, comes from the amino acid sequence that was identified that
marked it as a vanilloid receptor (Caterina & Julius, 2001). The
amino acid strain was first designated VR1 but when it was joined
to the receptor family it was abbreviated to TRPV1. 
The discovery of TRPV1 led to the discovery of a subset 
of thermal-sensitive TRP-type receptors which are also called 
thermoTRPs (Trevisani & Szallasi, 2011). Other members of 
this family include TRPV2, TRPV3 and TRPV4. TRPV1 is highly 
expressed on normal nociceptive C-fibers and Aδ-fibers and 
after inflammation show increased upregulation and sensitivity 
(Lebovitz, et al., 2012). It is part of the nociceptive pathway and 
is activated by a variety of stimuli including protons, noxious 
heat, phorbol esters, fatty acids as well as vanilloids like cap-
saicin and RTX.The receptor only experiences maximum acti-
vation when activated by multiple types of stimuli (Vyklicky, et 
al., 2008), which is consistent with the polymodal nature of the 
C-fibers that are involved in nociception.
TRPV1 has been proved to be involved in many forms of 
pathophysiology including inflammatory bowel syndrome (IBS),
osteoarthritis, rheumatoid arthritis, post herpetic neuralgia 
(PHN) and cystitis amongst others (Andreev, et al., 2013).This 
makes understanding this receptor necessary for the treatment 
of many different disorders. 
There are two ways that TRPV1 can be targeted pharmaco-
logically, either it can be desensitized by vanilloids or blocked 
by antagonists.There are two types of desensitization, acute de-
sensitization and tachyphylaxis, which is a reduction in response 
to noxious stimuli as a result of repeated application (Vyklicky, 
et al., 2008).There is also a difference between high dosage and 
low dosage desensitization such as between the short-term 
refractory period that takes place after any application of a 
vanilloid and longer lasting defunctionalization that takes place 
after the administration of a high dosage application (Finch & 
Drummond, 2015) (Trevisani & Szallasi, 2011). 
Multiple biomechanisms have been discovered by researchers 
to have a role in the process of sensitization and desensitiza-
tion of the TRPV1 receptor including the phosphorylation and 
dephosphorylation of the receptor (Trevisani & Szallasi, 2011), 
although the process isn’t fully understood.The dramatic influx 
of Ca2+ ions in the primary afferent neurons that takes place 
during vanilloid applications have also proved to be a part of 
the long-term desensitization mechanism (Vyklicky, et al., 2008). 
Vanilloid induced messenger plasticity, which refers to changes 
in the expression of neuropeptides on the receptor such as 
a decrease of the proinflammatory neuropeptide SP and the 
increase of analgesic peptide galanin, and is also part of the long-
term desensitization or ‘defunctionalization’ associated with the 
application of high dosage capsaicin. 
Antagonists that block the TRPV1 receptor are a popular ave-
nue of research, but many promising leads often lead to disaster. 
These compounds often induce spontaneous hypothermia in 
humans making them impractical for use. However, there have 
been promising breakthroughs by a group in Russia with a com-
pound that only partially blocked the receptor which shows 
that partial blockage of the receptor may be a better outcome 
than a full blockage (Andreev, et al., 2013). This is backed up 
by research that has shown that partial binding is enough to 
activate the TRPV1 receptor and that there are multiple levels 
of activation based on the state of binding of the receptor (Hui, 
Liu, & Qin, 2003). 
There used to be a theory that the main function of TRPV1 
is thermoregulation.This was based on its role in thermal sensi-
tivity and the hypothermic effect of capsaicin and TRPV1 antag-
onists, but this was later mostly debunked (Trevisani & Szallasi, 
2011). Other studies have also shown that the gene deletion 
of TRPV1 in mice still allowed for a level of noxious thermal 
sensitization (Dubin & Patapoutian, 2010). 
TRPV1 is the therapeutic focus of a common analgesic and 
other drugs on the market. Paracetamol or acetaminophen is 
thought to interact with TRPV1 as part of its analgesic mecha-
nism.Also drugs such as Taramidol which is used to treat fibro-
myalgia and nefopam, a benzoxazocine analgesic, also interact 
with TRPV1.There are also compounds in Eastern medicine that 
may target TRPV1 (Trevisani & Szallasi, 2011). 
Capsaicin 
Capsaicin, or 8-methyl-N-vanillyl-noneamid, is the compound 























   
  















2011) which are of the genus capsicum (Finch & Drummond, 
2015).Any ingestion of hot chili will cause a painful burning sen-
sation. However, perhaps ironically, capsaicin has been proved 
to have extensive analgesic qualities. It is also a potential neu-
rotoxin and large doses can cause permanent nerve damage 
(Trevisani & Szallasi, 2011). 
For thousands of years capsaicin extracts were used as part 
of native medicine as a primitive analgesic.Aztec physicians may 
have used it to treat tooth ache and sources show that RTX, 
which is derived from the latex of the palm Euphoria Resinifera, 
may have been used in Ancient Rome to treat the arthritis of 
the Emperor Augustus. In Northern India a native plant contain-
ing capsaicin called bhut jolokial has been used by the people 
who live there to treat arthritis (Finch & Drummond, 2015). 
Modern pharmacy, however, was late to discover its qualities 
and did not recognize it’s potential until the year1878 (Trevisani 
& Szallasi, 2011). 
The Hungarian chemist Endre Hӧgyes is credited with the 
discovery of the effect of capsaicin on sensory fibers but his 
find remained lost until the turbulent years and scientific inno-
vation of World War Two.Another Hungarian chemist, Nicholas 
(Miklόs) Jancsό further developed the use of capsaicin by devel-
oping its potential as a promising analgesic. In the 1970’s capsa-
icin research exploded, with the number of papers on record 
jumping exponentially. Capsaicin continues to be of a topic of 
interest for the general scientific community and continues to 
be extensively researched until today (Trevisani & Szallasi, 2011). 
Originally the analgesic properties of capsaicin were though 
to come from its counterirritant and warming properties 
(Hanpaa & Treede, 2012) but now we know that there are many 
mechanisms involved (Vyklicky, et al., 2008). It is a TRPV1 agonist 
(Factor, et al., 2011) and it is the complex interaction between 
TRPV1 and capsaicin that is the crux of its analgesic abilities. 
Initial exposure to capsaicin activates the TRPV1 ligand gated 
channels on the primary afferent nociceptive neurons which 
cause depolarization, the initiation of an action potential and 
transmission of a pain signal to the spinal cord (Backonja, et 
al., 2008).This is followed by a lasting refractory period know 
as desensitization (Factor, et al., 2011) and if the dose is high 
enough it generates a longer lasting local desensitization which 
is also known as defunctionalization (Finch & Drummond, 2015). 
In high dose applications when TRPV1 is activated, high lev-
els of calcium enter the cell overwhelming the mitochondria 
and causing apoptosis.The nociceptive nerve fibers in the area 
where the capsaicin is administered begin to die which prevents 
the initiation of new nociceptive input, causing a defunctional-
ization of the nociceptive ability in that area.) After the applica-
tion of a high dose capsaicin patch for one week there was an 
80% decrease in the density of epidermal nerve fibers (ENFs).
However, if the dosage is not too high the damage is reversible, 
which was corroborated by the study. Partial regeneration was 
present twelve weeks after the treatment and complete re-
generation at twenty-four weeks (Wallace & Pappagallo, 2011). 
This is consistent with the pain relief that patients who use high 
dosage capsaicin treatment experience,often pain relief lasts for 
up to three months per application (Finch & Drummond, 2015). 
This is one of the reasons that capsaicin is so well suited to 
treating chronic pain, especially neuropathic pain. Long lasting, 
comprehensive relief without daily drug use is very attractive 
for chronic pain sufferers.Also, the ability of capsaicin to tempo-
rarily destroy nociceptive nerve endings provides a way to cut 
off nociceptive input, the glutamate barrage to the spinal cord. 
This allows the spinal cord and higher pain areas to minimize or 
perhaps extinguish the effects of central sensitization or ‘wind-
up,’ which is the hyperactivity of neurons in the spinal cord and 
brain, due to neuroplasticity that makes them extra sensitive to 
pain input. Central sensitization is characteristic of neuropathic 
pain and extremely hard to treat. Doctors who have been using 
the high dose capsaicin patch have reported anecdotally a re-
duction in the symptoms of windup in their patients (Wagner, 
Roth-Daniek, Sell, England, & Kern, 2012). 
Medications 
There are many forms of capsaicin based pharmacological treat-
ments. Initially, low dose, topical creams were the form of choice,
but studies found them to have a disappointing effect. In a compre-
hensive study they were found, at best, to have a moderate effect
and many subjects reported poor or no effect (Trevisani & Szallasi,
2011).The creams come in two different strengths 0.075% under
the name Zostrix® (Finch & Drummond, 2015) and 0.025% with
lidocaine under the name Axain® (Trevisani & Szallasi, 2011). 
The most popular form of capsaicin-based treatment is the 
Quetenza® 8% patch. The dosage of the patch is significantly 
higher than the creams which allows the treatment to enable 
long-term desensitization within the treatment area.The patch 
promises relief for up to three months (Wallace & Pappagallo, 
2011) which is consistent with capsaicin mediated nerve fiber 
death.. This means that the patch only needs to be reapplied 
every three months, which greatly increases patient compliance. 
The potential for capsaicin to cause irreversible nerve dam-
age may make physicians wary of using the high potency patch. 
However, a study shows that the recommended dosage of up 
to four patches per application (Wallace & Pappagallo, 2011) 
is within estimated dietary consumption of cultures that con-
sume a diet heavy in capsaicin such as Mexico,Thailand and India 
(Hanpaa & Treede, 2012). 
The patch has shown to be effective for a variety of syn-
dromes and can be cut to size so that it can be applied almost 
anywhere on the body. Capsaicin’s unique mechanism of analge-
sia means that it has no known drug interactions which allows 
it to be incorporated into a treatment plan that includes other 

















































Other forms of capsaicin include an injectable form that can 
be used to treat osteoarthritis, tendonitis and some forms of 
neuropathic pain.There is also an intranasal form that has been 
clinically proven to be effective in the treatment of migraines 
(Trevisani & Szallasi, 2011). 
Clinical Applications 
Capsaicin treatment has been adapted for the treatment of many
disorders.The most obvious of these are pain related including
PHN, stump pain, headaches, trigeminal neuralgia and osteoarthri-
tis amongst others (Wagner, Roth-Daniek, Sell, England, & Kern,
2012). Interestingly, capsaicin has also been used for the treat-
ment of urinary incontinence as well (Trevisani & Szallasi, 2011). 
The treatment of PHN by capsaicin has been the focus of many
studies into the efficacy of capsaicin- based analgesia. PHN is one
of the most common forms of neuropathic pain after chronic
back pain and painful diabetic neuropathy (Wallace & Pappagallo,
2011). PHN is a chronic pain disorder that develops the varicella
zoster (shingles) virus comes out of dormancy.The treatment op-
tions of PHN are limited and often poorly tolerated which makes
the disorder very hard to treat (Backonja, et al., 2008). However,
multiple studies that have investigated the outcome of using a
capsaicin patch have seen favorable results with minimal side ef-
fects and marked relief experienced by the patient (Backonja, et
al., 2008; Wallace & Pappagallo, 2011). Some patients with HIV
associated neuropathy have also reported relief from capsaicin
patch treatments (Capsaicin dermal patch: a guide to its use in
non-diabetic peripheral neuropathic pain, 2011). 
A tertiary hospital studied the results of their hospital-wide 
adoption of capsaicin patches to treat non-diabetic patients 
with a variety of neuropathic pains.These included PHN, CRPS-I, 
knee arthroplasty related pain, painful scaring, femoral cutane-
ous neuropathy, HIV related neuropathy and neuroma. They 
found a 23% reduction of pain in a population of twenty patients 
that had been treated with the patches.They also noted that six 
of the patients had not found relief with any other treatment 
that they had tried so far.They also found that patients that had 
a higher basal quality of life experienced a better response to 
the drug (Gimenez-Mila, et al., 2014). 
A novel way that capsaicin is being used is to facilitate rehabil-
itation for knee arthroplasty patients. Often pain following knee
arthroplasty surgery can impede recovery and rehabilitation,
leading to prolonged hospital stays and a more painful, prolonged
recovery. Capsaicin has been introduced as a novel way to dull
the pain through temporary desensitization of the local area for
the duration of the initial recovery.This allows the patient to pro-
ceed with exercises and activities that will improve their function
and help them get back on their feet quicker. It was expected that
patients may report increased post-operative pain because the
capsaicin had been applied, but pain scores were found to be well
within range (Hartrick, Pestan, Carlson, & Hartrick, 2011). 
Trials of capsaicin being used as ‘molecular scalpels’ for the 
treatment of cancer-related neuropathic pain are showing 
promising signs (Trevisani & Szallasi, 2011). The principle be-
hind this method of treatment is that physicians can use the 
neurotoxic ability of capsaicin to target very specific cells to 
treat chronic, intractable pain that cancer patients experience. 
The treatment carries obvious risks which is probably why the 
clinical applications that are being pursued right now are very 
limited, but the potential of this technique is very exciting. 
Drawbacks 
Although capsaicin is an exciting new frontier in analgesia it has 
some risks and limitations that must be addressed. Exposure of 
the mucosa of the throat to capsaicin can cause coughing and 
bronchoconstriction. However, bronchoconstriction from such 
a scenario is very rare and even coughing had a very low inci-
dence rate during the clinical trials (Wallace & Pappagallo, 2011). 
Capsaicin can only be applied to a local area. In high doses 
that would be needed to give systemic relief it can cause a drop 
in body temperature and may be cardiotoxic (Lebovitz, et al., 
2012). The hypothermic effect of capsaicin is posited to be a 
result of the defunctionalization of the TRPV1 receptor. This 
warps the thermosensitivity of the preoptic heat sensors and 
fools the animal into thinking that they are warm. This is re-
flected in the animal’s loss of ability to regulate their own body 
temperature (Trevisani & Szallasi, 2011). 
Researchers have also found a correlation between a diet high 
in spicy food and an elevated risk of cancer. However, further 
research needs to be done to see if this is applicable to all forms 
of capsaicin exposure or just ingestion of capsaicin. Capsaicin 
is poorly metabolized by the skin (Wallace & Pappagallo, 2011) 
so topical application may not carry the same risk of ingestion. 
The patch system, despite having many advantages, has the 
drawback of needing a minimal infrastructure and attending 
medical personnel to a be able to incorporate them into a treat-
ment plan (Gimenez-Mila, et al., 2014).Also, they often require 
the administration of a local topical anesthetic such as Lidocaine 
before application due to the sensation of painful burning that 
is experienced during the hour long application time (Wagner, 
Roth-Daniek, Sell, England, & Kern, 2012). 
The disadvantage of the creams is that they require multiple, 
daily applications which greatly decreases patient compliance. It 
may also induce a painful burning sensation that will discourage 
its application and hasn’t even been proven to be an effective 
analgesic because of its low dosage (Backonja, et al., 2008). 
Conclusions 
The ingenuity that is being employed to find pathology and tech-
niques suited to capsaicin treatment is astounding and there is 
no doubt that the scientific community will continue to come 








      
























    
 
to treat other pathologies. However, there is a need for the 
development of a standardized schedule of treatment for using 
capsaicin in a clinical setting (Factor, et al., 2011). 
A better understanding of the biology of neuropathic pain 
would also be an advantage for the development of capsa-
icin-based pharmacology. If the mechanisms of pain disorders 
were better understood, treatments could be targeted to di-
rectly counteract them in a technique similar to the molecular 
scalpel being used for cancer-related neuropathic pain. 
Perhaps capsaicin could also be adapted for the treatment of 
phantom limb pain (PLP).The source of PLP is a combination of 
sensitization and inflammation that takes place in both the cen-
tral and peripheral nervous systems. Perhaps the desensitizing 
ability of capsaicin could be effective in this scenario by reducing 
peripheral sensitization and central nervous system input. 
Capsaicin is a novel pharmacological agent that promises an 
alternative to traditional analgesics and opioids in the treatment 
of neuropathic pain and other pain syndromes. Research into 
capsaicin is fairly recent but clinical data has yielded favorable 
results and new research seems hopeful of making new break-
throughs in techniques and applications of capsaicin in medicine. 
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Abstract 
Since 1978 when the first “petri dish” baby was born, In-Vitro Fertilization (IVF) has been used as a tool to give couples struggling 
with infertility the opportunity to have children. Using this method of Assisted Reproductive Technology (ART), the woman is given 
medication to stimulate her ovaries for the maturation of multiple eggs, which are then retrieved via needle aspiration, fertilized 
in a petri dish, and inserted in the uterus with the hopes of achieving a successful pregnancy. Many times IVF is completed with 
another technique known as Intracytoplasmic Sperm Injection (ICSI), where the sperm is injected straight into the egg increasing 
the chance of fertilization. In 2002, researchers discovered a clear association between an increased risk for birth defects with 
the use of In-Vitro Fertilization and Intracytoplasmic Sperm Injection. Since then, multiple studies were conducted to determine 
whether it is instigated by a mechanism of IVF itself, or influenced by the infertility problems of the couple (Hansen et al., 2002).
There are various reasonable explanations for the findings of the surfeit occurrence of birth defects in pregnancies with use of 
IVF or ICSI. Firstly, the advanced age of couples undergoing infertility treatments could be the basis for the underlying increase in 
birth defects. Maternal factors such as obesity, metabolic disease, and chronic health issues are independent factors proven to 
increase the risk for birth defects as well (Davies MJ et al., 2012). Factors associated with the treatment such as, freezing and 
thawing of embryos, exposure of oocytes or embryos to a culture medium, or ICSI gamete manipulation, could also contribute
Additional explanations point to the medications given to induce follicular numbers, or to speed the maturation of follicles into 
oocytes (Hansen et al., 2002). This paper reviews numerous studies that have been done to resolve the question at hand. 
Introduction
Infertility 
Intervention with medical assistance is required for one in ten 
couples who have difficulty conceiving naturally. Conception is 
a complex process that requires many factors to be working in 
synchrony to develop into a successful pregnancy.The problem 
can be attributed to female or male components.After one year 
without conceiving, couples are referred to a specialist to deter-
mine the root of the infertility.When the woman is over the age 
of 35, they are advised to seek medical advice after six months 
without conceiving.The most common causes of female infertil-
ity are irregular ovulation, obstructed fallopian tubes or, congen-
ital anomalies of the uterus. Male infertility is most often caused 
by azoospermia, when no sperm is produced, or oligospermia, 
too few sperm.When faced with any of these factors,Assisted 
Reproductive Technology may be required. 
In-Vitro Fertilization Process 
The first step in the process of IVF is to produce ovarian hy-
perstimulation by giving medications to stimulate egg production.
Injections of gonadotropins are given daily until multiple follicles
develop into optimal size. Next, Human Chorionic Gonadotropin
(HCG) is administered to speed the maturation of the follicles
into oocytes. The eggs are then retrieved via needle aspiration
using transvaginal ultrasonography and stored in a special culture
medium until insemination. In a case with normal sperm, 50,000
to 100,000 motile sperm/ml are transferred into the petri dish
with the mature eggs. When quality of the sperm is abnormal,
such as poor motility or morphology, intracytoplasmic sperm in-
jection (ICSI) is used to fertilize the egg. During ICSI, an embryol-
ogist uses a micro needle to inject one single sperm directly into
the egg cytoplasm. After insemination, the embryo or embryos
are placed in a catheter and injected into the endometrium in
hopes of implanting onto the uterine wall (Wdowiak et. al. 2016).
Cultured embryos often have difficulty exiting from the zona
pellucida membrane. Artificial disruption using laser perforation
may be required to aid in the process and increase the chance of
implantation (Zakharchenko et al., 2015).
Methods 
The research discussed in this paper was compiled from var-
ious published articles taken from Touro’s database, including, 
Proquest Science, EBSCO, PubMed, and Google Scholar. All 
articles are original scientific papers that were analyzed and 
explored to obtain accurate data. 
Discussion
IVF & Birth Defects 
Researchers wondered whether the process of Assisted 
Reproductive Technologies, specifically IVF, can affect the risk of 
congenital birth defects, or developmental delays. Investigators 
used data from The Reproductive Technology Register in 
Western Australia, to analyze pregnancies between the years 
1993 to1997, that were a product of IVF or ICSI.They surveyed 
all pregnancies that reached 20 weeks and were terminated 
because of fetal abnormalities. The Western Australian Birth 
Defects Registry listed all of the birth defects in pregnancies 
in Western Australia, from natural pregnancies and pregnancies 
that required the use of ART.With the data from these two in-
stitutions, researchers examined all pregnancies that were ter-
minated, stillborn,or live births during these years, to determine 
whether birth defects were more common in infants conceived 
with use of IVF or ICSI. The presence of major birth defects 
diagnosed until the age of one year was examined. 
There were a total of 168 out of 4000 infants conceived nat-
urally, 75 out of 837 conceived via IVF, and 26 out of 301 from 
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ICSI, that were diagnosed with birth defects before the age of 
one year. The authors reported that the risk of birth defects 
was twofold in pregnancies that required Assisted Reproductive 
Technology. The results remained significant when only single-
ton births and full term births were taken into consideration. 
Other studies attribute the increase in risk of birth defects to 
the multiple births and preterm births that often are associated 
with use of ART.This research restricted the analysis to single-
ton and full term births so the results would not be explained 
by these factors. The overall risks remained the same when 
factors such as, maternal age and parity, sex of the infant, and 
association of siblings with birth defects, were taken into con-
sideration. Furthermore, when analyzing the prevalence of birth 
defects in terminated pregnancies, the results remained similar 
to the original analyses.The prevalence of birth defects in ter-
minated pregnancies was 4.5% in natural conception, 9.4% with 
use of IVF, and 8.6% in the ICSI category (Hansen et al., 2002). 
After use of IVF the most commonly seen birth defects were 
cardiovascular, musculoskeletal, urogenital, gastrointestinal ab-
normalities and cerebral palsy.Also seen was an increased risk 
for multiple birth defects in singleton births specifically in the 
areas of cardiovascular defects, musculoskeletal, urogenital and 
cerebral palsy. The risk of respiratory disorders increased in 
cases of multiple births brought about by IVF. No association 
of increased risk in trisomy’s, such as Down’s, Edward’s and 
Turner’s was found (Davies et al., 2012). 
Parental Factors 
Factors related to maternal and paternal age and health were 
examined to find reliable information on the association of birth 
defects and parental issues.A study was done examining the oc-
currence of birth defects diagnosed before age five and includ-
ing pregnancies that were terminated at any gestational age.The 
risks of birth defects were compared in pregnancies that were 
spontaneous versus assisted conception. Additional data was 
analyzed in women who reported infertility but eventually be-
came pregnant without the use of ART.With this information it 
can be determined whether infertility is the major factor in the 
cause of birth defects or if the technology is to blame.A total of 
308,974 births was used for analysis.The risk of birth defects in-
creased significantly in pregnancies of women who experienced 
a history of infertility but were not treated with ART, versus 
spontaneous pregnancies without history of infertility.This indi-
cates that the association of birth defects may be attributed to 
the patients’ medical factors rather than the IVF. On the other 
hand, some patients use treatments such as clomiphene citrate 
which is given outside the clinic and data on who used this med-
ication is not available for analyses. Clomiphene citrate is used 
for women experiencing anovulatory infertility to stimulate an 
increase in estrogen, a hormone that supports the growth of 
oocytes.This treatment could be the sole reason for increase 
in birth defects without use of IVF treatments, and may explain 
why women with a history of infertility had children with birth 
defects more commonly (Davies et al., 2012). Another study 
was done examining the mental health of children born to infer-
tile women who conceived spontaneously.The study indicated 
that there was a significantly higher increase in mental disorders 
such as schizophrenia, mood disorders, and psychological devel-
opment compared to children born to women without fertility 
problems (Svahn et al., 2015). 
Another study was done to examine the degree at which 
maternal health issues were related to the increase in birth 
defects after IVF and ICSI. The South Australian Birth Defects 
Register contained all of the data on maternal medical condi-
tions following various fertility treatments.The maternal factors 
that were considered were maternal age at delivery, parity, BMI, 
smoking habits, hypertension, diabetes, asthma, epilepsy, and 
gestational conditions such as, pre-eclampsia, impaired glucose 
tolerance, gestational diabetes, anemia, and UTI occurrences. 
With regard to health conditions, only smoking and obesity 
were linked to an increase in the risk for birth defects over the 
general population risk.With regard to ICSI, parity, anemia, and 
UTI occurrence, were also associated with an increase in birth 
defects.Additionally, the report indicated that the women with 
the greatest risk for an increase in birth defects with use of IVF 
were aged 29 and younger compared to fertile women of their 
age.The study suggests that the uterine environment of younger 
women is more likely to be able to sustain an embryo with birth 
defects or, the implantation success in older women is limited 
which helps to prevent developmentally compromised embryos 
from implanting.Women aged 40 and older were at a lesser risk 
for an increase in birth defects compared to fertile women of 
their age. A possible explanation may be the influence of the 
gonadotropins that may protect oocyte development (Davies 
MJ et al., 2012). 
Paternal factors also add to the increased risk for birth de-
fects with use of ART.According to one study, children born to 
fathers over the age of 40 are at an increased risk for childhood 
fatality due to congenital abnormalities and malignancies.When 
paternal age increased to over 45, the childhood fatality rate 
increased from 1.24% to 1.65% compared to fathers aged 30 
to 34 (Urhoj et al., 2014). When the sperm of infertile men 
was analyzed under light microscopy, it was noticed that there 
was an excess of DNA damaged sperm. DNA damage limits the 
ability of apoptosis to occur. Typically, apoptosis removes the 
damaged sperm but with IVF, fertilization can take place with 
damaged sperm that would have been excluded in natural con-
ception.This increases the risk for miscarriage and birth defects 
(Lewis & Kumar, 2015). Additionally, men with reproductive is-
sues often require the use of ICSI because of the poor motility 
and morphology of their sperm. ICSI can be problematic when 

















































   
could damage the chromosome spindle formation in the oocyte 
(Winston & Handyside, 1993). 
Multiple studies imply that the increase in birth defects or 
mental disorders with use of IVF is likely associated with pa-
rental factors. One study pointed to alternative treatments that 
may be used in addition to IVF. Overall, parental issues play a 
large role in the increase in birth defects with use of ART, al-
though there are other factors that are likely associated as well. 
Cryopreservation 
Cryopreservation involves preservation of an embryo or oo-
cyte in liquid nitrogen after cooling the sample in a cryopro-
tectant to -30 degrees Celsius (Winston & Handyside, 1993). 
The two methods for cryopreservation are slow freezing and 
vitrification. Currently, vitrification is the preferred method as it 
instantly solidifies the samples preventing the formation of ice 
crystals causing less damage to the oocytes or embryos. Slow 
freezing involves the use of a less toxic concentration of cryo-
protectants however, the limited ability to prevent ice crystals is 
thought to increase the risk for abnormalities. 
There are severe problems involved in oocyte cryopreserva-
tion which is a common practice used for women approaching
advanced maternal age. First, oocytes are temperature sensitive
due to the high content of cytoplasmic liquid and, the arrange-
ment of the chromosomes in the sensitive spindle formation.
Disruptions during the freezing and thawing process lead to a
threefold increase in aneuploidy when spindle formation is dis-
turbed. The risk of polyploidy also increases, as frozen oocytes
are more vulnerable to polyspermic fertilization when the corti-
cal granules are unevenly distributed (Jiminez- Trigos et al., 2012).
Caution must be taken with these results because most studies
are done on mice and the effect of chromosomal segregation is
different between species. Additionally, cryopreservation of oo-
cytes reduces successful fertilization by inducing changes in the
zona pellucida specifically, zona hardening, and, producing chang-
es on the sperm receptors of the zona (Winston & Handyside,
1993). Data on the results of cryopreserved oocytes is limited
as the number of births resulting from this technique is small.
Further results on the health status of children born afterwards
is not yet available, however reports do not indicate an increase
in birth defects or developmental delays (Schattman, 2015). Some
reports reveal that oocytes that developed in vitro have a de-
creased live births and pregnancy rates. 
By analyzing the effect of vitrification on the oocyte, it can be 
determined if this technique causes adverse effects to oocyte 
functionality. The mitochondrial function of vitrified oocytes 
was observed by analyzing the condition of ATP synthase in the 
oocytes. ATP synthase in Metaphase II stage was analyzed by 
looking at the ratio of FAD to NAD(P)H. If the ratio is abnor-
mally elevated, it insinuates a decrease in the ATP synthase func-
tion of the oocytes which results in abnormal spindle formation. 
Additionally, the stage at which the oocytes are vitrified effects 
the outcomes.Vitirification can be performed at the Metaphase 
II stage which contains sensitive spindle formation,or the germi-
nal vesical stage, before the spindle is formed.The germinal vesi-
cle stage has to go through maturation after thawing which may 
also effect the value of the oocyte.  Live births have been seen 
from vitrification at both of these stages and it is not yet known 
which has a better success rate (Gao et al., 2017). Ultimately, the 
ideal method for freezing oocytes is not yet known, and it has 
been shown to increase the risk for aneuploidy or polyploidy, 
and decrease risk for fertilization. However, cryopreservation 
of oocytes is an opportunity for women who wish to preserve 
eggs for future use because of medical or age related issues. It 
is currently the only option to preserve fertility for women un-
dergoing treatments such as radiation or chemotherapy which 
may affect their ability to conceive. 
The transfer of frozen embryos has been used more fre-
quently in the past few decades as it has shown several advan-
tages. Multiple studies show that using frozen-embryo transfers 
increases the rate of live births compared to fresh-embryo 
transfers. Most reports point to the non-stimulated menstrual 
cycle that is associated with frozen transfers.When fresh-em-
bryos are transferred, the artificial hormone induced menstrual 
cycle adversely effects the endometrial receptivity leading to 
implantation failure (Aflatoonian et al., 2016). Studies have been 
done to determine differences noted between fresh-embryo 
and frozen-embryo transfers.A study of, 1508 infertile women 
diagnosed with Polycystic Ovarian Syndrome and were under-
going their first IVF treatment, were randomized in two groups.
They received either fresh-embryo or frozen-embryo transfers. 
The women were all between the ages 20 to 34 and were in a 
healthy weight range.All patients went through the standard IVF 
procedure and subsequently a transfer of up to 2, day-3 embry-
os. The frequency of live births was considerably higher after 
the frozen-embryo transfers.The rates showed a 49.3% versus 
42% difference. It was proposed that when frozen-embryos are 
transferred, it allows time for the reproductive system to re-
cover from the induced ovulation by hormones. The exposed 
endometrial lining has time to shed, increasing the chance that 
the embryo will implant. The results may not be pertinent to 
the overall population undergoing IVF since these subjects were 
PCOS patients.Another study was done to assess whether in-
fertile women without Polycystic Ovarian Syndrome who were 
undergoing IVF showed the same results.The same method was 
used and in this case, the transfer of frozen embryos did not 
increase the chances for a higher live birth rate. Reasons for 
the different results may be due to the method of cryopreser-
vation or the timing of the freezing (Vuong et al., 2018). In both 
studies no increase in the risk for congenital malformations was 
noticed (Zi-Jiang et al., 2016). Other studies note, that when 
comparing the risk of birth defects in the fresh-embryo and 
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frozen-embryo cycles, there was a significant increase in the 
risk of birth defects for the former. Plausible justifications may 
be related to the cryopreservation that would eliminate the 
developmentally compromised embryos, because they would be 
less likely to survive the freezing and thawing process.Additional 
explanations that would eliminate the inferior embryos would 
be the separation of the embryo from hormonal stimulation 
drugs (Davies et al., 2012). 
Various researchers have attempted to observe the effects of
the cryopreservation process and the health status of the re-
sulting children. Most studies were done involving results from
single-center analyses. A multi-center study between the period
of 1995 to 2013 was done to analyze the miscarriage rates, birth
weight, pregnancy complications and congenital malformations
in IVF centers worldwide. It was determined that the subopti-
mal results were more likely caused by parental factors such as
advanced age, concurrent metabolic, genetic and epigenetic al-
terations, which affects the health of gametes (Keshishian, 2014).
After much research into the matter, the consensus appears to
be that there is an increase in live birth rates after the use of
frozen-embryo transfers although the reason is still unknown. It is
most likely from the natural exclusion of unfit embryos during the
freezing process, or the separation of the embryo from hormonal
drugs giving the uterus time to readjust for the implantation pro-
cess.The presence of birth defects does not seem be affected by
the freezing process and is more likely associated with parental
issues.This interpretation is consistent with the majority of stud-
ies done to analyze the effects of embryo cryopreservation.
Although cryopreservation of embryos is associated with an
increase of pregnancy rates and a decrease in preterm labor, it is
important to determine that there are no long term unforeseen
consequences with regard to this technique. National registries in
Denmark were used to examine the intellectual abilities of chil-
dren aged 15 to 16 born from cryopreserved embryos. A stan-
dardized test was given to all children ages 15 to 16 and overall
test scores were evaluated. No apparent difference in the test
scores between children conceived via IVF, fresh or frozen, and
natural conception, was noticed. The study was limited as they
did not observe the children that did not enter the school system
due to intellectual disabilities (Spangmose et al., 2019) 
Culture Medium 
Fertilization normally takes place in a protected well-controlled 
setting in the oviduct. During IVF, the male and female gametes 
are brought together in a medium that is intended to provide 
conditions for the sperm to go through the process of capac-
itation and produce acrosome reactions, in order for sperm 
penetration, fertilization, and cleavage to occur (Bavister, 1981). 
Studies done on mouse embryos show that different conditions 
in the culture can lead to changes in gene expression. Good 
quality human day 4 cryopreserved embryos were donated to 
observe the effect of culture media on transcription.The embry-
os were randomly selected to be cultured in one of two media 
(HTF or G5) and one of two oxygen levels.The two media used 
were Human Tubal Fluid mixed with glucose and phosphate, and 
the second, a more enriched version of the medium contain-
ing additives such as additional amino acids (G5).The two HTF 
cultures and two G5 cultures contained either 5% or 20% ox-
ygen levels.The embryos were also classified for maternal age 
and developmental stage at the time of transfer.After culturing, 
89 embryos were transferred to PCR and further analyzed. 
Microarray data analysis was used to observe any correlation 
between differentially expressed genes (DEG’s), the upregula-
tion or downregulation of genes, and whether they were caused 
by different culture conditions, or whether biological factors 
such as maternal age and developmental stage played a larger 
role. The number of differentially expressed genes was signifi-
cantly higher with regard to biological factors when comparing 
it with the differentially expressed genes from different culture 
conditions. Notwithstanding the conviction that maternal age 
only effects oocytes, this data indicates that maternal age and 
developmental stage has a much greater effect on transcription. 
Although the correlation between transcription errors and cul-
ture conditions was minimal, it was noted that human embryos 
developed best in the G5 5% oxygen level culture medium. G5 
medium caused an upregulation in genes involved in regulation 
of phosphorylation and mitosis, and the lower oxygen level 
led to an upregulation of genes involved in cell morphogenesis 
which aids in embryo development (Mantikou et al., 2016). 
Intravaginal culture (IVC), also known as INVO, is an ART 
technique where oocytes and early embryos are cultured in a 
gas permeable air-free plastic device placed in the vaginal cavity 
for incubation.The advantages are that INVO mimics the envi-
ronment of the uterus and excludes of use of a culture medium 
to sustain the fertilization and early growth of the embryo. IVF 
involves the use of a culture medium which influences embryo 
quality with changes in oxygen and carbon dioxide concentra-
tions, and,PH or temperature changes. If any of these factors be-
come unproportional, embryo fragmentation can occur.Oxygen 
in the uterine cavity is less than 5%. The INVO device is able 
to offer an environment similar in that way.The almost anaer-
obic oxygen concentration level guarantees a safe atmosphere 
for the energetic metabolism required for successful gamete 
viability, fertilization and embryo development. Carbon dioxide 
is another important factor involved in embryo development 
as it directly effects PH levels (Lucena et al., 2012).The INVO 
device is absorbent to gas in the uterus and allows for a bal-
anced equilibrium of CO2 to uphold the PH level of 7.2 to 7.4 
(Garcia-Ferreyra et al., 2015). On the other hand, in traditional 
IVF, the concentration of carbon dioxide can be altered when 
the large gas-filled incubators are opened. This effects the PH 































   
 
  






























embryo quality. A study was done to assess the outcomes of 
INVO and compare the pregnancy results to common existing 
IVF techniques (Lucena et al., 2012). Embryos were cultured in 
the INVO device and then transferred to the uterus on day 3 or 
day 5 after fertilization.The implantation rates, pregnancy rates, 
and miscarriage rates were considered.The results showed that 
the INVO-ICSI procedure had similar outcomes to the tradi-
tional IVF-ICSI procedure. Pregnancies were evaluated 14 days 
after embryo transfer by measuring hCG-beta subunits in the 
blood, and ultrasounds were utilized to reveal gestational sacs, 
and heartbeats 21 to 28 days after the transfer. INVO-ICSI was 
concluded to be alternative option for couples struggling with 
infertility, with advantages in cost effectiveness, and psycholog-
ical benefits, allowing a more direct involvement in fertilization 
which was shown to reduce stress levels in patients (Garcia-
Ferreyra et al., 2015). 
Another study was done to assess the effect of culture con-
ditions on Imprinting Disorders. Syndromes, such as, Angelman
Syndrome, Beckwith- Wiedmann Syndrome, and Silver-Russel
Syndrome, were found to be more prevalent after IVF.These syn-
dromes are referred to as genomic imprinting disorders and are
an epigenetic phenomenon that restricts the expression of one
parental allele leading to activation of only one copy of a chromo-
some. Imprinting genes are controlled by the Imprinting Control
Region (ICR) where abnormal cytosine methylation occurs on
various genes causing them to deactivate.A study was done that
observed the methylation levels of ART produced human em-
bryos at day 3 of cleavage and the blastocyst stage.The specific
ICRs analyzed were KCNQ1OT1, SNRPN, and H19, which are
the ICR regions where most maternal methylation occurs in the
syndromes studied. In the Beckwith-Wiedmann Syndrome chil-
dren conceived with ART, there were 90% observed methylation
errors at KCNQ1OT1 as compared with 50% in the general pop-
ulation of cases with Beckwith-Wiedmann Syndrome. SNRPN
methylations occurred in 46% of the Angelman Syndrome ART
children versus 5% in the general population.The ART children
with Silver-Russel Syndrome were observed to have 92% of the
H19 hypomethylations while only 40% of the general population
had these defects (White et al., 2015). Some researchers ponder
whether the prolonged exposure to a culture medium plays a role
in development of these imprinting methylation errors (Davies et
al., 2012). Day 3 embryos as well as blastocyst embryos were
studied to determine if time spent in the media culture relates to
an increase in methylation errors. It was noted that 76% of the
day 3 embryos, and 50% of the blastocysts, exhibited defects in
imprinting methylations (White et al., 2015).This report demon-
strated that the extent of time spent in the culture does not pose
a greater risk for the imprinting errors to occur. Multiple studies
show that media culture does not significantly affect the outcome
of IVF, and therefore does not play a role in the increased risk for
birth defects.
The absence of natural reproductive fluids in early embryonic 
development has shown to influence the outcomes of gene ex-
pression in the embryo.Downregulation of embryonic nutrition-
al elements and upregulation of apoptosis factors in the oviduct, 
have been seen with the absence of seminal fluid (Bromfeild et 
al., 2014) In mice studies, seminal fluid has been shown to influ-
ence fetal development by inducing immune responses from the 
female reproductive tract.The production of T-regulatory cells 
which act as a protection to the embryo is activated by sem-
inal fluid. T-regulatory cells are programmed to recognize the 
male antigens present and to suppress inflammation that would 
normally occur with an unidentified antigen.This aids in the ad-
aptation of the uterus required for implantation and placental 
development. Mice studies have shown that with the absence 
of seminal fluid, fetal development, phenotype, and metabolic 
function are altered (Schjenken & Robertson, 2015). Follicular 
fluids have also been shown to influence embryo development.
A study was done to detect methylation levels in pig blastocysts 
to show differences between fluids present in IVF and natural 
embryos.Whole-genome DNA sequencing was performed for 
methylation analysis.The addition of reproductive fluids into the 
culture for IVF produced embryos of higher quality that were 
similar to embryos produced in vivo.The methylation patterns 
were closer to the methylation of naturally produced embryos. 
Additionally, fewer irregularities in genes involved in imprint-
ing, development, and reprogramming, were noticed in the IVF 
culture that included reproductive fluids (Canovas et al., 2017).
Globally it has been proven through multiple studies that the 
culture medium does not play a role in the increased risk for 
birth defects. Reports on the amount of time spent in the cul-
ture and the culture conditions were analyzed and no increase 
in congenital anomalies was seen. There is a slight association 
between improved gene expression and addition of natural re-
productive fluids to the culture.
Alternative Treatments 
For couples who are having difficulty with conception, espe-
cially at advanced maternal age, the ideal approach is uncertain. 
Infertile couples have a 2 to 12% chance per year of becoming 
pregnant spontaneously.Alternative treatments include but are 
not limited to intrauterine insemination and ovulation induc-
tion. These treatments are less costly than IVF however the 
success rates are well below those of IVF. During intrauterine 
insemination, semen is condensed in a laboratory and then in-
jected past the cervix into the uterus (Van Vorhis & Bradley, 
2007). Ovulation induction involves use of Clomiphene Citrate 
to stimulate follicles and hence egg growth. Clomiphene citrate 
works to increase estrogen levels which then signals the an-
terior pituitary gland to release Luteinizing Hormone which 
stimulates ovulation. Ovulation induction is most often used in 
women with Polycystic Ovarian Syndrome which is the most 
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common cause of anovulatory infertility. Multiple studies found 
links between use of ovulation induction medications and an 
increase in birth defects such as neural tube and cardiac defects. 
This was reportedly due to the fact that these medications are 
given to PCOS patients who often struggle with obesity (Balen 
& Rutherford, 2007). One study suggests an association be-
tween use of clomiphene citrate and craniosynostosis (Reefhuis 
et al., 2003). This is likely due to the multiple births that are 
expected with ovulation induction. Multiples are at increased 
risk for mortality and long term consequences such as congen-
ital anomalies and developmental delays (Corchia et al., 1996). 
The use of prefertilization and preimplantation genetic di-
agnoses combined with IVF significantly increases the rates of
successful pregnancies.With advanced maternal age, egg quality
is reduced resulting from abnormalities in the spindle formation
of the chromosomes. Eggs enter prophase 1 in the first meiotic
division during the fetal period, and remain in that phase until
ovulation. When meiosis resumes many years later, the spindle
formation can be disturbed, leading to a failure to fertilize, abnor-
mal embryo development, and fetal loss (Van Vorhis & Bradley,
2007). Genetic diagnosis of oocytes, also known as polar body
analyses, is useful to differentiate between mutations in genetic
material of the oocyte. Each polar body contains complemen-
tary genetic material to the oocyte.This can reveal any genetic
alterations of the oocyte which would then be excluded from
use in IVF.The procedure incorporates, laser microdissection of
the zona pellucida with a UV-A laser, and extraction of the polar
body with a micropipette (Clement-Sengewald et al., 2000).After
genetically normal oocytes are recognized by polar body analy-
ses, they are fertilized and cultured until either day 3 embryos
or blastocyst stage when they can then be transferred into the
uterus. Polar body analyses are only useful to detect problems
with maternal genes. Therefore, another technique known as
preimplantation genetic diagnosis in commonly used to select
embryos for transfer using genetic analysis that is performed on
cells biopsied from embryos.The procedure normally does not
affect embryo development because the cells at this stage are
totipotent.The practice allows for a choice of embryos that are
unaffected by the heritable condition or chromosomal mutations
prior to pregnancy and thus avoiding termination of pregnancy
(SenGupta & Delhanty, 2012).
Conclusion 
Multiple studies show a clear association between the use of 
IVF and an increase in birth defects. The research discussed 
above was done to determine whether certain techniques in-
volved in IVF are related to the risk. In multiple studies, cryo-
preservation of oocytes and embryos was not seen to increase 
the risk for birth defects or intellectual disabilities. It was noted 
however, to increase the live birth rate. The various culture 
conditions were examined and they were noted to have slightly 
different effects on transcription but no overall effect on the 
risk for birth defects. Many reports are limited due to the eth-
ical and practical difficulties that are involved while studying 
topics such as human embryonic development. Birth defects 
are rare and thus the observational results were done on small 
sample sizes. Larger studies are required to give a definite an-
swer to the underlying cause of the association. A number of 
studies indicated that the infertility problems of the couples 
undergoing IVF are a likely answer for the increase in congenital 
anomalies. ICSI has also been thought to increase birth defects 
because of the increase in chromosomal abnormalities in men 
with low sperm counts. There is an association between IVF 
and Imprinting Disorders, however the underlying cause is 
not known.The generally older age of patients undergoing IVF 
adds to the plausible complications such as implantation fail-
ure, miscarriage, congenital anomalies, and fetal death. Some of 
these problems can be addressed with Preimplantation Genetic 
Screening (PGS) which screens for embryos with chromosomal 
abnormalities or Preimplantation Genetic Diagnosis (PGD) to 
search for a specific genetic disease.Overall, the comprehensive 
data related to children born from IVF shows that majority are 
not born with birth defects. The risk is greatly reduced when 
IVF is used together with PGD and PGS. Couples considering 
IVF should discuss genetic testing options with their doctor to 
determine if this service is appropriate for their situation. 
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Abstract 
Despite all the available therapies,Acute Lymphoblastic Leukemia (ALL) remains extremely difficult to eradicate. Current available 
therapies, which include chemotherapy, radiation, and stem cell transplants, tend to be more successful in treating children than 
adults.While adults are more likely than children to relapse after treatment, the most common cause of treatment failure in 
children is also relapse. Improved outcomes for all ALL patients may depend upon new immunotherapies, specifically CAR T-cell 
therapy. CAR T-cell therapy extracts a patient’s own T-cells and modifies them with a CD19 antigen.This modification allows the 
new T-cells to recognize and kill cancer cells that contain the antigen on their surfaces, like leukemia cells do.Although CAR T-cell 
therapy may cause toxicities such as Cytokine Release Syndrome (CRS), they are mostly short term and reversible.Trials indicate 
that almost all patients who undergo CAR T-cell therapy will enter complete remission.Though a large percentage of those patients 
will experience a relapse, relapse rates of CAR T-cell therapy are lower than other treatments. By reviewing the available research 
literature regarding CAR T-cell therapy, this paper examines the effectiveness of this therapy in different patient populations and 
demonstrates that CAR T-cell therapy significantly improves event-free survival rates in ALL patients.
Acronyms Used: 
ALL - Acute Lymphoblastic Leukemia 
ACT - Adoptive Cell Transfer 
CAR - Chimeric Antigen Receptors 
CRS - Cytokine Release Syndrome 
CSF - Cerebrospinal Fluid 
Ph - Philadelphia chromosome 
TKI - Tyrosine Kinase Inhibitors 
CNS – Central Nervous System 
WBC – White Blood Count 
Introduction 
The leading cause of disease related death in U.S. pediatric pa-
tients is cancer, most commonly Acute Lymphoblastic Leukemia
(ALL) (Tumaini, et. al., 2013). For many years, cancer treatments
were limited to radiation therapy, chemotherapy, or surgery. More
recently, newer types of treatments called immunotherapies, have
become available. Cancer immunotherapies are therapies that
enlist and strengthen the power of a patient’s immune system to
fight and attack the cancer. Of the immunotherapies discovered,
adoptive cell transfer (ACT), in which a patient’s own immune
cells are collected and used to treat their cancer, has achieved
the most successful outcomes.The most effective ACT therapy
is CAR T-cell therapy (Brentjens, et. al., 2013). In 2017, CAR T-cell
therapy was approved by the FDA as a treatment for ALL and for
adults with advanced forms of lymphoma. However, while it may
seem that CAR T-cell therapy is poised to revolutionize cancer
therapy, some of the optimism surrounding it is tempered by con-
cerns about its safety and potentially severe toxicities (Lim, June,
2017), calling into question if CAR T-cell therapy is an improved
treatment for ALL and relapsed ALL. 
Methods 
The research used in this paper was located and compiled 
from papers obtained through Touro College’s access to on-
line publications. Google Scholar and Blood Journal were used 
for additional references. The articles were critically selected, 
compared, and analyzed to evaluate if CAR T-cell therapy is an 
effective treatment for ALL. 
CAR T-cell Therapy 
CAR T-cell therapy is relatively straight forward. T-cells, which 
play a critical role in orchestrating an immune response, are re-
sponsible for killing cells that are infected by pathogens. In order 
to retrieve these T-cells, blood is drawn from a patient and the 
T-cells are separated from the rest of the blood.The T-cells then 
undergo genetic modification via the insertion of genes that 
encode for tumor specific chimeric antigen receptors (CARs).
These receptors allow the T-cells to recognize and subsequently 
attach to a specific antigen.The antigen CD19 was chosen be-
cause it is universally expressed on all ALL tumor cells and not 
on pluripotent hematopoietic stem cells (Tumaini, et. al., 2013). 
Once the T-cells have been successfully engineered to express 
the CD19 antigen, they are expanded in a lab to form hundreds 
of millions of cells.This process has been refined and advanced 
over the years and can now quickly create large quantities of 
T-cells that have genetically engineered receptors on their sur-
face to treat both pediatric and adult ALL patients. The CAR 
T-cells are then infused back into the patient’s body where they 
continue to multiply, recognize, and kill the cancer cells con-
taining the antigen on their surfaces (Tumaini, et. al., 2013).This 
step is considered to be an in vivo expansion, which requires 
the new host to support these engineered T-cells.Therefore, the 
administration of the T-cells is preceded by a lymphodepleting 
regimen, as lymphopenia (the condition of having an abnormally 
low level of lymphocytes in the blood) generates changes that 
support T-cell expansion and survival (Klebanoff, et. al., 2005).As 
a result, most adoptive cell therapy protocols incorporate some 
version of lymphotoxic therapies prior to cell transfer. 
Like most cancer treatments, CAR T-cell therapy has serious 
side effects.The most common side effect that patients usually 
experience is cytokine release syndrome (CRS). Notably, CRS 
has been seen in patients treated with other immunotherapies 
and is therefore not limited to CAR T-cell therapy (Lee, et. 
al., 2014;Teachey et al., 2013). CRS is caused by the cytokines 
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released from the T-cells as CAR T-cells rapidly expand within 
the patient’s body. It can also be caused by other immune cells, 
such as macrophages that might produce cytokines in response 
to the cytokines produced by the infused CAR T cells. CRS 
patients have high levels of IL-6 (the cytokine secreted by the 
T-cells) and is characterized by systemic symptoms that usually 
begin with a fever (Giavridis, et. al., 2018).The onset of the fever 
can range from a few hours after the treatment to more than 
a week after CAR T-cell infusion (Brudno, Kochenderfer, 2016). 
The fever is followed by nausea, chills, headaches, muscle pain, 
and difficulty breathing (Maude et al., 2014).
CRS can lead to many different related toxicities that attack 
organ systems. Cardiovascular toxicities most commonly cause 
tachycardia, although more severe cases of CRS have prompted 
hypotension, arrhythmia (irregular heartbeat), and decreased 
cardiac ejection fraction. CRS can lead to pulmonary edema 
and hypoxia, the deficiency in the amount of oxygen reaching 
the tissues that may require mechanical ventilation. It can also 
lead to reduced renal perfusion, the volume of blood delivered 
to the kidneys per unit time, which can cause a kidney injury. 
However, CAR T-cell related renal injuries are mostly reversible. 
The same goes for other laboratory abnormalities that CRS 
causes, such as elevated levels of bilirubin and/or serum trans-
aminases. Patients also commonly become neutropenic and 
lymphogenic when undergoing and following CAR T-cell therapy 
because they are severely immunocompromised and are not 
protected against opportunistic infections, such as salmonella, 
bacteremia, and urinary tract infections.Viral infections such as 
influenza, respiratory syncytial virus, and herpes zoster virus,
have also been known to affect patients following CAR T-cell 
infusion (Brudno, Kochenderfer, 2016). Unfortunately, in such a 
setting, fevers, tachycardia, hypotension, and other regular symp-
toms associated with CRS can be difficult to differentiate from 
sepsis, which is a life-threatening infection. In an early trial, a 
patient with chronic lymphocytic leukemia who received che-
motherapy prior to his CAR T-cell treatment died with fever, 
hypotension, and renal failure four days after the administration 
of the CAR T-cells. It was discovered later that there were ele-
vated serum levels of inflammatory cytokines before CAR T-cell 
infusion, suggesting that the patient had a prior infection that 
caused his death (Brentijens, Curran, 2012). 
CAR T-cell therapy also has neurological toxicities associated 
with the treatment. The toxicities can be diverse, as they do 
not always localize to one specific area of the nervous system.
The occurrence of neurologic toxicity is quite variable, with 
published reports stating that there is a 0% to 50% chance of 
neurological toxicities developing (Brudno, Kochenderfer, 2016). 
Neurologic events are not always associated with CRS toxici-
ties, which suggests that in some cases, they might have a differ-
ent mechanism than many of the other usual toxicities caused 
by CRS, such as fever and hypotension (Maude, et. al., 2014). 
Ironically, CRS is considered to be an “on-target” effect of 
CAR T-cell therapy, as the presence of the cytokines show that 
the T-cells are working in the body.Various grading systems for 
the “CRS-related adverse events” caused by immunotherapies 
have been proposed.They depend on many things, such as the 
temperature of the fever, the number of severe signs of toxici-
ties, and cytokine levels in the patient. A category of severe CRS 
is defined as CRS requiring pharmacologic and medical inter-
vention. In such cases, tocilizumab, an IL-6 receptor antagonist 
that is used to treat rheumatologic disorders, is used as a first 
line agent.While not approved for this use by the FDA, it has 
effectively treated CRS-related toxicities in clinical trials with no 
life threatening or toxic effects (Maude, et. al., 2014), and is now 
a widely used off-label for the patients who have received CAR 
T-cell infusions. (Brudno, Kochenderfer, 2016). 
Systemic corticosteroids have also been used for CRS-related 
toxicities. However, there is some evidence that corticosteroids 
can possibly inhibit CAR T-cell persistence and anti-malignancy 
efficacy. For this reason, corticosteroid therapy is only used as a 
last resort if the tocilizumab does not succeed in ameliorating 
the CRS. However, because neurologic toxicities may not come 
along with CRS, these toxicities may differ from that of CRS 
alone. It is unclear if tocilizumab has any beneficial effect on neu-
rologic toxicities, as severe neurologic toxicities are commonly 
treated with systemic corticosteroids right away, rather than 
initially beginning with tocilizumab. 
Toxicities caused by CAR T-cells are diverse. Management
of these toxicities requires continuous and vigilant monitoring,
aggressive supportive treatments, and, in some cases, intensive
care. Another harmful side effect of CAR T-cell therapy is that
the engineered CAR T-cells with the CD-19 receptor could dam-
age other tissues that express the antigen recognized by it.This
mechanism of toxicity can be mostly eliminated by searching for
any expression of the targeted antigen on normal tissues in the
body prior to the development of the CAR (Lamers, et. al., 2013). 
Other Therapies 
There are several other therapies used to treat ALL.The goal 
of these treatments is to remove all traces of the ALL from the 
patient.The most commonly used treatment for ALL is chemo-
therapy.The chemo treatment is divided into three phases.The 
first stage is known as the induction phase and usually takes 
about a month.The next phase, consolidation, also referred to 
as intensification, is, as its name suggests, extremely intense as 
well, and typically lasts for a few months.The last phase, mainte-
nance, or post-consolidation, is less intensive, and lasts for about 
two years (Pui, et. al., 2008). 
The goal of induction, is to remove more than 99% of the 
initial leukemia cells from the patient and to restore normal 
haemopoiesis, the production of blood cells and platelets in the 
























































show no evidence of persistent leukemia and blood counts have
returned to normal, then the patient achieves remission. Studies
show that 96 to 99% of children with ALL enter remission after
the induction treatment.Adults have a lower remission rate with
only 78-93% of adults entering clinical remission (Pui, et. al., 2008).
Nevertheless, a remission is not necessarily a cure, and since the
first month is such intense treatment, many complications and
serious infections can arise. As a result, this phase of treatment
requires lengthy hospital stays and frequent visits to the doctor,
as these complications can be life-threatening. Recent advances in
supportive care have helped lower these complication rates, mak-
ing them considerably less common than they have previously
been. Examples of supportive care are better nursing care, prop-
er nutrition, prescribed antibiotics, and red blood cell or platelet
transfusions as needed (Locatelli, et. al., 2012). 
There are three major types of drugs that children with stan-
dard-risk ALL receive during the first month of treatment.These 
are chemotherapy drugs L-asparaginase and vincristine, as well 
as a steroid drug, usually dexamethasone (Goekbuget, et al., 
2005). For children in high-risk groups, a fourth drug from the 
anthracycline class, typically daunorubicin, is added.ALL patients 
also require chemotherapy via the cerebrospinal fluid (CSF), as 
there may be leukemia cells that spread to the brain and spinal 
cord.This treatment is known as intrathecal chemotherapy and 
given through a lumbar puncture/spinal tap. Patients with high 
risk leukemia or leukemia in their CSF receive this treatment 
more frequently than other ALL patients do. In the past, along 
with intrathecal therapy, patients were also given prophylactic 
cranial irradiation. Recent studies have found that children who 
are given more intensive chemotherapy may not need radia-
tion therapy at all. Doctors try to avoid giving radiation to the 
brain, especially in younger children, because even low doses 
may result in problems with cognition, growth, and development 
(Locatelli, et al., 2012). 
The next phase, consolidation, is the phase of chemotherapy
that further reduces the number of leukemia cells still in the body.
Several chemo drugs are used together to prevent the remaining
leukemia cells from developing a resistance. Intrathecal therapy is
continued at this time, and patients with high-risk leukemia usual-
ly receive more intense chemotherapy. During this phase, patients
with Philadelphia chromosome-positive ALL may benefit from the
addition of other types of cancer therapies, such as targeted can-
cer drugs or stem cell transplants (Pui, et. al., 2008).
If the leukemia remains in remission after induction and 
consolidation, the third phase, maintenance therapy, can begin. 
Most treatments use medication given either as pills or intra-
venously, and a steroid, usually prednisone or dexamethasone. 
Depending on the type of ALL and the risk of recurrence, other 
drugs may be added as needed. In the beginning of the mainte-
nance phase, most treatment plans include one or two repeat 
intensified treatments like the initial induction.These four-week 
intensifications are called re-induction or delayed intensification.
Some children at higher risk may receive more intense mainte-
nance chemotherapy and intrathecal therapy. The total length 
for the three phases of chemotherapy for most ALL treatment 
plans is two to three years. However, patients with a higher risk 
of relapse are given several extra months of treatment as an 
added precaution (Pui, et. al., 2008). 
Throughout the entire chemotherapy process, the combina-
tion of anti-cancer drugs used often causes serious side effects. 
This is mainly because the chemotherapy drugs affect healthy 
body cells as well cancer cells. Many organs, such as the kid-
neys, liver, testicles, ovaries, and lungs, can be damaged by these 
drugs. In an effort to reduce the number of side effects, the 
chemotherapy is given in cycles, and each round of treatment is 
followed by a rest period, so the body has time to recover. Some 
of the main side effects of chemotherapy are loss of hair and 
appetite, vomiting and nausea, constipation, and mouth sores. 
Chemo drugs also affect the normal cells in bone marrow, which 
can lower blood cell counts.This leads to an increased risk of 
infections, due to low white blood cell counts, easy bleeding 
and bruising from low platelet counts, and constant fatigue and 
shortness of breath, as patients do not have enough red blood 
cells (hemoglobin) to carry the oxygen needed in their bodies 
(Pui, et. al., 2008). 
As with most treatments, steps can be taken to reduce the 
toll these side effects can have on the patients. Drugs, such as 
Ondansetron (Zofran) can be given to decrease nausea and 
vomiting. Transfusions or drugs can be administered to raise 
a platelet or red blood cell count, and antibiotics are given 
at the earliest sign of a developing infection. Even tumor lysis 
syndrome can be prevented. This potentially life-threatening 
side effect of chemo is usually seen in the induction phase of 
treatment.As the leukemia cells are killed by the chemo drugs, 
they break open, releasing their contents into the bloodstream. 
These components can overwhelm the kidneys because they 
are unable to filter out and remove all these substances from 
the blood at once, and the excess amounts of certain minerals 
can affect the heart and nervous system.Administering certain 
drugs and extra fluids during treatment can help the body elim-
inate these substances (Goldman, et. al., 2001). Patients need to 
be carefully monitored while being treated with cancer drugs to 
reduce the risk of these side effects as much as possible. 
High-energy radiation used to kill cancer cells is another 
therapy used to treat ALL. Most often, external beam radiation 
therapy is used, in which a machine delivers a beam of radiation 
to a specific part of the body at a certain angle.Although radia-
tion is not used as the main treatment for ALL, it is used in cer-
tain situations, such as preventing or treating leukemia that has 
spread to the brain, (though lately, radiation has been omitted 
from treatment plans) spinal fluid, and testicles. Before a bone 
marrow or peripheral blood stem cell transplant takes place, 
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the whole body often needs radiation. Rarely, radiation can help 
shrink a tumor if it is causing breathing problems by pressing on 
the trachea, although chemotherapy is often used instead, as it 
normally achieves the same effect more rapidly (Cherlow, et. al., 
1993).The side effects of radiation therapy depend on the loca-
tion at which the radiation beam was targeted.The treated area 
can appear sunburned and undergo hair loss.  Radiation to the 
abdomen can sometimes cause nausea, vomiting, or diarrhea. 
Effects of radiation that targets large parts of the body may in-
clude fatigue, shortness of breath, and an increased risk of infec-
tion due to lower blood cell counts (Pearce, et. al., 2012). 
One of the most serious, but not very common side effects of 
ALL chemotherapy and radiation therapy is an increased risk of 
getting another neoplasm, a new and abnormal growth of tissue 
in some part of the body that can become cancerous later on. 
Although effective treatments for ALL now result in five-year 
survival rates above 70%, the treatments used are ironically 
carcinogenic. Studies show that there is a substantial chance 
of secondary neoplasms among patients treated for ALL with 
chemotherapy and radiation. Children five years old and under,
as well as patients who received radiation as a form of therapy, 
are at a higher risk for second tumors arising in their central 
nervous system, as well as patients who received radiation as a 
form of therapy. (Neglia, et. al., 1991). 
Allogenic hematopoietic stem-cell transplantation, the trans-
plantation of multipotent hematopoietic stem cells, is the most 
intensive form of treatment for ALL. This stem cell transplan-
tation seems to benefit several types of high risk ALL patients,
such as patients with poor initial responses to treatments, 
patients who have relapsed, and those with Philadelphia chro-
mosome-positive disease (Pui, et. al., 2008). The Philadelphia 
chromosome (Ph) is the most frequent cytogenetic abnormal-
ity in adult ALL. Most patients with Ph+ ALL cannot be treated 
with chemotherapy alone, as chemotherapy can only induce a 
complete remission for a few months until most patients expe-
rience a relapse.The five-year survival rates for those who have 
Ph+ ALL and were treated with chemotherapy alone are less 
than 10%. However, those who underwent allogenic stem cell 
transplantation during early remission have a 35-65% chance of 
long-term survival (Lee, et. al., 2005). Bone marrow transplants 
(BMT) are sometimes needed as well for patients with underly-
ing malignancies or genetic disorders (Slavin, wt. al., 1998). 
Targeted cancer drugs are also being used as a treatment for 
ALL. Cancer cells are cells that undergo changes to their genes. 
These changes cause the cancer cells to grow faster and work 
differently from others.Targeted cancer drugs use these differ-
ences in cell genes to differentiate them from other normal cells 
and target the specific gene changes.The main targeted cancer 
drugs used for ALL are tyrosine kinase inhibitors (TKIs). They 
block tyrosine kinases, chemicals that cells use to signal to each 
other.The main side effects of targeted cancer drugs, specifically 
TKIs, are fatigue, a sore mouth, rashes or reddening of the skin, 
and loss of appetite (Pui, et. al., 2008). 
Success Rates 
Chemotherapy affects children and adults with ALL differently. 
Children that undergo chemotherapy treatment have a much 
greater chance of survival than adults, yet only 80 – 85% of 
children can be cured. A large chemotherapy trial comprised 
of children up to eighteen years old was conducted on 1,114 
patients. Of those patients, only 998 became protocol patients, 
and were divided into three groups; a standard risk group, those 
without central nervous system (CNS) disease, a risk group, 
those with CNS disease, and an experimental group.They all re-
ceived induction therapy and some variation of continued che-
motherapy, including cranial irradiation as needed. Additionally, 
an intensive reinduction therapy was added for patients in the 
standard risk group who had increased risk of failure during the 
trial. The event-free survival for the 110 patients who did not 
receive reinduction therapy was almost 30% lower than those 
with reinduction therapy. In this trial, a complete remission was 
measured by several parameters: the absence of leukemic cells 
in the blood and CSF, fewer than 5% lymphoblasts in marrow, 
and no evidence of localized disease. Relapse was defined as 
reappearance of lymphoblasts or localized leukemia infiltrates 
at any site (Reiter, et. al., 1994). 
Figure 1 presents results of this trial. Of the 998 patients, 985 
(98.7%) entered complete remission.Thirteen patients did not 
enter remission; seven had resistant leukemia, one died of renal 
failure, and five died an early toxic death.At the 5.0-year (range 
3.4 - 6.9 years) median follow up, 233 patients experienced a 
relapse (23.3%).Thirteen more patients died while in complete, 
continuous remission and three patients developed a second 
malignancy. There were 734 patients (73.5%) still in their first 
continuous complete remission. 
The six-year, event-free survival estimate was for 888 pa-
tients.The 110 patients who did not receive reinduction were 
excluded from this estimate. Of all three branches together, the 
estimate was 74% ± 2%. Detailed analysis showed that male pa-
tients had higher white blood counts (WBC), were six years 
old or greater, or had T-ALL, had a better outcome than others. 
For example, 69% ± 5% of T-ALL patients with WBC ≥ 20,000/
µL had event-free survival at six years. This is a comparatively 
larger number than 58% ± 3% for the complementary group of 
patients with an immunophenotype other than T-cell ALL.These 
other immunophenotypes had no predictive strength for treat-
ment outcome (Reiter, et. al., 1994). 
There was a trial for 525 patients under 19 with a first-time 
relapse of T-cell or B-cell ALL. The patients were treated with 
intensified, short course multi drug chemotherapy.A major aim 
of this study was to improve outcomes through a third inten-















































*16 Patients died 
13 in complete continuous 
remission 
3 from second malignancy 
*233 Patients Relapsed 
(23.3%) 
*734 Patients(73.5%) were 
still in their first continuous 
remission 
13 Patients: 
7 Resistant Leukemia 
6 Died 
*5.0 year (range 3.4 - 6.9) median follow up Figure 1: Breakdown of patients in the trial 
etoposide. Results showed that 440 patients (84%) achieved a 
second complete remission, 25 patients (5%) died during in-
duction, and 60 patients (11%) did not respond to treatment. 
Thirty-one patients (6%) died in the second complete remis-
sion as a result of treatment-related adverse effects. Of those 
patients who achieved second complete remission, 246 patients 
(56%) suffered subsequent relapse, and six patients (1%) expe-
rienced a secondary malignant neoplasm.At a median follow-up 
of twelve years, 153 (29%) of 525 patients remained in com-
plete continuous remission. The study concluded that neither 
R3 nor adaptation of chemotherapy intensity was capable of 
improving event-free survival or of overcoming prognostic fac-
tors. Therefore, induction regimens need to be improved for 
high risk patients, and allogeneic stem cell transplant should be 
recommended in patients achieving second complete remission 
(Tallen, et. al., 2010). 
Adult recovery rates are not as high as children’s. ALL ac-
counts for about 15 – 20% of all adult leukemias.Although some 
of these patients enter complete remission, most of them re-
lapse and die. With chemotherapy alone, those younger than 
sixty have a 30 - 40% chance of recovery (Mohty, et. al., 2010). 
Anyone older than sixty has less than 10% chance. In many 
cases, chemotherapy is not enough and adult patients need 
other therapies, such as transplants. However, the patients still 
need to undergo chemotherapy maintenance after the induc-
tion therapy and transplant. (Goldstone, et. al., 2008). 
A study was performed on 609 adults with relapsed ALL, all of 
whom were previously treated in the Medical Research Council 
study, in which the overall survival of newly diagnosed patients 
was 38% at 5 years. By contrast, in this chemotherapy study, 
the overall survival at 5 years after relapse was 7%. Factors 
predicting a good outcome after salvage therapy were young 
age (overall survival of 12% in patients younger than 20 years 
vs overall survival of 3% in patients older than 50 years) and 
short duration of first remission.Treatment received in the first 
complete remission did not influence the outcome after relapse.
This study concluded that adults who have an ALL relapse can-
not be rescued using currently available therapies, even if stem 
cell transplantation is available. 
Prevention of recurrence would 
be the best strategy for long-term 
survival from this disease (Fielding, 
et. al., 2007). 
The most common cause of 
ALL treatment failure is relapse, 
as approximately 15 – 20% of 
children experience relapse. With 
intensive chemotherapy and trans-
plantations, 30-50% of all children 
with relapsed ALL can be cured. 
However, because relapsed ALL is 
difficult to treat, most relapsed children still die, despite the 
aggressive therapies (Locatelli, et. al., 2012). CAR T-cell therapy 
may be able to overcome the limitations of conventional thera-
pies and induce remission in patients with relapsed and refrac-
tory ALL (Maude, et. al., 2014). In one trial, thirty patients were 
selected. Twenty-five patients were aged from five to twen-
ty-two, and the other five patients between twenty-six and sixty.
Of these patients, twenty-six had B-cell ALL in a first to fourth 
relapse, three had primary refractory B-cell ALL, and one pa-
tient had relapsed T-cell ALL. Eighteen patients had experienced 
their relapsed ALL after allogenic stem-cell transplantation. All 
the patients in this study experienced CRS. Eight patients devel-
oped severe CRS, and all required respiratory support and va-
sopressor support for hypotension. However, all neurotoxicity 
was reversible and there was no lasting damage form the CRS 
(Maude, et. al., 2014). 
One month after the infusion, twenty-seven patients (90%) 
obtained complete remission. Of these patients, nineteen 
remained in remission. Fifteen patients received no further 
therapy, and five withdrew to receive other treatments. At six 
months, the event-free survival rate was 67%, and the overall 
survival rate was 78%.This is a much better rate than the <25% 
complete remission rates of the recently approved drugs (nelar-
abine, liposomal-encapsulated vincristine, and clofarabine) for 
ALL.This study showed an encouraging sustained remission of 
up to two years (Maude, et. al., 2014). 
In another trial, 53 pretreated adults received CAR T-cell 
therapy.A total of thirty-six patients (68%) received CAR T-cell 
therapy as a third or later salvage treatment, twelve had primary 
refractory disease, nineteen had undergone allogeneic hema-
topoietic stem-cell transplantation previously, and thirteen had 
received the drug blinatumomab previously. A total of sixteen 
patients had Philadelphia chromosome positive ALL, and ten of 
the sixteen patients had disease that was refractory to the drug 
ponatinib. After infusion, 26% of the patients had severe CRS. 
Complete remission was defined as less than 5% bone marrow 
blasts, the absence of circulating blasts, and no extramedullary 
sites of disease regardless of cell-count recovery. Relapsed 
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disease was defined as the reappearance of blasts in blood or 
bone marrow or in an extramedullary site after a complete 
remission. One patient died from multiorgan failure and severe 
CRS on day five, and complete remission was observed in 83% 
of the patients. At a median follow-up of twenty-nine months 
(range one to sixty-five), the median event-free survival was 6.1 
months, and the overall survival was 12.9 months. Patients with 
a low disease burden (<5% bone marrow blasts) before treat-
ment had distinctly enhanced remission duration and survival, 
with a median event-free survival of 10.6 months and a median 
overall survival of 20.1 months. Patients with a higher burden 
of disease (≥5% bone marrow blasts or extramedullary disease) 
had a greater incidence of the cytokine release syndrome and 
neurotoxic events and shorter long-term survival than did pa-
tients with a low disease burden.This is a better outcome than 
the three to nine months of median overall survival seen from 
chemotherapy (Park, et. al., 2018). 
Of the 44 patients who had a complete remission after the 
infusion of CAR T-cells, 26 did not undergo further therapy, 
including nine who were alive and seventeen who had a re-
lapse or died. One patient received alternative treatment for 
minimal residual disease–positive disease, and seventeen pa-
tients progressed to transplantation.The median time from the 
CAR T-cell infusion to transplantation was 74 days (range, 44 
to 312). Of the seventeen patients who underwent allogeneic 
transplantation after the CAR T-cell infusion, five patients were 
alive and had a complete remission, six had a relapse, and six 
died from transplant-related toxic effects. This study showed 
that CAR T-cell therapy had favorable long-term remission rates 
in a population of patients with low disease burden, who had 
significantly longer event-free survival and overall survival with 
markedly lower incidences of toxic effects than did those with 
a high disease burden (Park, et. al., 2018). 
In another trial, 20 patients (aged 1-30 years, including eight 
patients who underwent allogenic stem-cell transplantation) 
with relapsed or refractory ALL were infused with CAR T-cells. 
CRS was recorded in 16 patients, and all toxicities associated 
with the therapy were reversable. Complete remission was ob-
served in 70% of the patients. Many of the patients in the trial 
underwent further stem cell transplantation therapy, which led 
to the conclusion that CAR T-cell therapy is an effective bridge 
to stem cell transplantation for patients with chemo refractory 
B-ALL. Because most patients who entered remission eventually 
underwent stem cell transplantation, this study was not able to 
assess the durability of response to the CAR T-cells, yet it was 
associated with a favorable long-term survival.Additionally, this 
study showed that CAR T-cells mediate a complete remission 
in refractory ALL that is substantially higher than the 8-20% 
reported with clofarabine, a drug that was approved in 2004 for 
refractory pediatric ALL (Lee, et. al., 2014). 
Conclusion 
CAR T-cell therapy is currently being used as a treatment for 
patients who have already been treated with other therapies 
and relapsed.This makes the effectiveness of the therapy diffi-
cult to gauge, as CAR T-cell therapy trial outcomes cannot be 
compared to first time treatment data of other therapies such 
as chemotherapy. Nevertheless, the trials have shown that the 
toxicities from CAR T-cell therapy are manageable and are no 
longer a big concern.The trials also show that although it does 
not have perfect results, CAR T-cell therapy is far more suc-
cessful in treating relapsed ALL than other therapies have been, 
as the complete remission rates and longer survival rates are 
higher for relapsed ALL than any other treatment. Some studies 
indicated that many patients may have needed additional stem 
cell transplants and other therapies after undergoing CAR T-cell 
therapy, so it cannot always be used as a lone therapy. However, 
some patients did achieve event-free remission from only CAR 
T-cell therapy. There were no attempts in proving that CAR 
T-cell therapy should not be done, making this therapy a great 
treatment option for ALL, especially relapsed ALL. 
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Abstract 
It has long been debated whether or not cell phones have a deleterious effect on the brain. Recent studies indicate that the elec-
tro-magnetic field emitted by cell phones called RF-EMF is linked to cancer. Guidelines created to limit the exposure have not been 
changed since 1981 and do not consider children.The mechanism thought to cause cancer is reactive oxygen species (ROS), which 
cause the creation of micronuclei. RF-EMF poses a greater threat to children than adults.This is due to the major anatomical 
differences between the head of a child and an adult.The skull of a child is much thinner than that of an adult.Additionally, the 
marrow in the skull of a child is much more vulnerable to RF-EMF.Another difference is the presence of myelin in the brain of a 
child. Until the age of two production of myelin sheath occurs at a frenzied pace.After age two production slows but continues into 
adulthood.The uncompleted myelin sheaths, as well as the unprotected axons, can be easily damaged by RF-EMF.This can lead to 
axonal degeneration and decreased action potential speeds.Another difference is the presence of neural stem cells. Neural stem 
cells differentiate from neuroepithelial tissue.These cells then commit to oligodendrocytes or astrocytes and undergo cell division 
to form immature glial cells. Research shows that children contain a substantial amount of these stem cells, whereas adults do 
not. RF-EMF inhibits cell division resulting in a decreased number of immature glial cells. Because of these anatomical differences, 
parents should be wary of the amount of “screen time” they provide their children.The guidelines of acceptable SAR should also 
be changed to take the risks to children into account. 
Key Abbreviations 
ROS- Reactive Oxygen Species. 
RF-EMF- Radio Frequency Electro Magnetic Fields. 
ELF-EMF- Extremely Low Frequency Electro Magnetic Fields 
SAR- Specific Absorption Rate
SAM- Standard Anthropometric Mannequin 
GSM- Global Systems for Mobile communication 
MWF- Myelin associated Water Frequency 
Introduction 
It has been estimated that as of the end of 2017 there have 
been more cell-phone subscriptions than humans (International 
Telecommunication Union 2016). Cell phones use radiofre-
quency waves to carry information from one phone to another 
via base towers.As of May 2011, the IARC officially recognized 
RF-EMF as a Group 2B human carcinogen (International Agency 
for Research on Cancer 2011).This means that RF-EMF is now 
classified as a “possible human carcinogen”. There are those 
who believe that it should be moved up to the “known carcino-
gen” category due to the studies done on rats that show a pos-
itive correlation between cell-phones, and cancer (Belpomme 
et. al 2018). With the arrival of 5G networks and the ever-in-
creasing dependency on cell-phones the potential risks of these 
networks must be determined. One area of study that has not 
been as defined is the potentially greater hazards of RF-EMF to 
children than adults. 
It is thought that there are two mechanisms in EMF that cause 
cancer.The first is thermal radiation and the second non-ther-
mal. Thermal radiation is due to the friction caused by polar 
molecules as they move along with the electromagnetic field.
This effectively heats up the brain the same way a microwave 
heats up food.This can cause denaturing of DNA. Non-thermal 
radiation is the emitting of a particle that denatures DNA or 
splits ROS (reactive oxygen species) creating free radicals that 
are detrimental to human health. It is now being discovered 
that even ELF-EMF, such as those that provide electricity, can 
cause cancer when one is exposed long-term.This is also seen 
in RF-EMF, as studies show that one who uses a cell phone for 
≥10 years will double his chances of getting acoustic neuroma 
(Khurana et. al 2009) 
Another factor that must be considered is the intensity of the 
radio-wave.The average GSM (Global Systems for Mobile com-
munication) phone operates on a wavelength of 800 MHz to 
1900 MHz.This is broadcasted at different strengths depending 
on the signal strength and how hard the phone has to work to 
connect to the closest base station.There are guidelines in place 
to limit the amount of radiation emitted by a phone.This is lim-
ited to 1.6 W/Kg in a 1-gram cube of tissue. It is estimated that 
up to 80% of the radiation emitted by the phone is absorbed 
by the head when one is talking on the phone normally.The aim 
of this paper is to explore the potential effects RF-EMF waves 
emitted by a cell-phone have on a child’s brain. 
Methods 
To complete this study, online scholarly databases were searched 
for relevant articles. Databases included Google Scholar, as well 
as ProQuest, EBSCO, and EMF-PORTAL. Key words included 
“head,” “child,” as well as “cell phones” among many others. 
While most of the material found is available to the public, many 
of the articles needed special access that was provided by Touro 
College for the use of this paper. 
Background 
In 1982 the IEEE (Institute of Electrical and Electronic Engineers) 
was commissioned to find a level of intensity of RF-EMF expo-
sure that could be considered safe. It is worthwhile to keep in 
mind that the IEEE is an organization dedicated to “advancing 
technology for the benefit of humanity” according to the mis-
sion stated on their webpage.They are also not a group whose 
main focus is health sciences. Their studies resulted in a near 
unanimous conclusion of 1.6 W/kg to be safe for non-occupa-
tional use (IEEE, 1982), however no rationale was provided for 
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this number.These guidelines have remained unchanged since a 
remodeling of the guidelines in 1991 to a two-tier system based 
on a “controlled environment,” i.e. workers in a profession who 
are aware of the potential hazards of the job, and an “uncon-
trolled environment,” i.e. the general population. 
Cell phone compliance with these guidelines are tested 
through SAM (Standard Anthropometric Mannequin), a model 
head with dimensions based off of the 90th percentile of U.S. 
military recruits in the year 1989. The corresponding body 
of the head would be a six foot, two inches, 220 lb. male.The 
model is filled with dielectric material of similar composition 
to that of brain tissue.A phone is then positioned next to the 
head and the model is subjected to a phone call. A probe is 
inserted between the mannequin’s head and the cell phone, 
which measures the radiation levels emitted and calculates it 
as W/kg based off of 1-gram of tissue.This is referred to as the 
psSAR (peak spatial Specific Absorption Rate), or the SAR of a 
cell phone.  It must be noted that this method can only measure 
the effects of thermal radiation. 
There is another way of calculating SAR called the FDTD 
(Finite Difference Time Domain) method. This method is a 
computational program in which a magnetic field is arranged 
as a three-dimensional grid. The permeability, permittivity, and 
conductivity are then entered into the program for the material 
contained in each specific cube.Through this the program can 
compute based off of all the materials in the cubes how much 
radiation was absorbed by each specific tissue.
There have been multiple experiments done to prove the haz-
ards of RF-EMF. One of the more popular studies exposed rats 
to a GSM-like frequency and monitored long-term and short-
term effects. The most recent study exposed rats to RF-EMF 
to monitor long-term effects and found a positive correlation 
between these waves and cancer (National Toxicology Program 
2018). One of the disadvantages of this study was the inability 
to expose rats in the same manner that a human is exposed. 
Additionally, the SAR that was used for this experiment was 
higher than that of normal cell phone use. 
Another study that has gained popularity in recent years is 
the computer simulation of an RF-EMF. This involves studying 
the characteristics of the electromagnetic field and the specific 
features of the tissues being exposed.The researchers will then 
create virtual models and simulate exposure to an RF-EMF.The 
shortcoming of this type of study is that one can only monitor 
the effects of thermal radiation.The FDA uses a four-member 
family for all their simulations consisting of male and female 
adults and children. Both the SEMCAD program, which moni-
tors EMF, and the virtual family are available to the public. 
Potential Effects 
These studies, as well as most other recent experiments con-
ducted by experts in the field, yield results that indicate that 
RF-EMF’s are potentially hazardous to one’s health. The ques-
tion remains as to whether RF-EMF causes cancer. Most recent 
studies find a positive correlation between RF-EMF and malig-
nant glial cell tumors (Falcioni et al 2018).This study is unique as 
the researchers projected a lower SAR over a longer period of 
time.This suggests that long-term exposure may in fact be the 
cause for concern and not the SAR. If this is the case, it would 
render todays safety standards useless, as they are based on 
SAR.Another study found that there was an increased risk for 
glioblastoma and acoustic neuroma in heavy cell phone users 
(Hardell et al. 2013).The tumors observed were usually ipsilat-
eral to the preferred side of cell phone use.These results are 
extremely important. Acoustic neuroma is a benign tumor on 
the vestibulocochlear nerve, just inside the inner ear.This is the 
closest organ to which one holds the cell phone while talking 
on the phone.While acoustic neuroma is not malignant, it can 
cause deleterious effects by putting pressure on the brain stem. 
The mechanisms by which RF-EMF potentially causes cancer are 
unclear. It is highly unlikely that RF-EMFs have enough energy 
in them to significantly heat up brain tissue to the point that 
would cause denaturing of DNA. It is highly debated whether 
they have enough energy to break a strand of DNA. However, 
even if there is not enough energy to denature or break strands 
of DNA, there would be enough energy to create ROS which 
can lead to genetic damage in the long term. 
Another adverse effect that RF-EMFs can have is on memo-
ry. It has been reported that RF-EMF impair memory, cognitive 
function, and learning. Experiments show that rats that have 
been exposed to RF-EMFs for four weeks have performed 
poorly on inhibitory avoidance tests.The suggested mechanism 
for learning and memory impairment is that RF-EMF stimulates 
the opioidergic system in the amygdala, hippocampus and other 
areas crucial for memory consolidation.This may in turn impair 
the release of NO, which plays a role in memory consolidation 
(Ahmadi et al. 2018). Despite this, many researchers have not 
found RF-EMF to impair memory, learning or cognitive function 
(Klose et al. 2014). 
RF-EMF has been blamed for many other conditions that are 
not associated with the brain, such as hypofertilization and can-
cers of the eyes and glands. These are extremely broad fields 
and are beyond the scope of this paper. Researchers are of the 
opinion that the mechanism that causes all these ailments is 
long-term exposure to RF-EMF. However, RF-EMFs do have 
the energy to potentially create ROS. ROS can be created by 
transfer of energy from the EM wave to the oxygen molecule 
or the transfer of a free electron.This has been shown to cause 
the creation of micronuclei (Kesari et. al 2014).A micronucleus 
contains a chromosome or part of a chromosome that is not in-
cluded in the daughter nucleus after the nuclear envelope forms 
around the chromosomes during mitosis.This part of DNA that 


































envelope and is attached to the nucleus. Formations of micronu-
clei have also been associated with DNA double-strand breaks 
that lead to the incorrect copying of the chromosomes and for-
mation of the nuclear envelope around them. Micronuclei have 
been used as markers for researchers and healthcare providers 
to reveal DNA damage and potential cancerous cells. If these 
micronuclei are a direct consequence of the EMF, then we can 
see a definite link between RF-EMF and DNA damage.However,
even if the mechanism of the formation these micronuclei is 
not DNA damage, research has shown that the chromosomes 
inside the micronucleus have reduced functioning (Hatch et. al 
2013). Eventually, due to the close proximity of the micronu-
cleus to the nucleus, the contents of the micronucleus will be 
released into the nucleus.This often results in incorporation of 
non-functional DNA into functional DNA which can cause the 
cell to turn cancerous.Thus, even if the mechanism for micro-
nuclei formation is not DNA damage, it is almost inevitable that 
the formation of micronuclei will lead to DNA damage. 
Each of these effects is highly debated amongst researchers. 
It is not clear whether the cause is the cell-phone or perhaps 
some other environmental stressor. However, there is over-
whelming evidence that cell-phones have a negative effect on 
the brain of a child. 
Discussion: 
Bone Thickness and Density 
The head of a child differs anatomically in multiple ways from the 
head of an adult.These anatomical differences cause the brain 
to be more vulnerable to cell-phone radiation. One 
example is the thickness of the skull.The skull vault 
is comprised of two flat compact bones with a diploe 
or spongy bone sandwiched in between.The average 
skull of an adult is between 6 to 8 mm thick depend-
ing on the location on the skull. A study conducted 
measured the thickness of the cranial vaults of chil-
dren (birth-18) using CT scans. It was found that skull 
thickness increases as a child grows older (Smith et. 
al 2012). Not only does the thickness of the skull 
develop over time, but so does the cranial capacity. 
This is to accommodate for the ever growing and 
developing brain of the child. Additionally, the skull 
of an adult is completely ossified.The skull of a fetus,
however, is made of cartilage and it slowly ossifies 
until birth. Even after birth there are areas that are 
not ossified called fontanels. One of these fontanels 
or soft spots do not ossify and close until six years 
after birth. One advantage of the incomplete ossi-
fication is to assist the baby in descending through 
the birth canal. Skull thickness increases throughout 
development due to the remodeling of osseous tis-
interesting since remodeling of bone is usually due to stress 
on the bones. Subsequently, the bones restructure themselves 
to create new lines of stress.Yet the cranium undergoes little 
to no stress from the weight of the body as many of the other 
bones do.Remodeling of osseous tissue in the cranium has been 
shown to continue until age 18.The thickness of the skull of a 
child under the age of 1 has been shown to be between 3 and 4 
mm (Table 1).The skull of a 20-year-old, on the other hand, has 
an average thickness of 6 to 8 mm depending on the location on 
the skull (Delye et. al 2004).This is a significant increase in the 
protection provided to the brain. Additionally, the bones have 
been shown to increase in density as the child gets older.The 
density of the skull of a child under the age of 1 is between 750 
and 850 mg/cm3 (Table 2), whereas the density of a 20-year-old 
is around 1000 mg/cm3. 
The added thickness and density of the skull during the de-
velopment of the cranium is likely due to an increased compact 
bone formation and decreasing amount of spongy bone tissue. 
Thus, when a child is exposed to RF-EMF the compact tissue 
which is the protective covering is not as thick. This not only 
exposes the brain to RF-EMF, but it also exposes the vulnerable 
red bone marrow contained in the diploe in between the tra-
beculae to these waves.This could account for the correlation 
of leukemia and RF-EMF observed in children in Rome that 
were within a 2 km radius of base towers that communicate 
via RF-EMF (Michelozzi et. al 2002). Other studies found the 
same results in different communities, although the biological 









(months) 3.4 0.3 
7-12 
(months) 4.1 0.5 
5 5.2 0.7 
10 5.9 0.8 
15 6.2 1 









(months) 777.1 35.9 
7-12 
(months) 822.5 39.9 
5 935.5 65.9 
10 973 33.1 
15 999.2 59.4 
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is not fully developed, it leaves the marrow exposed. These 
waves could then potentially damage the marrow cells, creating 
cancerous white blood cells that interfere with the production 
of red blood cells.The lack of red blood cells carrying oxygen 
in the blood results in the devastating symptoms of leukemia. 
Another potential hazard of RF-EMF that can come about due 
to lack of bone protection is damage to the brain itself.The less 
radiation that the skull absorbs results in more radiation hitting 
sensitive brain tissue. 
Myelin 
A major anatomical difference between the brain of children and 
adults is the amount of myelin surrounding a neuron. Myelin is a 
fatty substance which surrounds neurons in the CNS and PNS. 
Its functions are to insulate neurons to allow action potentials 
to propagate quickly, as well as to provide protection for the 
neuron.Among other components, myelin is mainly comprised 
of sphingomyelin, long hydrocarbon chains, and sphingolipids. It 
is produced by Schwann cells in the CNS and oligodendrocytes 
in the PNS. Demyelination has been associated with many dis-
eases such as MS. It is also associated with many psychiatric 
disorders such as developmental disorders and schizophrenia. 
Demyelination leaves neurons vulnerable to toxins. It also in-
creases the internal resistance of the membrane, which leads 
to the decreased velocity of an action potential and less of a 
chance of this potential propagating into a post synaptic poten-
tial (PSP).When demyelination proceeds past a given value, axon 
degeneration occurs. 
Production of myelin begins in the brain at the fourth month
of gestation and continues rapidly until the age of two.This rapid
myelination relates to the rapid development of cognitive skills,
showing the importance of myelin in the brain development.The
production then slows; however, myelin is continually being syn-
thesized throughout adulthood. One way to be able to quantify
the amount of myelin in the brain is to differentiate between
white and gray matter.While myelin is contained in the gray mat-
ter, it is most heavily
concentrated in white
matter. MRI imaging is
used to create an MWF
(Myelin associated
Water Fraction). MWF
is a scale that measures
the movement and
volume of water mol-
ecules that are trapped
between the lipid bilay-
er of the myelin sheath.
Calculating the water
content can provide a
quantifiable measure
of the amount of myelin structure above these water molecules.
Units are given in mean VFM, or mean myelin water fraction on a
scale of zero through twenty-five on a Gompertz curve. Studies
using MWF show that the fastest myelination occurs in the first
two years after birth (Dean III et. al 2015). MRI images from this
same study show a clear progression of myelination throughout
the first five years of life (Figure 3).
This study also established a direct association between cog-
nition scores and myelination. It is not by coincidence that the 
most rapid development in cognition, learning and motor skills 
occurs during the fastest rate of myelination. 
RF-EMF can be a risk for demyelination in children whose my-
elin development has not been completed. Even adults whose 
myelin sheaths are fully developed are at risk of demyelination 
due to RF-EMF.The risk exists because formation of free radi-
cals by RF-EMF can cause lipid peroxidation.This can then cause 
the myelin to be oxidized, resulting in the formation of a free 
radical chain.The demyelination results in an exposed axon that 
risks further damage by RF-EMF, which could potentially degen-
erate the axon. Demyelination can also result in slower action 
potentials and the decreased likelihood of PSP propagation in 
the post-synaptic membrane. This may be the mechanism for 
the lower cognition scores observed by (Dean III et. al 2015) in 
children with lower VF¬M¬. Lower myelination levels can also 
result in the plaques of dead neurons associated with MS as de-
myelinated neurons die. Children whose myelin is still not fully 
developed in certain areas in the brain are at an increased risk 
of myelin and axonal degeneration. The more RF-EMF that is 
absorbed by the brain in a child, the more exposed the neurons 
can become as demyelination progresses. 
Neural Stem Cells 
When a child is born, most of the neurons needed are already 
differentiated from their stem cells. Development of the brain 
consists of axonal growth as well as formation of new synapses. 






























































cells into immature glial cells. Studies show that the number of 
mature oligodendrocytes and astrocytes significantly increase in 
the first three years after birth (Kjær et al. 2017). In this study,
researchers found that while there was an insignificant increase 
in neurons in the first three years of life, there was almost a 
threefold increase in the number of glial cells from birth until 
age three.   Oligodendrocytes added an average of 6 million new 
cells per month, which is about two new oligodendrocytes per 
second.After the age of three, addition of new oligodendrocytes 
declined, adding only another 10 million from the age 3 until 
adulthood, whereas addition of new glial cells is negligible. 
All neural cells including neurons and glial cells are originally
derived from neuroepithelial cells of the neural tube. The neu-
roepithelial cells that will eventually become glial cells differenti-
ate into precursors of oligodendrocytes and astrocytes, and then
migrate toward the neurons.These precursors then differentiate
into immature oligodendrocytes or astrocytes.The differentiation
of the neuroepithelial cells into oligodendrocyte precursor cells is
accomplished on three distinct waves of proliferation.The waves
are initiated by sonic hedgehog signaling (SHH), a signal that con-
trols differentiation of cells in an embryo.These signals cause the
formation and migration of precursors from neuroepithelial tis-
sue in both the CNS and PNS in the early days of gestation. Less
than 3% of the precursor cells do not differentiate and remain
as precursor cells in the adult brain. Once the precursor cells
have reached their destination, they differentiate into immature
glial cells.The precursor cells will then express certain sequences
of transcription factor codes that will determine whether this
cell will be an astrocyte or an oligodendrocyte. If the cell un-
dergoes genetic commitment to oligodendrocytes, it will devel-
op a PDGFα receptor that will be sensitive to platelet derived
growth factor (PDGF), a key component in the differentiation
of a precursor into an oligodendrocyte. Upon stimulation from
PGDF the cell will then undergo chromatin condensation and will
form heterochromatin.This will cause silencing of certain genes
and the activation of specific sequences of transcription factor,
which results in the formation of an immature oligodendrocyte
(Goldman, Kuypers 2015).
Exposure of glial cells to RF-EMF results in a decreased con-
version of precursor cells to immature glial cells.A recent study 
found that long-term exposure to RF-EMF resulted in a dramat-
ic decrease of proliferation (Eghlidospour et. al 2017). One must 
keep in mind that in this particular study a higher SAR (2.287 
W/kg) was used than that of a cell phone. Despite this, the RF-
EMF was not found to induce apoptosis of these cells which had 
been previously suggested. However, the results did show an in-
ability of precursor cells to undergo proliferation into immature 
oligodendrocytes, which resulted in a lower number of available 
oligodendrocytes to perform myelination of the neurons. The 
brain of a child contains many more of these precursor cells 
than an adult brain does.The development of a neuron, including 
its axonal growth and formation of new synapses, depend on 
the myelination by the oligodendrocytes. If oligodendrocytes 
are withheld from differentiation, a lower number of mature 
cells available for neuron myelination can result.The lack of my-
elination can affect action potential speeds and cause axonal 
degeneration.Additionally, the inability to differentiate not only 
results in less immature oligodendrocyte cells, it will also result 
in less immature astrocytes.This is because astrocytes and oli-
godendrocytes share the same precursor cell. 
Conclusions 
Both biologically and socially, the early years of development 
are extremely sensitive to environmental factors of a child.The 
SAR guidelines have still not been changed to accommodate the 
developing brain of a child.There has been little effort to mon-
itor how children get phones or how long they use them. As 
technology roots itself deeply in our lives and society depends 
increasingly on its conveniences, there must be an understand-
ing of the potential effects that they can have on children.While 
the effects of exposure continue to be debated amongst re-
searchers, it is clear that the guidelines are not sufficient when it 
comes to children.The current methods of testing SAR do not 
take into account many variables that change from children to 
adults.Additionally, the guidelines have not been changed since 
1981 despite the upgrade to the “known carcinogen” category. 
The difference between the brain of an adult and that of a child, 
as well as the importance of the of development of the brain, 
should warrant a difference in guidelines. 
One may question the relevance of these studies, as they 
all discuss the brain and the normal method of talking on the 
phone. In current society talking on the phone has been re-
placed by texting and using phones for virtual reality gaming. 
Therefore, one may question whether the studies done are rel-
evant to modern society.Yet studies show that while the head 
absorbs 80% of the radiation while one is talking on the phone, 
the head absorbs 50% of the of the radiation during gaming 
(Fernandez 2018).This is still a considerable amount. Especially 
with the current culture of letting children use cell-phones to 
stream movies and play games online.The effects of cell-phones, 
whether socially or biologically, clearly affect children.While the 
purpose of this paper is not to suggest that society abandon 
cell-phones entirely, there should be some sort of regulation 
for giving a cell-phone to a child, the same way there are rules 
regarding giving a minor tobacco or alcohol. 
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Abstract 
Of the 7% of men affected with infertility, about 54% suffer from pre-testicular and/or testicular factor induced azoospermia/ 
oligospermia.This agenesis of spermatozoa has been the subject of much andrology research over the past 50 years, with a par-
ticular focus in the triggers of spermatogenesis.While much of their work is limited to murine populations, researchers have put 
a lot of emphasis on the spermatogonial stem cell (SSC) niche as the source of the trigger(s). By following physiological patterns 
exhibited in the seminiferous epithelium, researchers have been able to detect distinct morphological stages that correlate with 
spermatogonial germ-line action. Different niche cells appear to release different concentrations of active compounds, androgens, 
and receptors during different stages. Specifically, in the steps leading up to and during SSC differentiation, Sertoli cells and germ 
line cells release retinoic acid and retinoic acid receptors. Retinoic acid appears to trigger SSCs in vitro as well.Testosterone, re-
leased by Leydig cells and potentially testicular macrophages, appears to play an essential role in a spermiation-SSC differentiation 
axis, as well as a role in GDNF production by peritubular myoid cells, both required for proper maintenance of SSC populations 
and commitment to meiosis.With new and promising research being done on the whole of the SSC niche, as opposed to just 
Sertoli cells, scientists are closer than ever to uncovering the secrets of male fertility. 
Introduction 
The mechanisms of spermatogenesis, the process by which male
gametes are produced in the testes, are held within the constant
and timed divisions of spermatogonial stem cells (SSCs). In a
healthy human adult male, to maintain adequate virility, about
1000 spermatozoa are produced per second (Johnson et al.,
1980). About 7% of men suffer from infertility (Lotti & Maggi,
2015), whether idiopathic or organic. In as many as 90% of these
cases, azoospermia, a lack of sperm in the ejaculate, or oligosper-
mia, a low sperm count (below 15 million sperm cells per cc
of semen), is typically observed (Sabra & Al-Harbi, 2014). Some
of this data can be attributed to post-testicular factors, includ-
ing anatomical blockages like tumors and congenital absence of
the vas deferens; but much of this data, perhaps 60%, is due to
pre-testicular and testicular issues. For example, a lack of anteri-
or pituitary hormones such as Luteinizing hormone and Follicle
stimulating hormone (FSH), deficiencies in SSC count or serum
testosterone could all be factors (Bernie, et al. 2013).All of these
factors appear to be of the utmost importance for the steps of
spermatogenesis to be carried out properly, or to be carried out
at all. Perhaps the most essential of these steps in the journey
from SSC to spermatozoon is the first. What triggers commit
undifferentiated spermatogonia to meiosis? Understanding the
triggers of spermatogenesis can ultimately lead to uncovering the
secrets of both male fertility and infertility.This review attempts
to collect and analyze the relevant research on this subject. 
Methods 
Data was collected using ProQuest and PubMed databases 
through Touro College’s online library. Among the key-phrases 
used were “triggers of spermatogenesis”, “spermatogonium”, 
“the cycle of seminiferous epithelium”, and “testosterone and 
spermatogenesis.” 
The Spermatogonial Stem Cell 
The testes are the male gonads, where both androgens and
sperm are produced. Sperm is more specifically produced in the
seminiferous tubules, which are tightly coiled throughout the tes-
tes. Sperm cells are developed within the walls of the tubules
and, by the process of spermiation, are released into the lumen
prior to their passage to the epididymis, where they are stored
until released into semen. In humans, this timed and coordinated
process, from type A pale spermatogonia to spermiation, takes
64 days (Heller & Clermont, 1963). In order to maintain virility,
mature sperm production must be continuous, tightly coordinat-
ed, and staggered over the 64 days. Otherwise, instead of being
released continuously, sperm would be released into the lumina
of multiple tubules in a pulsatile fashion, resulting in staggered
fertility (Griswold, 2016). All sperm cells stem from SSCs. They
are the cell that gives rise to the rest of the germ-line. 
Another necessary characteristic of spermatogonia is the 
ability to replenish SSC populations as they are continuously 
committed to meiosis. In this manner, an adequate sperm count 
is maintained.At the beginning of the germ-line in human testes, 
SSCs can be identified as two types: type A dark and type A 
pale. The exact functions of these cells, or whether they are 
actually different, are not completely agreed upon (Di Persio 
et al., 2017). However, most of the literature subscribes to the 
following theory. Pale cells transition into type B spermatogonia, 
which are committed to meiosis, as well as mitotically dividing 
to maintain the proper number of SSCs. Dark cells remain on 
reserve in case of damage to the testicle or SSC population. 
According to Clermont, dark cells can be considered the true, 
most undifferentiated, SSCs in the spermatogonial germ-line, 
while pale cells are best described as the actively dividing and 
self-replenishing progenitors of B cells (Clermont, 1969;Amann, 
2008; Dym et al., 2009).Type A pale spermatogonia are the cells 
which are regularly triggered by some mechanism to enter the 
process of spermatogenesis (Gilbert, 2000). 
Many labs regularly use murine SSCs for their studies. It is im-
portant to also be familiarized with the nuances of murine SSCs 
and how they differ from humans. In mice, type A spermatogo-
nia (known in mice as type Asingle spermatogonia) only exhibit 













































exist in murine SSC populations. Before committing to meiosis, 
type Asingle cells divide into chains, or syncytia, of 2 (known as 
Apaired), 4, 8, or 16 (all three known as Aaligned).After this, the 
type A cells transition into A1,A2,A3,A4, B spermatogonia, and 
primary spermatocytes, in that order, before initiating meiotic 
division.Without a type A dark cell reserve, murine SSC pop-
ulations run the risk of dwindling if commitment to meiosis is 
not properly regulated. This extensive germ-line, compared to 
the human model, is thought to be necessary for the proper 
maintenance of SSC populations.What hasn’t been observed is 
by what mechanism these type A spermatogonia are triggered 
to commit to spermatogenesis. 
There have been many reports that both human and mouse 
SSCs can be converted to an embryonic stem cell-like state 
without the addition of new genes (Shamblott et al., 1998; 
Donovan & de Miguel, 2003; Shim et al., 2008).The limit of the 
induced pluripotency of these cells appears to be indefinite 
(Mahapatra & Gallicano, 2014). This quality has led many re-
searchers to look solely extrinsically from SSCs for the source 
of their differentiation to spermatids. This conclusion doesn’t 
appear to be correct. Although the existence of an extrinsic 
signal seems likely, as the divisions of SSCs appear to be carefully 
timed and regulated by an outside mechanism, we cannot ignore 
the fact that intrinsic factors unique to SSCs, such as certain 
receptors, are required as well (Lin et al., 2008). 
In recent years, the dogma of where to look for influences of 
SSC commitment to meiosis has shifted from just the seminif-
erous compartment toward the whole testicular environment 
of the stem cells, otherwise known as the SSC niche (Potter & 
DeFalco, 2017).This niche is made up of cells found in both the 
seminiferous compartment, such as Sertoli cells, as well as the 
interstitial compartment, such as Leydig cells and peritubular 
myoid cells. 
The SSC Niche
Sertoli Cells, the Cycle of Seminiferous Epithelium,
and Retinoic Acid 
The most adjacent cells to SSCs, Sertoli cells (once referred to 
as nurse cells) are essential in assisting the successful matura-
tion of spermatids from SSCs.They do so through direct con-
tact with germ-line cells and by creating the specific environ-
ment needed for proper sperm development.These triangular 
cells are bound by tight junctions, and are seen extending from 
the basement membrane to the lumen of a tubule, with SSCs, 
developing luminally directly between them. These branching 
cells are also responsible for forming the blood-testis barrier 
through tight junctions, which prevents unwanted substances 
from entering the seminiferous tubules, as well as regulating 
which tubular substances can enter the bloodstream (Anatomy 
and Physiology).This makes them an obvious candidate for in-
fluencing SSC differentiation.
A murine spermatogonial transplant study, designed to cor-
rect genetic male infertility in mice, observed an interesting 
relationship between Sertoli cells and SSCs.Whether host, for-
eign, or rat stem cells were injected into the lumen of a mouse 
seminiferous tubule, Sertoli cells were observed transporting 
them to the basal layer, a movement that requires the break-
ing and making of tight junctions between adjacent Sertoli cells 
(Brinster & Avarbock, 1994; Russel & Brinster, 1996). It can be 
inferred that Sertoli cells have a specific mechanism for rec-
ognizing SSCs, perhaps through cadherins (Griswold, 1998). It 
follows that the relationship between Sertoli cells and SSCs may 
be more essential than previously thought. 
The number and size of murine Sertoli cells is potentially 
regulated by FSH released by the pituitary during the pubertal 
stage (Steinberger & Jakubowiak, 1993; Meachem et al., 1996). 
These conclusions continued to be confirmed by later studies 
performed with prepubertal murine Sertoli cells but proved 
difficult to be repeated with cells from older mice (Griswold,
2018b).The studies of the effects of FSH on murine Sertoli cells 
in culture also exhibitted a positive correlation between the ex-
posure of FSH and the production of Androgen Binding Protein 
(ABP) by Sertoli cells.There was evidence that spermatogenic 
cells took up ABP, and that overexposure to ABP led to an in-
creased number of SSCs in vitro and in vivo (Gerard et al., 1994; 
Jeyaraj et al., 2002).A homologue to ABP was isolated in human 
Sertoli cells (Hammond, 2011). Further studies on this chemical 
may be able to confirm an undeniable link between FSH produc-
tion, the number of Sertoli cells, and the number of SSCs in vivo. 
A reasonable conclusion is that the number of Sertoli cells has 
a high correlation to the number of SSCs in vivo. 
“This process [spermatogenesis] has been simplified mor-
phologically by recognizing cellular associations or ‘stages’ and 
‘phases’ of spermatogenesis, which progress through precisely 
Figure 1:A cross section of a seminiferous tubule highlighting the 
cellular associations between cells in the epithelial layers, maturing 





































 Figure 2:A representation of the linear associations between certain germ cell types at each 
stage of a cycle (Amann, 2008) 
timed and highly organized cycles. These cycles of spermato-
genesis are essential for continuous sperm production, which 
is dependent upon numerous factors, both intrinsic (Sertoli and 
germ cells) and extrinsic (androgens, retinoic acids), as well as 
being species-specific.” (Hess & de Franca, 2007) Observations 
of Sertoli cells during different stages of this cycle of the semi-
niferous epithelium has given insight to possible triggers of the 
all-important first step of spermatogenesis.
Simply, the cycle of the seminiferous epithelium is the asyn-
chronous cycle through which SSCs, located basally, eventually 
develop into spermatids and are released into the lumen (Figure 
1). An SSC must go through four complete cycles to become 
an elongated spermatozoon. After every cycle (cycles begin at 
stage IX and end at stage VIII), a germ cell graduates into a more 
luminal layer of epithelium; at stage IX after the fourth cycle, the 
spermatid is released into the lumen. Every cycle has fourteen 
stages. Each stage in a cycle is characterized by the linear asso-
ciation (luminally to basally) between certain germ cell types 
(Figure 2), as well changes in neighboring Sertoli cells. 
Understanding stages VII-IX is essential for understanding 
what triggers differentiation in SSCs. Stage VII seems to be the 
start of some obvious morphological changes in type A1/type A 
pale spermatogonia.At stage IX, type A pale spermatogonia ap-
pear to be officially committed to meiosis, by differentiating into 
the next cells in the germline. Neighboring Sertoli cells appear 
to go through many changes with the cycle, with notable chang-
es occurring at stages VII-IX as well (Parvinen, 1982; Parvinen, 
1993; Johnston et al., 2008). 
Morphologically, Sertoli cells experience dramatic changes 
with every stage of the cycle. Perhaps the two stage ranges that 
expressed the most dramatic changes were stages VII-IX and 
stages XIII-III. Stages VII-IX appeared to show an increase in ret-
inoic acid receptors, retinoic acid itself, and ABP. Stages XIII-III 
showed an increase in FSH and androgen receptors (Linder et 
al., 1991). These findings “fit the known 
functional modes of the cycle with sper-
miation, onset of spermatogonial differ-
entiation and meiosis, and tight junction 
dynamics in mode A [stages VII-IX], and 
spermatogonial expansion in mode B 
[stages XIII-III].” (Griswold, 2018b) 
It has been known since 1925 that 
vitamin A, more specifically retinol (a 
precursor of retinoic acid), is needed 
for spermatogenesis. Sertoli cells were 
also found expressing retinol uptake 
and retinoic acid production (Hogarth 
& Griswold, 2010). Many vitamin A de-
pletion studies have found dramatic 
cessations of sperm production, while 
reintroduction of vitamin A led to an 
almost equally dramatic, synchronous, start of spermatogene-
sis throughout the whole length of every tubule (Morales & 
Griswold, 1987).The vitamin A depletion would usually last for 
weeks and would often leave rats and mice in very unhealthy 
states, so unequal function of SSCs at reintroduction was ex-
pected. The true magnitude of the need for retinoic acid for 
spermatogenesis may need a different model to be properly 
observed. 
Since stages VII-IX, the period in which Sertoli cells have been 
observed producing retinoic acid and its receptors, directly co-
incide with the commitment of SSCs to meiosis, a connection 
between retinoic acid levels and type A pale spermatogonial 
differentiation was proposed. 
Subsequent experiments found that both drug-induced and 
diet-induced vitamin A depletion led to an accumulation of type 
A spermatogonia in mice, with no progression into later cells 
in the spermatogonial germline.WIN 18,446, a drug previously 
used in studies aimed at developing a male birth control pill, was 
found to directly interfere with the aldehyde dehydrogenase 
that converted retinal to retinoic acid. When mice, who were 
given this drug for 9 days,were finally injected with retinoic acid,
expression of Str8 mRNA and proteins (which were previously 
known to be stimulated by retinoic acid), was observed in both 
Sertoli cells and SSCs. After 24 hours, differentiation in these 
cells was observed (Hogarth et al., 2013). The drug-induced 
studies are more valid than the diet induced studies, because 
total body effects of vitamin A depletion was avoided by the 
short periods the drug was given in. 
In short, these studies laid incredibly strong evidence that 
Sertoli cells, a source of retinoic acid, triggered the commitment 
of undifferentiated spermatogonia to meiosis.An obvious limita-
tion to these studies is the fact that all of the test subjects were 
murine. Human studies of retinoic acid with equal specificity 







































Leydig Cells,Testicular Macrophages, and 
Testosterone 
Adult Leydig cells, located in the interstitial space between sem-
iniferous tubules, are responsible for the production of testos-
terone. Luteinizing hormone binds to receptors on the Leydig 
cell. This activates LDL cholesterol displacement from the cell 
membrane and its conversion to pregnenolone in the mitochon-
dria. Pregnenolone is then transported to the smooth endoplas-
mic reticulum to be converted to testosterone through a series 
of enzyme mediated reactions (Mechanisms in Medicine., 2011). 
Interstitial and peritubular testicular macrophages protect 
SSCs and other testicular structures from both foreign and 
auto-immune attacks (Mossadegh-Keller et al, 2017). Other 
mechanisms of these macrophages are not completely known 
or understood, but some researchers speculate that they might 
indirectly influence SSC differentiation by producing small 
amounts of testosterone. More plausible is the hypothesis that 
interstitial testicular macrophages interact with Leydig cells to 
affect the production of Leydig cell steroidal agents, like testos-
terone (Trpimir, 2014). 
The average serum testosterone for men over 30 years of age 
is 350-750 ng/dL (Davis, 2018). In the testicle, the concentration 
of testosterone can be up to a factor 125 times that amount; 
this is due to the local production of testosterone (Comhaire 
& Vermeulen, 1976). A study on rats found that spermatogen-
esis decreased significantly when testicular testosterone con-
centrations dropped below 70mM, five times average serum 
concentrations (Zirkin et al., 1989). Due to an unusually high 
concentration of testosterone in the testes required for proper 
spermatogenesis, some point to testosterone as a major extrin-
sic signal in SSC differentiation. 
Effectors of testosterone can be identified by the presence of 
androgen receptors on their cell surfaces. In the testicle, almost 
all cell types express androgen receptors and thus respond to 
testosterone. Knocking out (KO) this receptor in isolated cell 
types shows how testosterone acts in these cells. Surprisingly, 
androgen receptors have not been found on germ cells, indicat-
ing that testosterone must have an indirect effect on SSC differ-
entiation, if any effect at all.“Germ cells from testicular feminized 
mice that lacked testosterone receptors were transplanted into 
the seminiferous tubules of azoospermic mice expressing func-
tional androgen receptors.When recipient testes were analyzed 
between 110 and 200 days following transplantation, multiple 
colonies of qualitatively normal donor-derived spermatogenesis 
were seen in each recipient testis.”(Sorkitis et al., 2003) Studies 
on androgen receptor KO Leydig cells seem to show spermato-
genesis arresting at spermiation, but the protocols with which 
these experiments were carried out are questionable (Xu et al., 
2007, Smith & Walker, 2014).The agent used to knock out an-
drogen receptors was anti-Mullerian hormone. Later attempts 
at mimicking these methods found that not all Leydig cells were 
androgen receptor free, while some Sertoli cells were affected. 
In three independent studies, androgen receptor KO Sertoli 
cells exhibited normal growth and proliferation in all subjects, 
showing that testosterone isn’t required for those functions(De 
Gendt et al., 2004; Chang et al., 2004; Stanton et al., 2012). 
However, analysis of the seminiferous epithelium found that 
the blood-testis barrier under-expressed necessary cadherins, 
resulting in a loss of integrity in its structure. 
Further analysis found that spermatogenesis slowed at the 
formation of elongated spermatids and arrested completely 
at spermiation, suggesting that testosterone’s interaction with 
Sertoli cells is required for these actions. Additionally, the dif-
ferentiation of spermatogonia also ceased shortly after sper-
miation did; this suggests that the mechanism of spermiation is 
involved directly with the proper maintenance of the cycle of 
seminiferous epithelium. 
From the data presented, it seems likely that testosterone is at 
least indirectly involved in the differentiation of SSCs.Although 
it’s not fully understood, other studies suggest that testosterone 
is essentially involved in a regulatory axis of spermatogenesis. 
Peritubular Myoid Cells and GDNF 
Peritubular myoid cells (PMCs) make up the smooth muscle-like 
layer that surrounds the seminiferous tubules. Some main func-
tions of these contractile cells are to provide support as well 
as some peristaltic movement throughout the tubule. A few 
studies have suggested that PMCs may indirectly affect SSC 
differentiation. 
Glial cell line-derived neurotrophic factor (GDNF), thought 
to affect the maintenance of SSC populations and SSC renewal, 
is present in both murine and human Sertoli cells (Fouchécourt 
et al., 2006).When GDNF levels are depleted, SSC populations 
dwindle while SSC differentiation is agitated.When GDNF lev-
els are elevated, SSC populations are much higher than normal, 
while differentiation is arrested completely (Meng et al., 2000). 
It has been suggested that FSH stimulates the production of
GDNF by Sertoli cells, as observed by one study.Another study
attempting to recreate the previous study’s data was unsuccessful
(Crépieux, 2001). But what was generally agreed on was that, by
some unknown mechanism, Sertoli cell production of GDNF was
essential for maintaining SSC populations and differentiation.
An androgen receptor KO study on peritubular myoid cells 
incidentally found that SSC populations decreased significantly.
Further analysis found that GDNF levels were severely lowered, 
suggesting that testosterone-stimulated peritubular myoid cells 
synthesized GDNF.This was later confirmed by a study conduct-
ed in 2014 (Figure 3).The results of which bring up questions 
about which cell plays a more significant part in SSC population 

























































Figure 3: Stains of peritubular myoid cells and SSCs in culture with 
and without testosterone (Chen et al, 2014).A-D are grown with 
Testosterone. E-H are grown without.The molecule denoted at the 
top of each column is stained for 
in peritubular myoid cells is probably due to the fact that these 
cells are very thin and don’t stain as well as Sertoli cells. 
Germ-Line Cells 
Spermiation, the process of mature spermatids being released 
into the lumen prior to their passage to the epididymis, takes 
place at the apical surface of the seminiferous epithelium. 
However, the interruption of this process further impedes 
the basal processes of SSC differentiation and commitment to 
meiosis. Interestingly, the process of spermiation directly coin-
cides with this SSC differentiation.This suggests evidence of a 
regulatory axis between the tightly coordinated processes of 
spermiation and SSC differentiation. 
As spermatids are elongated, in preparation for spermiation, 
all nonessential organelles and cytoplasm are collected into a 
section attached to the head of the spermatid. Through a se-
ries of Sertoli cell interactions with these elongated cells, and 
through testosterone stimulation of a Src pathway (see Figure 
4), Sertoli cells break and remake tight junctions, mechanically 
severing this residual body from the elongated spermatid and 
releasing the sperm into the lumen.At the same time, this path-
way allows for conformational changes throughout the entire 
length of the Sertoli cell, allowing basal germ-line cells to move 
apically (Yan et al., 2008a;Yan et al., 2008b; Cheng & Mruk, 2010). 
Studies on germ-line cells have also found that descendent 
cells from SSCs exhibit a mechanism of taking up retinol and 
producing retinoic acid, a mechanism that is very similar to the 
mechanism of Sertoli cells.This discovery led to the manufac-
turing of a Sertoli cell specific variant of the drug WIN 18,446,
called WIN 14,446.When administered before the first wave of 
retinoic acid could be initiated in mice, at 2-3 days old, the ef-
fects of WIN 14,446 were very similar to WIN 18,446. However, 
when administered at day 9, after the first wave, there appeared 
to be no effect (Griswold, 2018c).This suggests that Sertoli cell 
production of retinoic acid may be essential for starting the 
cycle of spermatogenesis, while germ-line cells may be the pri-
mary source of retinoic acid afterward. 
Discussion and Conclusion 
Much of the research presented has been done strictly on mu-
rine populations, with few parallels found in humans.Almost the 
entirety of the research on retinoic acid has been done in mice. 
Future studies must be done in human populations in order 
to obtain a true understanding of spermatogenic processes in 
humans. Other topics that require more insight are (1) the con-
centration of intra-testicular testosterone needed for proper 
spermatogenesis, (2) the specific mechanisms of the regulatory 
axis between spermiation and SSC differentiation, particularly if 
the conformation of the Sertoli cell sets off differentiation, and 
(3) how the cycle of seminiferous epithelium in murine popula-
tions differs from humans. 
Additionally, a topic that goes hand-in-hand with triggers of 
spermatogenesis is the asynchronous nature of the cycle of sem-
iniferous epithelium.Throughout the length of the tubule, sperm
are released into the lumen constantly, in an uninterrupted fash-
ion. This is due to the fact that the stage (of the cycle) at one
portion of the tubule is not the same as the stage being carried
out in adjacent portions.All portions of every tubule are releasing
sperm into the lumen at a different time. In retinoic acid depletion
studies, after spermatogenesis was completely halted, injections
of retinol stimulated an almost synchronous restarting of the
cycle in every part of every tubule. After about six months, the
cycles had returned to their asynchronous nature. Obviously, this
is a very confusing phenomenon.When asked directly about it, Dr.
Michael Griswold, who is currently researching this issue states
that “the key to the cycle is the conversion of A spermatogonia to
A1 spermatogonia. Any variance in the timing of this conversion
would ultimately lead to asynchrony.” (Griswold, 2018a) Perhaps
the carefully coordinated cycle of seminiferous epithelium isn’t
as carefully coordinated as researchers once believed.This evo-
lutionary phenomenon proves to be incredibly important in the
maintenance of mammalian fertility. 
The ideas presented here is the relevant research done on the
topic of triggers of spermatogenesis. Obviously, the research is
heavily focused on the Sertoli cell. A reason for this is the fact
that the field is mainly contributed to by those that can be called
“Sertolists”. The Sertoli cell, because of its adjacency to germ
cells, has been the obvious focus of these researchers.An exam-
ple of dangers of this bias is the peritubular myoid cell and the late
discovery of its extremely important role in GDNF production.
Yes, peritubular myoid cells are small and hard to stain, but many
published micrographs didn’t even include the interstitial space.
Perhaps the original researchers weren’t expecting the interstitial
space to be involved. 
In February 2018, researchers successfully observed human
induced pluripotent stem cells (hiPSCs) transforming into active-
ly differentiating SSCs in vivo in mice (Fang et al., 2018). When
these results were attempted to be recreated in vitro with just












































niche must be present for proper functioning.As more research
is done on the rest of the SSC niche, the field is beginning to
experience a rise in extra-Sertoli cell understanding. And per-
haps, with this understanding, the mysteries of non-obstructive
azoospermia and oligospermia will be uncovered. 
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Degeneration of Rods and Cones in Retinitis Pigmentosa 
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Abstract 
Retinitis Pigmentosa, most commonly characterized by night blindness and loss of peripheral vision, is a rare genetically inherited 
group of diseases affecting the retina of the eye. It is estimated that 1 in 4000 people in the USA are affected by some form of the 
disease. Retinitis Pigmentosa (RP), is caused by a mutation or change in one or more of 55 genes.There are many causes to this 
disease as RP presents with many different symptoms and biological effects on the eye. These are then grouped together because 
they share a common result, deterioration of vision. Presently, there is no cure for the disease. Most of the present therapies are 
aimed at preserving visual function and preventing or slowing further cell death. Restoring vision is particularly difficult because 
human photoreceptors are not produced and do not divide after birth and therefore their loss is irreversible. Experimentation in 
gene and stem cell transplantation to retard the advance of the disease, as well as drug therapies and surgeries to diminish the 
effects of the disease are ongoing and have found some limited success. 
List of Acronyms: 
RP: Retinitis Pigmentosa 
RGCs: Retinal ganglion cells 
NGF: Nerve growth factor 
IPS: Induced pluripotent stem 
DHA: Docosahexaenoic acid 
Introduction 
The eyeball consists of three main layers and is one of the most 
complex organs in the body (fig.1). The outermost layer, the 
fibrous tunic, is made up of the sclera and the cornea.Then the 
middle layer, the vascular layer, consists of the ciliary body, iris 
and choroid. The innermost layer is the nervous tunic which 
consists of the retina.The retina contains two types of photo-
Fig 1 
receptor cells, the rods and cones.The rods and cones absorb 
and convert light into electrical signals that are then sent to 
the brain. The rod and cone cells are present throughout the 
retina with the exception of the fovea, the center of the retina, 
where only cone cells are present. Rod cells are accountable for 
peripheral and night vision whereas cone cells are accountable 
for more direct visual functions like reading, driving and facial 
recognition.The rods allow us to see in dim light and the cones 
allow us to see color and details. 
RP can manifest itself as early as the first years of life,
childhood, adolescence or young adulthood.  Near the begin-
ning stage it is hard to detect the disease, especially if there 
is no familial history, as most daily functions are not affected. 
The slow regressive pattern of deterioration that defines RP 
presents in the onset of the disease with night blindness and the 
reduction of peripheral vision. The lack of peripheral vision in 
the day becomes apparent when incidents like not seeing pedes-
trians walking, not noticing cars approaching from the side while 
driving, or missing handshakes when greeting people occur. As 
the disease advances patients become sensitive to light. This 
often leads to reading difficulties and difficulty perceiving pale 
colors particularly in the blue and yellow tones. 
In the last stages as the cones begin to be more affected the 
vision field continues to narrow, and the light sensitivity contin-
ues to grow. Often patients are still able to read a little, usually 
with a magnifying glass, until the central visual field vanishes.
Usually patients can still perceive light. 
Methods 
Articles and studies researched in this paper were obtained 
through the EBSCO and ProQuest databases with access pro-
vided by the Touro College Library. Images and diagrams that 
are used throughout the paper were obtained from the re-
search articles cited. 
How is RP Inherited? 
RP is a progressive inherited disease that occurs in one of three 
ways: autosomal recessive inheritance, autosomal dominant in-
heritance, or X-linked inheritance.Autosomal recessive inheri-
tance happens when both the mother and father are carriers 
of the recessive gene mutation giving them a 1 in 4 chances of 
having a child with the disorder. The parents typically do not 
show any signs or symptoms of the disease. Autosomal domi-
nant inheritance happens when one parent has a dominant gene 
mutation giving them a 1 in 2 chance of having a child with the 
disorder. In this form of the disease there is often a parent and 
other members of the family with the disease. 
X-linked inheritance is when the mutated gene is on one of 
the X-chromosomes. It can be passed on to sons who inherit 
only one X-chromosome and cannot offset the gene with their 









































have a 1 in 2 chances of having the disease. Fathers with X-linked 
RP cannot pass the disease on to their sons.Girls inheriting only 
1 affected X-chromosome have a 1 in 2 chance of being carriers. 
Girls usually need both X-chromosomes affected to get the dis-
ease.There are a small minority of woman who get the disease 
with only one X-chromosome affected. X-linked inheritance is 
by and large thought to be the most severe form of RP and can 
begin in early childhood (Melamud, 2006). 
In a situation where only one person in the family is affected, 
the disease is referred to as simplex.These cases could be the 
result of small families where there are few possible relatives 
to be affected, or it could be the result of a new gene mutation. 
RP is primarily a monogenic inherited disease. This form of 
inheritance refers to a single gene controlling a genetic trait. 
Digenic inheritance refers to a disease that is inherited through 
the mutation of two interacting genes.There are many diseases 
caused by single gene mutations but so far very few have been 
found which are caused by mutations in at least one copy of 
two genes interacting. Digenic inheritance is a rare form of the 
genetically complex RP. 
How are the Rods and Cones Damaged? 
RP is caused by the loss of use of the rods and cones. It is typ-
ified by the initial loss of rod function followed by the death of 
the cones. It is the genetic mutation that causes the initial rod 
death, but the subsequent cone death is thought to be caused 
by its dependence on the rods. It is the loss of the cones that 
causes the severe blindness associated with the disease. 
The rhodopsin genes’ function is to encode a protein called 
rhodopsin in the rod cells. Rhodopsin absorbs the light that 
is then converted into electrical signals in the rods. The most 
common cause of autosomal dominant RP is a sequence varia-
tion in the rhodopsin gene (Schuster, 2005). 
Mutations in the rhodopsin genes obstruct their ability to 
function properly and are the cause of over 25%, of autoso-
mal-dominant RP cases. The alteration at a specific point ac-
counts for the difference in the disease expression within fami-
lies.The majority of the mutations affect the folding, and stability 
of the rhodopsin molecule (Terray, et. al. 2017). In other forms 
of the disease the mutations produce a protein that is toxic 
to the cell, or the mutation doesn’t allow the cell to function 
properly. As a result, the rods followed by the cones cease to 
function and slow progressive vision loss occurs (Jensen, 2016). 
Discussion 
While there is a great deal of re search on the genetic sources 
of the disease, there is still much to be discovered and studied 
to extend our knowledge and treat RP effectively. For example, 
most of the current research focuses on the etiology of RP. 
However, because of the many differing genetic mutations that 
cause RP there is very little research that can be done on the 
disease as a whole, but it is rather approached in a very specific 
type by type manner. Since most of the accepted approaches 
target specific versions of the disease, they are only beneficial 
to particular groups of patients. 
In the past few years there has been a vast amount of sci-
entific research into treatments for RP. These include surgical,
pharmacological and non-invasive treatments. 
Recent studies have shown that as the rods degenerate, the 
cones are deprived of glucose and eventually die.The photore-
ceptors are dependent on glucose in order to function properly. 
One of the symptoms of RP is the breakdown of this process. 
Muller cells, which are non-neural cells of the retina, serve to 
protect the retina by providing a conduit to transport glucose 
to the photoreceptors, remove debris and provide electrical 
and mechanical support of the neural retina. The Muller cells 
are among the first to show signs of metabolic changes in the 
retinal degeneration of RP and are among the last cells left in 
the degenerate retina.As RP progresses, the Muller cells follow 
a chaotic metabolic path. Unlike the precise cohesive response 
Muller cells exhibit in healthy retinas, they appear to react to 
the degenerating photoreceptors in an unfamiliar non-homoge-
neous manner.The remodeling of the retinal cells caused by cell 
stress and death is an unavoidable consequence of the progres-
sion of the disease (Pfeiffer, et. al. 2016). 
As the photoreceptors degenerate, the surviving rods and 
cones reorganize (fig. 2).This is followed by the adjustment of 
inner retinal components such as the neurons, the glial cells 
and the blood vessels. This process of remodeling cannot be 
explained as an attempt to produce new cells as retinal cells 
cannot be reproduced or regrown. It is rather seen as a reaction 
to one or more possible negative inputs that causes the remod-
eling and the eventual cell death.The course of the photorecep-
tor cell death is dependent of the underlying genetic mutation, 
the type of RP.The path of the inner retinal layer degeneration is 
Fig. 2 Normal retina vs. reorganization of the retina in a patient with 
RP (Rawa.com) 
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similar in spite of the differing underlying genetic mutation.This 
is significant in the search for a cure or a reversal of at least part 
of the progressive path of the disease. 
The complex biological process of retinal remodeling is an 
active field of retinal investigation, as it shows promise for ther-
apeutic treatments of the disease (Terray, et. al. 2017). 
Scientists have tried a number of ways to surgically reverse 
this process. One of the methods is that they have attempt-
ed to bypass the effective rods by surgically replacing them 
and restoring the transportation of glucose to the cones. The 
cones remain latent for a period of time before they die and 
if the glucose supply can be replenished before that time they 
can be regenerated. In a study of rod transplantation, the rods 
from healthy mice were transplanted into RP affected mice that 
were totally lacking rods but still had some functioning cones. 
These mice were compared to a control group of RP mice to 
measure the normal degeneration for the same period of time. 
Two weeks after surgery the number of functioning cones were 
compared between the two groups of mice. Those mice that 
received transplanted healthy rods showed 40% greater cone 
survival than untreated mice.Another surgical method that has 
shown potential as a treatment for RP is the placement of glu-
cose directly under the retina so as to regenerate and reactivate 
the cones (Mohand-Said, 2000). 
The objective of the rod transplantation surgery is to help 
the survival of the cones as they gradually deteriorate over 
time and ultimately to prevent blindness from occurring. This 
is different than other surgical treatments being tried, such as 
cataract surgery. In cataract surgery the lens of the eye is re-
moved and replaced because the lens has become cloudy and 
thus the person’s vision is cloudy. For RP patients with progres-
sively limiting vision the start of cataracts can advance the loss 
of vision significantly.Therefore, cataract surgery has been found 
to be beneficial in some cases of RP. The difference between 
the rod replacement surgery attempts and cataract surgery is 
their goals.While they both are trying to restore as much sight 
as possible, the rod replacement surgery is trying stop the pro-
gression of the disease by replacing the genetically affected rods. 
By contrast the cataract surgery is treating only the symptoms 
and not the underlying cause (Dikopf, et. al. 2013). 
There are also a vast number of non-surgical research studies 
being done. One of the first symptoms of RP is night blindness 
and difficulties with dark adaptation. Researchers have investi-
gated the use of antipsychotic drugs on RP given that the side 
effect of certain specific drugs of this type is increased light sen-
sitivity.The increase in light sensitivity produced by these drugs 
was compared to their known adverse side effects to determine 
if they could be a useful treatment in RP. 
Most antipsychotic drugs act as dopamine antagonists. They
block the dopamine receptors. In order to reach the photore-
ceptors, incoming light must first pass through all the cell layers
of the retina.The first layer is composed of the ganglion cells.The
ganglion cells are a type of neuron in the inner surface of the ret-
ina that transmit information to the brain. Between the photore-
ceptor and the ganglion cells there are bipolar cells that transmit
signals from the photoreceptor to the ganglion cell.The ganglion
cell receptive fields are subdivided into two parts, center and sur-
round.They operate in an ON center OFF surround or an OFF
center ON surround manner. In the ON center/OFF surround a
small ray of light in the center increases the cells response.An Off
center On surround has the opposite effect where a small ray of
light in the center inhibits the cells response. 
The antipsychotic drugs haloperidol and clozapine were test-
ed to see whether they could similarly alter the light responses 
of the retinal ganglion cells (RGCs) in the rat retinas. 
The drugs have the effect of transforming abnormal long la-
tent ON-center RGCs into Off-center cells. It is believed that 
these RGCs might have been Off-center cells early in the onset 
of the disease. Antipsychotic drugs are divided into two cate-
gories, typical and atypical. The difference between these two 
categories is the side effects they produce.Atypical antipsychot-
ic drugs like clozapine are considered second generation anti-
psychotic drugs that have fewer negative side effects than the 
first-generation drugs like haloperidol.The responses of the ret-
inas of the rats were recorded before and after the application 
of the various drugs. Both haloperidol and clozapine increased 
light sensitivity of the affected rat retinas. For those retinas 
that exhibited an abnormally long latency ON response to the 
onset of a small spot of light, both haloperidol and clozapine 
brought about a change and a reduction in the long latency ON 
response. Both these drugs act as an antagonist to receptors in 
the rats.The haloperidol acts as a D2 receptor antagonist while 
the clozapine acts on the D2 receptor as well as a 5-HT2A 
(serotonin) receptor antagonist.On the whole, the results imply 
that antipsychotic drugs may be useful in temporarily improving 
vision in patients with RP (Jensen, 2016). 
Other pharmacological treatments such as the supplementa-
tion of different vitamins, DHA (docosahexaenoic acid) a type 
of omega 3 fatty acid, oral valproic acid and topical brimonidine 
tartrate NGF drops, are all being explored in the hope they can 
help of protect and slow the progression of the disease. 
Vitamin A is a powerful antioxidant that has been found to 
be essential for good vision, eye health and the ability to help 
protect the eyes from night blindness and age-related degenera-
tion. Supplementation of vitamin A over a period of 4 to 6 years 
showed a significantly slower rate of visual decline. The study 
included different genetic types of RP as well as children in the 
early stages of the disease.These results contrasted the results 
of the supplementation of vitamin E. Patients receiving vitamin 
E showed a greater loss of retinal function than placebo groups. 
In a 4-year study of DHA supplementation vs. placebo the 








   
 



















Another study comparing the effects of taking DHA with vita-
min A or taking vitamin with a placebo showed that the addition 
of the DHA did not alter the results of the effects of the vitamin 
A on RP patients.The rate of decline of the progression of the 
disease remained the same (Sacchetti, 2015). 
Nerve Growth Factor 
NGF, nerve growth factor, is important in the regulation, growth
and survival of the neurons. It has been found to promote the re-
covery of neuronal damage in several animals. NGF drops were
administered in a 10-day trail to see the short-term effect of the
drops on patients with advanced stages of RP. The possible adverse
effect of the drops was monitored closely.The study showed nei-
ther adverse effects nor significant improvement in RP patients.
Stem Cell 
Stem cell transplantation is a potential treatment that is show-
ing great promise. Allogeneic stem cell transplantation, which 
are stem cells taken from matching donors, or human embry-
os, have the potential to be effective and safe. However, there 
is the ongoing controversial debate on the morality of using 
embryonic tissue in medical experiments or treatments. This 
issue coupled with the greater risk of rejection and need for 
immunosuppressant therapy when using allogeneic stem cells 
has encouraged scientists to investigate the use of autologous 
stem cells transplantations, which are treatments using stem 
cells derived from the patients themselves (Bassuk, et. al. 2016). 
IPS: Induced Pluripotent Stem Cells 
IPS cells, induced pluripotent stem cells are autologous stems 
cells that come from the person’s own skin or blood cells.These 
cells are then reprogrammed to enable them to develop into 
any type of human cell. 
The use of IPS cells as a treatment for RP has shown some 
promise in restoring some of the lost vision. Because of the 
many different genetic causes of RP there is hope of developing 
specific IPS cells to target precisely the various forms of the 
disease independently.The goal of this treatment is to edit and 
correct the patient’s pathogenic mutation in very specific type 
by type RP cases. X-linked RP is a very aggressive form of the 
disease. IPS cells have been used in studies to try to correct 
the specific X-linked form of the disease and have been found 
to correct 13% of the gene mutation that causes the X-linked 
RP. Researchers are optimistic with their success of the gene 
editing treatment of X-linked RP thus far. It establishes that this 
treatment should be continued to be studied and used as part 
of autologous transplantation of other photoreceptor degen-
eration cases. 
There are still other challenges with this treatment due to 
complications with incorrect placement, the development of 
tumors and disturbance of other types of cell which need to be 
resolved in order to further the use of this stem cells research 
(Bassuk, et.al. 2016). 
In contrast to the pharmaceutical approach to the early onset 
of light sensitivity and vision loss, the nonpharmacological inter-
ventions are based on strategies of light protection.The use of 
specialized electronic glasses to protect the eye from contact 
with light has been employed. In more advanced stages of RP 
there is the Argus ll which combines both glasses with surgery. 
The Argus ll involves the implantation of an artificial device that 
must connect to a functioning optic nerve. Electrodes are then 
implanted into the eye and connected to the glasses that can 
convert images into electrical pulses that the brain perceives as 
patterns of light. 
Conclusion 
There is promising research for treating the symptoms of RP. 
There is also promising research into fixing the underlying ge-
netic mutation that is associated with RP, with the use of stem 
cell therapy. Continued research is needed before the stem cell 
therapy can be used as a widespread treatment. it is the goal of 
researchers to treat patients earlier on in the progression of the 
disease, before complete visual function is lost. 
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The Effects of Aging on Skeletal Muscle 
ATP Production 
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Abstract 
The study of the aging process and its prevention is an incredibly popular field; the natural course of the human body is to age 
and theories abound on how to avoid it. Age affects every system and pathway of the body and alters many of the bodily func-
tions.This paper, using articles from Touro’s library database examines the different areas in which aging negatively affects ATP 
production.The multifaceted process associated with the production of ATP in the human body was analyzed. Several features such 
as the mitochondria, physical activity, and hormones are linked to ATP production and the relationship was further explored.The 
findings reveal that a dysfunction or lack of these factors, a feature of aging, is the initiator of the decrease in ATP production that 
is attributed to the natural aging process.Together, a lack of mitochondrial function, physical inactivity, reduced growth hormone 
levels, and increased insulin sensitivity levels contribute to the decline in ATP production that is concomitant with the progression 
of age.The diminishing presence of ATP then stimulates further dysfunction or lack of these elements, which in turn drives the 
aging process even further. 
Introduction 
Aging is a phenomenon that all creatures go through. It is be-
lieved to be a degenerative process caused by accumulated 
damage that leads to cellular dysfunction, tissue failure and 
death. The physiological changes which lead to senescence in 
humans may involve spine curving (kyphosis), reduced fertility, 
loss of hearing and eyesight, frailty, cognitive decline and many 
other symptoms (Trifunovic et. al., 2004). All these changes in 
the body are triggered by a variety of molecular and biochemi-
cal modifications. One of the major pathways that is altered as 
people age is the cellular respiration pathway which produces 
ATP, the body’s main source of energy. 
Methods 
The research discussed in this paper was collected from various 
different databases.The majority of the articles were compiled 
from databases such as PubMed and ProQuest, with access to 
restricted articles gained by using Touro’s library system. Some 
articles were also found through google scholar. 
An Overview of Cellular Respiration 
Cellular respiration is a set of metabolic reactions to convert 
biochemical energy from nutrients into adenosine triphosphate 
(ATP). ATP is the primary energy carrier in living organisms. 
When the cell requires energy, it breaks down ATP through 
hydrolysis; a high energy bond is broken where a phosphoryl 
group is removed and energy is released. In humans, aerobic 
cell respiration has three parts. Glycolysis is the breakdown of 
glucose into two pyruvate molecules where two molecules of 
ATP and two molecules of NADH are produced without ne-
cessitating oxygen.The next step is known as the Krebs cycle, 
the citric acid cycle or the tricarboxylic acid cycle.The carbons 
in the pyruvate molecules are pulled apart and the energy 
stored in those covalent bonds is released.This step produces 
two molecules of ATP, six NADH molecules and two FADH2 
molecules. The third and final step is the electron transport 
chain and oxidative phosphorylation. Here, oxygen is required 
and about thirty-four molecules of ATP are produced. The 
second two steps of cellular respiration, which are the main 
energy-producing steps, occur in the mitochondria, unlike gly-
colysis which takes place in the cytoplasm (Fernie et. al., 2004). 
Oxidative phosphorylation is the metabolic pathway in which 
cells use enzymes to oxidize nutrients. Electrons are fed from 
reduced substrates such as NADH, FADH2, fatty acids or glyc-
erol phosphates into the electron transport chain located in 
the inner membrane of the mitochondria. Big membrane-bound 
enzymes such as the dehydrogenases of b-oxidation, glycerol 
phosphate dehydrogenase,NADH-Q oxidoreductase (Complex 
I) or succinate-Q oxidoreductase (Complex II) pass electrons 
down the gradient of redox potential to ubiquinone (Q) which 
is a mobile lipid-soluble carrier.The electrons then get passed 
down from ubiquinone to the final acceptor, oxygen, through 
Q-cytochrome c oxidoreductase (Complex III), cytochrome c 
(a second, water-soluble, mobile carrier) and cytochrome c oxi-
dase (Complex IV).As the electrons move from less electroneg-
ative to more electronegative molecules, they lose energy, and 
with that energy, Complex I, Complex III and Complex IV pump 
protons against their electrochemical gradient from the matrix 
to the intermembrane space.A protonmotive force, consisting 
mostly an electrical gradient (membrane potential) and a small 
chemical gradient, (pH difference) is set up due to the pumping 
of protons. This protonmotive force then pushes the protons 
back into the matrix through the ion channel ATP synthase 
which harvests the energy and creates ATP (Saraste, 1999). 
Being that the main organelle involved in cellular respiration 
is the mitochondrion, dysfunction of this organelle must be the 
driving force behind the lack of energy in cells, resulting in cell 
death.This implies that dysfunctional mitochondria must be of 
central focus in aging.The decline of mitochondrial function with 
age has been recognized for some time and has been linked to 
a decreased number of mtDNA and mitochondrial protein lev-
els in human heart, brain and skeletal muscle cells.Additionally, 
aged muscle suffers from functionally impaired respiratory 
chain units, inhibiting respiration associated with ATP produc-
tion (Zapico et. al., 2016).The mitochondria in elderly tissue has 
often been found to be larger, fewer in number and contain ab-
normal cristae, vacuoles and paracrystalline inclusions (Hutter 
et. al., 2007).When the quadriceps of thirty participants whose 
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ages ranged from 78.5 ± 5. years were examined, an inverse rela-
tionship between the fatiguability level and the level of oxidative 
phosphorylation (ATPmax) was reported. Higher fatigue levels, 
a condition which is extremely common with advancing age, 
is caused by a decrease in mitochondrion capacity for oxida-
tive phosphorylation (Santanasto et. al., 2014). In another study, 
permeabilized muscle fibers from the vastus lateralis were stud-
ied from twenty-four young (approximately thirty years) and 
thirty-one older (approximately sixty-five years) subjects. This 
study was to determine if there was a change in mitochondrial 
respiratory capacity and coupled respiration (respiration linked 
to ATP production) with age and the results showed a decline 
in both (Porter et. al., 2015).There are many possible reasons 
for this decline in mitochondrial function but the most accepted 
theory seems to be the Free Radical Theory of Aging. 
Mitochondrial Free Radical Theory of Aging 
Oxidative damage is a main cause of cell degeneration. Since the 
mitochondria are involved in many redox reactions, they are 
extremely prone to oxidative stress. The source of oxidative 
damage is the free radicals known as oxidants or reactive oxy-
gen species (ROS) which are a byproduct of redox-reaction and 
therefore produced during aerobic respiration (Harman, 1956). 
Normally, a small fraction of the oxygen consumed by the mito-
chondria is converted into reactive oxygen species, but defects 
in the respiratory chain lead to greater production of these free 
radicals (Lee et. al., 2000). Superoxide Dismutase (SOD), an 
enzyme whose activity is present in subcellular compartments 
where there is O−2⋅ formation, was used as a tool to reveal 
that the mitochondria are a principle source of endogenous ox-
idants. Some of the SOD activity was recognized in the matrix 
space and the other half in the inner and outer membranes of 
the mitochondria (Imray, Fridovich, 1991). 
Ground state diatomic oxygen is not too reactive itself because
its two unpaired electrons are located in different molecular or-
bitals and possess parallel spins. As a result, in order for O2 to
simultaneously accept two electrons, they must both possess an-
tiparallel spins relative to the unpaired electrons.Consequentially,
O2 preferentially accepts electrons one at a time from other
radicals (such as transition metals in certain valences). In living
organisms, therefore, oxygen must participate in coordinated,
serial, enzyme-catalyzed one-electron reductions in order to be
reduced by two or four electrons. The enzymes that carry out
these reactions generally possess active-site radical species such
as iron.This method of O2 reduction generates O−2⋅ and hy-
drogen peroxide (H2O2).When in the company of free transition
metals (specifically iron and copper), O−2⋅ and H2O2 together
produce the hydroxyl radical (⋅OH) (Wood, 1988).This extreme-
ly reactive radical is presumed to be the species responsible for
initiating the oxidative destruction of biomolecules (Harman,
1956). When mitochondrial DNA of cells which can no longer
reproduce undergoes oxidative damage it results in mutations
and blocks in replication, leading to mitochondrial dysfunction
and ultimately a decline in ATP production. 
One study demonstrated that older people have significantly 
higher oxidative damage to DNA and that mtDNA abundance 
decreases with age.The decrease in mtDNA is attributed to the 
lessened content of mRNA transcripts that encode mitochon-
drial protein.The skeletal muscle of the elderly population was 
found to contain a reduced amount of mitochondrial proteins 
and oxidative enzymes (enzymes that catalyze redox reactions 
and increase the rate at which ATP is produced aerobically). 
Accumulated oxidative damage can be the reason for lessened 
mtDNA content in aging muscle. DNA oxidation, the process of 
oxidative damage on Deoxyribonucleic Acid, was observed to 
increases with age.Also, there is a higher activity of antioxidant 
enzymes in older rat muscles, indicating that the ROS produc-
tion rate increases with age; the ROS production rate surpasses 
the activity of the antioxidants defense enzymes (Short et. al., 
2005).The decline in mtDNA content is a contributing factor 
to dysfunctional mitochondria because it means that there is a 
lack of template availability for transcription and translation of 
crucial mitochondrial proteins.The reduction of mitochondrial 
protein synthesis and oxidative enzyme activity helps explain 
the reduced ability of mitochondria to perform oxidative phos-
phorylation in older muscle.This study concluded that there is 
a decline in mitochondrial ATP production rate (MAPR), and its 
point of validity comes from the fact that the subjects were well 
suited for the study.They had a large group of one hundred and 
forty-six healthy men and women ranging in age from nineteen 
to eighty-nine.Their physical activity was taken into account and 
they were subjects who were not regularly doing exercise (less 
than thirty minutes less than two days a week). In response to 
the studies which show that physical activity improves muscle 
mitochondrial biogenesis, the physical activity of the subjects 
was taken into account. Only men and women who were not 
regularly exercising, with activity totaling less than thirty min-
utes for less than two days a week, were chosen. Also, the 
participants were kept on a standard diet for three days be-
fore muscle biopsies from their vastus lateralis were taken for 
study.A key finding of this study was the decline in the MAPR 
of skeletal muscle with age due to a combination of reduced 
mitochondrial content and a functional alteration in the existing 
mitochondrial population (Short et. al., 2005). 
In response to the production of ROS, uncoupling agents such 
as dinitrophenol (DNP) are produced.These agents are lipid-sol-
uble weak acids that can cross the mitochondrial membrane. 
Once inside the mitochondria, these proteins eliminate the link 
between oxidation and phosphorylation. They accomplish this 
by setting up a catalytic cycle that dissipates the protonmo-
tive force, allowing the continuation of substrate oxidation all 
































































This is a thermogenic process and occurs in many living cells 
including skeletal muscle cells (Brand, 2000). The first known 
UCP, UCP1 is the one that controls brown fat which is one of 
the body’s ways of regulating thermogenesis. In the brown adi-
pose tissue, the proton leak through UCP1 is a mechanism that 
exploits energy generally used to create ATP to generate heat. 
This method of thermogenesis regulated by brown fat UCP1 is 
important in numerous physiological conditions such as arousal 
from hibernation and cold exposure in newborns.The question 
of the reason for this process arises.What reason is enough to 
validate a reduction in ATP level and such a high energetic price?
To strengthen this question, it is known that thermogenesis is 
not enough of motivation because this uncoupling process is 
done by both endotherms and ectotherms. The reasoning be-
hind this seemingly troubling process is the diminution of ROS 
production, a protection against cellular degeneration (Brand, 
2000).When calculated, the respiratory capacity used for phos-
phorylation and respiratory function linked to ATP production 
in older adults was lower than in the young (Porter et. al., 2015). 
Not only do the presence of free radicals (which are a result of 
aging) lower the skeletal muscle ATP production, but the cell’s 
natural response and method to protect itself against oxidative 
damage, which involves uncoupling proteins, is also a major con-
tributing factor to the reduction of ATP production. 
A more indirect but lethal effect oxidants have on the mi-
tochondria is that they disrupt the activity of the lysosomes. 
Oxidative damage is responsible for depositing lipofuscin in
the lysosomes. Lipofuscin us the yellow pigment granules made
up of lipid residues of lysosomal digestion, and accumulation
of lipofuscin alters the lysosomal autophagic ability. Because
the lysosomes take care of recycling unnecessary material and
organelles (such as viruses or damaged particles), their failure
results in a buildup of unwanted particles in the cell (Konig et. 
al., 2017). Decreased macroautophagic activity from lysosomal
leakage was observed in rat cells, and is a central reason for
the accumulation of damaged mitochondria in aged cells.This
buildup is associated with a decrease in mitochondrial effi-
ciency and an increase in oxidant generation (Roberg, Ollinger, 
1998).The decline in autophagic activity as a common charac-
teristic of aging makes for clogged lysosomes due to lipofuscin
and mitochondrial deterioration.This process in which mito-
chondrial ROS encourage lipofuscin generation while the ac-
cumulation of lipofuscin disturbs the mitochondrial autophagy
is known as the “garbage catastrophe theory of aging” (Hutter
et. al., 2007). 
Therefore, oxidative destruction of molecules involved in 
aerobic respiration (such as oxidative enzymes, mitochondrial 
proteins or mtDNA) leads to defective mitochondria.The mi-
tochondria themselves are primary targets of oxidative damage 
and increase their production of ROS once destroyed. Putting 
these two processes together results in a disastrous vicious 
cycle in which the synthesis of malfunctioning electron trans-
port chain subunits results in oxidative phosphorylation impair-
ment, decreased ATP production and further ROS generation. 
Physical Activity 
There are many studies which say that the primary contributing
factor to reduced mitochondrial function is the lack of physical
activity. In one study, thirty-nine volunteers were to complete
graded exercise tests to determine their daily physical activity,
fitness, and exercise efficiency.The group of volunteers included
ten young active people about thirty years old, ten older active
people about sixty-seven years old and nineteen older sedentary
people. Mitochondrial energetics from biopsies of the vastus lat-
eralis were measured via magnetic resonance spectroscopy and
respirometry. The results of this study showed a higher fitness
level in the young active compared to the older active and older
sedentary.The mitochondrial respiration, maximum mitochondri-
al capacity, Maximal ATP production/Oxygen consumption (P/O)
ratio, and exercise efficiency were similar in the young active and
older active and were significantly lower in older sedentary.This
study concluded that constant physical activity makes for better
mitochondrial capacity (Distefano et. al., 2018).
 Besides for physical activity having an effect on the mitochon-
drial efficiency (ATPmax/max O2 consumption), the reverse is 
also true. Lessened mitochondrial efficiency seems to have a 
negative effect on older peoples’ physical activity. A study was 
done to analyze whether or not slower walking speed in older 
adults is related to reduced mitochondrial capacity and effi-
ciency.A group of thirty-seven older people (ages ranging from 
seventy to eighty-nine) who were of normal weight (under 286 
lb for the men and under 251 lb. for the women) were chosen. 
They were able to walk unassisted and had no symptoms of 
cardiovascular or pulmonary disease.They had no pain or stiff-
ness in the legs, hips, knees, feet, or ankles when walking and no 
difficulty bending or straightening the knees. The participants 
were told to complete a 400-meter walk within 15 minutes at 
their normal walking speed. Afterward, muscle fibers biopsies 
from the vastus lateralis were taken to be observed.A key find-
ing was that muscle mitochondrial efficiency correlated with the 
participants walking speed.This study concluded that the loss of 
mitochondrial capacity and efficiency with age may be import-
ant contributors to the reduction in mobility and increase in 
disability.This is due to the relationship between mitochondrial 
capacity and walking speed (Coen et. al., 2012). 
The link between physical activity and mitochondrial ener-
getics is that aerobic exercise enhances muscle mitochondrial 
biogenesis. Resistance training in older people can increase 
the protein synthesis rate.The content and function of certain 
proteins in the muscle which are vital to its functioning, de-
pend on the protein synthesis rate (Short et. al., 2005). Exercise 
counteracts decay which happens in aging muscle by heightening 
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muscle protein turnover. Because muscle mitochondrial content 
and function is reduced with age, the resting and maximal oxy-
gen consumption also decline with advancing age (Short et. al., 
2004). The VO2max of an individual is closely associated with 
mitochondrial ATP production and so a decline in the VO2max 
with age means that it is correlated with a decline in ATP pro-
duction. In muscle samples taken from healthy individuals ranging 
from eighteen to eighty-seven years, the VO2max while cycling 
declined approximately eight percent per decade (Short et. al., 
2005). If constant physical activity throughout one’s life is what 
can keep the VO2max at a decent level, it must be that physical 
decline, a common occurrence in aging, is in part a contribution 
to the reduction of ATP production. 
Sarcopenia and Physical Decline 
Sarcopenia, a natural part of the aging process, is the progressive 
decline of muscle mass, strength and physical function.The loss 
rate is believed to accelerate after the age of sixty-five.The de-
terioration of muscle quantity and quality leads to a decline in 
strength and power and a slowing of movement, all features of 
sarcopenia (Baumgartner et. al., 1999).A deterioration in muscle 
mass is followed by a decline in physical activity which has been 
negatively linked to mitochondrial function. 
Age-related hormonal changes seem to be a possible mech-
anism for the onset of sarcopenia. Insulin-like growth factor 
1 (IGF-1) is a protein that is encoded by the IGF-1 gene. This 
hormone plays a fundamental role in childhood growth and 
continues to have anabolic effects in adulthood.The production 
of IGF-1 is stimulated by growth hormone. Growth hormone 
(GH) is made in the anterior pituitary gland, released into the 
blood stream, and then stimulates the liver to produce IGF-
1. IGF-1 is the stimulation for systemic body growth, and has 
proliferating effects on many cells in the body, especially skeletal 
muscle (Laron, 2001).After twenty years of age, the secretion of 
growth hormone decreases by approximately fourteen percent 
per decade. This decline is followed by a reduction in IGF-1, 
which is responsible for cell production, energy metabolism, and 
inhibition of apoptosis (Giannoulis et. al., 2008). 
Testosterone, an anabolic steroid which increases muscle 
protein synthesis, begins to drops in male serum levels in the 
late thirties and continues to decline throughout adulthood. A 
group of older men were treated with testosterone in order 
to increase their testosterone level to that of younger men. 
The treatment attenuated one symptom of sarcopenia, the loss 
of muscle mass (Storer et. al., 2016). In females, the positive 
correlation between plasma estrogen levels and muscle mass 
suggests that reduced estrogen following menopause may result 
in reduced muscle mass as well (Van Geel et. al., 2009). 
Although there was no change in muscle mass or strength 
when healthy males were treated with GH alone, the addition 
of testosterone to the treatment resulted in a 6.8% increase in 
muscle strength.There was also an increase in lean body mass 
(LBM=total body weight minus the fat) which indicates the cor-
relation between lean body mass and strength; a change in LBM 
results in a change in strength.Along with increase in LBM came 
an increase in VO2max. (Blackman et. al., 2002). An effective 
mechanism to increase the endogenous levels of somatotropic 
hormones (such as GH and IGF-1) in the blood is training and 
exercise.A thirteen-week combined sprint and resistance train-
ing in middle-aged men improved the body composition and 
increased circulating GH. There was also an increase in IGF-1 
level following the exercise which shows that training can coun-
teract the natural decline in somatotropic hormones during 
aging (Sellami et. al., 2017).A decrease in GH and testosterone, 
vital anabolic hormones, plays a big role in the loss of muscle 
mass which is a key element in the development of sarcopenia. 
Another possible cause of sarcopenia is the acceleration of
apoptotic pathways. Apoptosis is the highly regulated and con-
trolled process of cell death in multicellular organisms.This pro-
cess can happen via the intrinsic pathway in which the cell kills
itself because it senses cell stress, or the extrinsic pathway, where
the cell kills itself because of signals from the other cells. Both
pathways initiate the activity of caspases, enzymes that destroy
proteins. Apoptosis is a homeostatic process which keeps our
body balanced between all the new cells arising from stem cells
and the billions of cells dying each day.This very beneficial process
becomes a problem when it accelerates with age and results in
the loss of muscle mass and strength.Although the mechanism for
the acceleration of these pathways is unknown, what is known is
that there are many contributing factors such as oxidative stress
and impaired insulin sensitivity (Marzetti et. al., 2012).
Insulin Resistance 
A major finding in old age is insulin resistance. Insulin is a hor-
mone produced by the pancreas and regulates the amount of 
glucose in the blood. Resistance to this hormone can result in 
type 2 diabetes. Age associated decline in mitochondrial func-
tion seems to be related to insulin resistance.The MAPR was 
found to be approximately thirty percent less in patients who 
were insulin resistant compared to those who were not, and 
that was consistent with the finding of altered mitochondria 
(Petersen et. al., 2004).The altered mitochondria and reduced 
MAPR is known to be a contributing factor to insulin resistance. 
In addition to that, insulin stimulates transcription and trans-
lation of mitochondrial proteins and genes thereby increasing 
MAPR and this effect is lacking in those with type 2 diabetes. So, 
whether insulin resistance causes a decrease in mitochondrial 
function or the reverse, both possibilities are plausible for they 
seem to each have an effect on the other (Short et.al., 2005). 























     
 
 













mitochondrial ATP production in skeletal muscle, both subjects 
with and without type 2 diabetes were recruited and muscle bi-
opsies of the vastus lateralis were examined.The muscles were 
infused with a low dosage of insulin and a high dosage of insulin 
and were studied after eight hours. Mitochondrial protein com-
plexes, whose syntheses are dependent on coordinated tran-
scriptional regulation of mitochondrial and nuclear genes, must 
be available for mitochondrial ATP production to occur. In the 
subjects without diabetes, the high dose insulin infusion resulted 
in a higher mitochondrial fractional synthesis rate.Additionally, 
there was an increase in the activities of the oxidative enzymes 
citrate synthase and cytochrome-c¬-oxidase subunit IV (a part 
of complex IV). (Citrate synthase is the pace-making enzymes of 
the first step in the citric acid cycle and increased activity of the 
citric acid cycle may increase the rate of ATP production.) There 
was also an increase in the mRNA level from both mitochondri-
al (NADH dehydrogenase subunit IV) and nuclear (cytochrome 
c oxidase subunit IV) genes encoding mitochondrial proteins. 
After eight hours of high dose insulin infusion, the mitochondri-
al ATP production rate of the individuals with type 2 diabetes 
did not change. Clearly, insulin infusion increases mitochondrial 
protein synthesis and the mitochondrial capacity for oxidative 
phosphorylation in skeletal muscle (Stump et. al., 2003). Insulin 
is not only important for regulating the blood sugar level but 
it is also heavily involved in ATP production. Resistance to this 
hormone, resulting from dysfunctional mitochondria, causes a 
decrease in mitochondrial protein content thus reducing mito-
chondrial respiration and ATP production. 
Conclusion 
The free radical theory of aging which gives reason for the mal-
functioning mitochondria is itself a result of dysfunctional mito-
chondria. Increased ROS production, a byproduct of mitochon-
drial decay disrupts lysosomal activity creating the additional 
accumulation of damaged mitochondria followed by an increase 
in oxidants.An additional result of oxidative damage is the de-
crease in muscle mass, muscle strength and movement.The op-
posite is also true, physical activity has been shown to increase 
muscle mass and counteract the production of free radicals 
(ROS) while physical inactivity has shown to increase ROS lev-
els, increase sarcopenia and decrease insulin sensitivity. Insulin 
resistance is another result of oxidant accumulation and phys-
ical inactivity and causes additional ROS content by disturbing 
mitochondrial protein synthesis. Essentially, all of these factors 
are negative feedback loops that influence each other. Studies 
which failed to see the correlation between these features and 
decreased ATP production with age, may be because they failed 
to look at all of these factors as a whole and recognize that 
when they all come together, create a vicious cycle. Although 
it is unclear how and where this natural process starts, once it 
does, there is no way to end it.The decrease in ATP production 
in skeletal muscle is an ordinary part of the aging process which 
results in driving the aging process even further. 
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Abstract 
Energy drink usage as a stimulant is on the rise among adolescents and young adults.While these drinks have positive energizing 
effects, they pose significant health concerns.This paper examines the adverse cardiovascular effects of energy drinks and the 
components that could possibly be responsible.Analysis was conducted by reviewing and comparing many studies available in this 
area of research. Studies of energy drinks in general and energy drinks versus drinks containing caffeine alone were analyzed. 
Additionally, this review investigated studies of the specific ingredients in energy drinks such as caffeine, taurine, guarana, and 
sugar.This review found that energy drinks cause varying degrees of adverse cardiovascular effects when consumed in specific 
dosages.While the highest levels of consumption led to arrythmias, syncope and death, lower levels led to increased QTc interval 
and increased blood pressure. Longer lasting effects of energy drinks, such as possible energy-drink induced hypertension, were 
also uncovered.The effects of energy drinks were deemed greater than those caused by caffeine alone.When analyzing energy 
drinks’ ingredients, caffeine, sugar, and guarana were found likely responsible for the adverse effects of energy drinks, while the 
effect taurine was less convincing. Overall, while energy drinks were found to be safe in small and infrequent amounts, significant 
public health concerns were related to increased and habitual use. 
Introduction 
Energy drinks are widely used stimulants that are said to en-
hance performance, alertness, and concentration. Marketing 
of these beverages specifically targets adolescents and young 
adults, many of whom are said to take advantage of these drinks 
and their stimulant effect. Despite the perceived ‘invincibility’ 
connoted by names such as ‘Monster’ and ‘Red Bull,’ these 
pick-me-ups may pose significant health concerns. Substances 
present in energy drinks such as caffeine, sugar, and taurine have 
numerous hemodynamic effects.As such, these drinks are sus-
pected of leading to various health threats including adverse 
cardiovascular events.These range from high blood pressure to 
cardiac arrythmias, which, in more extreme cases, can lead to 
sudden cardiac death.The goal of this review is to evaluate the 
following question: What are the energy drink-related cardio-
vascular health concerns, are they valid, whom do they concern, 
and how do energy drinks lead to these events? 
Methods 
This review was conducted by typing keywords and phrases such 
as “energy-drinks,” “energy drinks and cardiovascular effects,” 
“the effects of energy drinks,” “energy drinks and mechanisms,” 
and the like into database search engines such as EBSCO and 
ProQuest.The databases were accessed through Touro College, 
Einstein Medical College, and Johns Hopkins University. Many 
articles were also retrieved through Google Scholar. 
Results and Discussion 
How widespread is the usage of these drinks,and who is using them? 
Energy drink sales have been steadily increasing since the turn 
of the century and are not expected to decrease in the near 
future. In 2006, the industry’s retail market value was already 
$5.4 billion (Packaged Facts, 2007), a value dwarfed by 2016’s 
$25 billion market (Packaged Facts, 2017). 
Young adults are the heaviest consumers.Whether one gen-
der drinks more heavily than the other is arguable. According 
to the NIH, the most common drinkers are men of ages 18-34 
(NIH, 2018). Furthermore, in a study of 496 college students, 
51% reported using energy drinks more than once a month on 
average. Of these users, most said they used one energy drink 
at a time. More concerning though, is that a considerable sub-
group admitted to using three or more drinks at a time when 
mixing energy drinks with alcohol. In contrast to the NIH data, 
this study found 53% of the users to be female, trumping the 
42% who were male by a significant percentage. It should be 
noted that while the results of this study are comparable to 
those of similar studies, they should serve solely to paint a gen-
eral picture, as the 496 participants were all from one college 
(Malinauskas et al., 2007). 
Studies of the rampancy of energy drink usage in adolescents 
also show worrisome results.The CDC reports that 30-50% of 
adolescents consume energy drinks (CDC, 2016). Even higher 
rates were found in two studies done in Canada and the US, in 
2012 and 2014, respectively, which found that two thirds of par-
ticipants used energy drinks occasionally, with others consum-
ing them monthly, or even weekly (Azagba, et Al., 2014; Miller, 
et al., 2018). Therefore, when weighing the damage of energy 
drink usage, we must bear in mind that the affected population 
not only includes many adults under 30, but also a great number 
of adolescents, on whom the damage may have longer-lasting 
consequences. 
The Substances in Energy Drinks 
While energy drinks contain various ingredients, their main
active ingredient is caffeine. It is well known that the amount
of caffeine in energy drinks varies greatly, with most drinks
containing between 50 and 360 milligrams. More importantly, 
many of these drinks fall into the 100 mg – 200 mg range. 
A formal study that measured caffeine content of 14 ener-
gy drinks found values ranging from 67 mg – 240 mg, and an
even wider range of 34 mg-330 mg in energy shots (smaller, 
more concentrated drinks) (Attipoe, et al, 2016).These doses
64 
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are not higher than the amounts of caffeine in many coffees
such as those sold by Starbucks and Dunkin Donuts.This, and
the fact that there is a decaffeinated ‘5-hour Energy’ drink, 
suggests that caffeine may not be the only factor causing the
effects attributed to energy drinks. 
Consequently, this review should also consider the other
ingredients and their functions.These substances include glu-
cose, ginseng, high amounts of taurine, B vitamins, green tea
extract, guarana (a seed that contains caffeine), green coffee
extract, carnitine (an amino acid), glucuronolactone, and ino-
sitol.When analyzing the effects of these ingredients, though, 
caffeine should not be disregarded. The fact that much is
known about caffeine’s effect on the body and that energy
drink manufacturers employ high amounts of caffeine in the
making of their drinks implies that caffeine may still be the
most important ingredient to study. 
Cardiovascular/Hemodynamic Effects of Energy 
Drinks/Caffeine 
Many studies have analyzed the hemodynamic influence of ener-
gy drinks. Some studies’ results are consistent, while others are
contradictory. These differences are often due to differences in
dosages of energy drinks. Since caffeine is considered their most
active ingredient, this review will group studies by caffeine dosage in
the tested drinks when trying to compare studies and their results.
Whereas caffeine is known to have numerous energetic and 
hemodynamic effects on the body, the FDA advises that doses 
of less than 400 mg of caffeine a day are generally safe. Still, the 
administration says that safe dosages can only truly be set on 
an individual basis, as levels of sensitivity vary throughout the 
population (FDA, 2018). This is one of the many factors that 
can account for variation between results of studies, even when 
similar dosages of caffeine were used. 
Energy Drink Dosage as a Factor: 
Extreme Caffeine as a Danger 
A retrospective analysis of 101 patients who arrived at the 
emergency room having consumed extreme amounts of caf-
feine showed that many displayed conditions such as tachypnea, 
tachycardia, and arrhythmia. Seven patients experienced cardiac 
arrest. Of the 101 patients, most survived after treatment, but 
three of the seven who developed cardiac arrest died.The pa-
tients’ estimated caffeine dosages were between 1.2 g to 82.6 
g of caffeine with a median ingestion of 7.2 g.Although hard to 
believe, some of these patients consumed these dosages using 
energy drinks. Consequently, while this study illustrates the dan-
gers of extreme caffeine usage, the results hardly concern the 
general public, as a person would have to drink 37 cans of a 
highly caffeinated energy drink within a few hours to reach the 
minimum lethal dosage of caffeine in this study, 6 mg. (Kamijo, 
et al, 2018) More important though, is that this study shows 
that caffeine and energy drinks certainly affect blood flow,
heart rate, and other vital variables. Whether or not smaller 
amounts of caffeine can induce the same conditions remains to 
be determined. 
More Moderate Dosages: Case reports 
Even in smaller amounts, caffeine, and energy drinks specifically,
can have serious pathogenic effects.There have been many case 
reports describing episodes of energy-drink related cardiovas-
cular incidents, including cardiac arrest, which developed after 
the patients had consumed much lower dosages than those 
mentioned in the above study. 
In one such case, a 28-year-old, otherwise-healthy motocross 
racer experienced cardiac arrest after just seven or eight cans 
(640 mg) of a caffeinated energy drink (Berger, Alford, 2009). 
In another, a 16-year-old volleyball player experienced repeat-
ed episodes of orthostatic tachycardia and rapid changes in 
blood pressure, diagnosed as reversible postural tachycardia 
syndrome. This was ultimately attributed to her usage of Red 
Bull, of which she had started to drink 4-5 cans daily (400 mg at 
most) (Terlizzi, et al., 2008). Moreover, doctors report cardio-
vascular events linked to dosages not only less than the previ-
ous study, but to doses that are less than FDA-recommended 
safe consumption.A 23-year-old woman presented with supra-
ventricular tachycardia at 219 bpm after just one GNC speed 
shot (250 mg of caffeine) and a Mountain Dew (55 mg/12oz) 
(Nagajothi, et al., 2008). Lastly, and most intriguing, is the case 
of a 28-year-old basketball player who fell unconscious while 
playing and later died after drinking only three 250 ml energy 
drinks, amounting to only 180 mg of caffeine (Avci, et al., 2013). 
Although case reports cannot stand alone as evidence, that the 
patients in these cases were otherwise healthy and that doctors 
ruled out other probable causes, as well as the myriad of similar 
case reports, give reason to believe that the energy drinks could 
have caused these negative outcomes. It is important to note 
that high physical activity after consumption is a characteristic 
of many of these cases (Avci et al., 2013; Berger, Alford, 2009; 
Terlizzi, et al., 2008), suggesting that exercise plays a role precip-
itating these side effects. 
More Moderate Dosages: Formal Studies 
In order to scientifically test if energy drinks have these cardio-
vascular and hemodynamic effects on the general public,many re-
searchers have conducted studies which gave specific amounts of
energy drink to young, healthy participants, measured vital signs
before and after ingestion, and determined the drink’s hemody-
namic effects either using participants as their own controls or
splitting the participants into case and control groups. 
Energy drinks containing 320 mg of caffeine seemed to con-
sistently raise QTc intervals as well as systolic blood pressure. 






























































energy drinks found similar results regarding these two param-
eters (Fletcher, et al., 2017; Kozik, et al., 2018). These results 
are concerning because prolonged QTc intervals are known 
to lead to dangerous cardiac arrhythmias, or changes in heart 
rhythm (Priori, et al., 2003). Furthermore, the second study 
found QTc to rise to extremely high levels of above 500ms in 
eight participants (Kozik, et al., 2018). As with the above case 
studies, these extreme findings developed after physical activity,
and QTc normalized once participants rested.This points to the 
positive relationship between the degree of physical activity and 
the severity of the effects of energy drink consumption. 
While more moderate dosages do not cause electrocardio-
graphic effects in most people, they still have consistent hemo-
dynamic effects. Researchers in at least seven different studies 
found that energy drinks with caffeine dosages ranging from 77 
mg to 215 mg did not increase QTc (Brothers, et al., 2016; Elitok, 
et al., 2015; Garcia, et al., 2016; Hajsadeghi, et al., 2015; Ragsdale, 
et al., 2009; Shah, et al., 2016; Steinke, et al., 2009). On the other 
hand, in at least nine studies where blood pressure changes 
were measured, results showed that energy drinks containing 
anywhere between 114-215 mg of caffeine consistently raised 
systolic blood pressure (Brothers, et al., 2016; Elitok, et al., 2015; 
Garcia, et al., 2016; Grasser, et al., 2014a; Hajsadeghi, et al., 2015; 
Marczinski, et al., 2014; Ragsdale, et al., 2009; Shah, et al., 2016; 
Steinke, et al., 2009). Many of these studies found an increase in 
diastolic blood pressure and/or heart rate as well (Elitok, et al., 
2015; Grasser, et al., 2014a; Hajsadeghi, et al., 2015; Marczinski, 
et al., 2014; Shah, et al., 2016; Steinke, et al., 2009). Although 
many of these studies used seemingly small participant groups, 
the number of necessary participants was statistically calculated 
beforehand. Moreover, since multiple studies have shown similar 
results, the size of the studies is less of a concern. In total, the 
studies show that even moderate amounts of caffeine tend to 
raise blood pressure. A rise in blood pressure can be induced 
by many factors, including exercise alone, and this may not be a 
public health concern if the effect is transient. 
Small Dosages: Formal Studies 
In terms of the potential detrimental effects mentioned above, 
energy drinks with a small amount of caffeine do not seem dan-
gerous for healthy people. Studies in which participants were 
given dosages of up to 80 mg found hemodynamic and electro-
physiologic parameters to be for the most part unchanged, with 
the exception of an increase in heart rate found in one study 
(Hajsadeghi, et al., 2015; Ragsdale, et al., 2009). 
Effects on Patients with Cardiovascular Disease 
While it seems that caffeinated energy drinks used in modera-
tion are safe for most healthy people, for the large population of
those with cardiovascular abnormalities and diseases, they may
not be as safe. Studies of the cardiovascular effects of energy
drinks show that while these drinks may not directly cause more
serious hemodynamic or electrophysiologic effects in this group
than in healthy subjects (Gray, et al., 2017), these same effects may
be safe for healthy people, but may indirectly cause more serious
consequences in people with underlying cardiovascular compro-
mise. People with cardiovascular diseases are often predisposed
to dangerous arrythmias, which can lead to syncope and sudden
cardiac death (Priori, et al., 2003). Ingesting energy drinks, which
affect the sympathetic nervous system, cardiac function, and
blood pressure, increases the chances for arrythmia development.
For example, one serious type of arrhythmia-caused myocardi-
al event is known to occur when a ventricular premature beat
sparks during the T-wave and leads to circus action in the heart.
Therefore, substances like energy drinks, which lengthen the QT
interval, increase the possibility of this extra beat landing on the
T-wave.Although it would be hard to test these concepts in a for-
mal study, many case studies have reported patients with previous
cardiovascular diseases whose arrythmias developed after energy
drink consumption (Dufendach, et al., 2012; Rottlaender, et al.,
2012; Rutledge, et al., 2012). 
Furthermore, since many cardiovascular diseases go undiag-
nosed, the dangers of caffeine consumption affect a larger pop-
ulation than just those with diagnosed cardiac diseases. Many 
case studies describe people whose cardiac syndromes came to 
light only after an adverse effect, caused by energy drinks, lead 
to a cardiovascular evaluation (Dufendach, et al., 2012; Rutledge, 
et al., 2012). 
Longer-Lasting Effects 
A further concern is that studies indicate that moderate doses 
in repeated amounts may have a long-term effect. In two studies, 
participants were instructed to drink the energy drink for seven 
consecutive days. Hemodynamic measurements were taken on 
the first and seventh days at baseline and after consumption. In 
one study, on the first and seventh days, heart rate increased by 
7.8% and 11%, systolic blood pressure by 7.9% and 9.6%, and 
diastolic blood pressure by 7.0% and 7.8%, respectively. While 
the increases in heart rate and systolic blood pressure were not 
statistically significant, the increase in diastolic blood pressure 
was (Steinke, et al., 2009). The second study did not find any 
statistically significant changes between the days but did notice 
a trend of increased blood pressure after chronic consumption 
of the energy drink (Shah, et al., 2016).These data point to the 
possibility that the effects of the drinks on blood pressure can, 
in fact, last more than a few hours. 
These results are strengthened by those of a differently de-
signed study of 333 adolescents, in which hemodynamic measure-
ments were taken at baseline, during emotional stress, and during
recovery without the ingestion of caffeine. Serum caffeine at the
time of the study was determined to be nonexistent or trivial.
At the start of the lab sessions, the teenagers were asked about
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their habitual caffeine consumption.The study found that total pe-
ripheral resistance was significantly higher in those who reported
high habitual caffeine consumption (about 258 mg per day) during
exercise and at rest.The researchers also noticed a slight trend
of increasing systolic and diastolic blood pressure correlated with
high, medium, and low habitual consumption groups. This sug-
gests that daily caffeine ingestion and blood pressure are directly
proportional (James, et al., 2018).As increased blood pressure is
a precursor to many serious cardiovascular complications, the
implication that energy drinks cause not only transient, but last-
ing increases in blood pressure is of concern. It is possible that
these long-lasting effects more strongly influence young chronic
drinkers than adults,but more extensive studies would have to be
conducted to confirm this hypothesis.
Caffeine Consumption Patterns Considered 
When analyzing safe amounts of energy drinks, caffeine con-
sumption patterns should not be overlooked. Since caffeine of-
fers consumers a positive feeling, they tend to want to increase 
consumption. The efficacy of caffeine is in keeping drinkers 
awake, many habitual users gradually sleeping less and drinking 
more. Lastly, with habitual consumption, some drinkers develop 
tolerance to caffeine (Shah, et al., 2016). One the one hand, this 
may render habitual consumers less susceptible to the sudden 
negative developments associated with caffeine. One the other 
hand, this tolerance may lead them to slowly increase their caf-
feine intake to a level that will affect them negatively.Therefore, 
it is likely that many energy drink consumers may start drinking 
at a safe level and later reach dangerous levels of consumption 
(Malinauskas, et al., 2007). To reinforce this point, most of the 
energy drink-related case reports were not of suicide attempts, 
but rather of consumers who had mistakenly increased their 
dosage to a dangerous level. 
What in Energy Drinks is Causing these Effects?
Energy Drinks versus Caffeine 
While it is clear that energy drinks can have serious cardiovas-
cular effects, the question of which ingredients are causing those 
effects is still a disputed topic.There have been many studies in 
which researchers tried to isolate the effects of one ingredient 
as it relates to the general effects of the drinks. 
Even so, it is understood that while energy drinks’ other
ingredients can have some effects, their caffeine content plays
a big role in the health effects mentioned. Proving this, re-
searchers tested the hemodynamic effects of caffeinated en-
ergy drinks versus those of decaffeinated or non-caffeinated
energy drinks. In both studies reviewed, studiers found chang-
es in various blood pressure parameters to be greater after
the caffeinated version of the same drink (Kurtz, et al., 2013; 
Phan, Shah, 2014). 
Knowing caffeine to be the most apparent active ingredient, 
researchers attempted to clarify whether the other substances
in energy drinks could possibly strengthen the drinks’ effects. 
As a first step towards analyzing the other ingredients, many 
studies attempted to test the consumption of energy drinks 
versus the consumption of caffeine. In four such studies, energy 
drinks were found to have a greater effect on the parameters 
that researchers watched. While not all the studies observed 
changes in identical parameters, variables such as QTc inter-
val, systolic and diastolic blood pressure, cardiac contractility 
and stroke volume were found to be more affected by energy 
drinks than by the caffeinated control drink (Baum, et al., 2001; 
Doerner, et al., 2014; Fletcher, et al., 2017; Franks, et al., 2012). 
Three studies similar to the previous ones reported that they 
did not see any difference between energy drinks and caffeine in 
these parameters.This could give reason to doubt the previous 
studies but does not for the following reasons:Two of the stud-
ies not only did not see a difference, but also did not observe 
any cardiovascular effects after either drink, so their results may 
not be a good means for comparison of the two. (Brothers, et al., 
2016; Laizure, et al., 2017) Also, one of the studies used a Guru 
energy drink that lacked taurine and sugar, two ingredients that 
are often focused on in evaluation of the drink’s effect. (Laizure, 
et al., 2017) Lastly, the third study only measured parameters 
for twenty-five minutes following energy drink consumption 
(Pettit, et al., 2013).This is not a valid analysis as many studies 
have shown that the effects of energy drinks are apparent one, 
two, or three hours after drinking and many times cannot be 
seen during the first hours (Fletcher, et al., 2017; Grasser, et al.,
2014a; Elitok, et al., 2015). Moreover, in a graph of this study’s 
data, heart rate elevation after energy drink consumption starts 
to slightly surpass the caffeine-induced elevation just at the end 
of the twenty-five-minute interval (Pettit, et al., 2013). Based on 
the time taken to see results in other studies, it is highly prob-
able that the researchers would have seen a more prominent 
difference had they measured parameters for longer.Therefore, 
although the above studies report varying results, it is likely that 
energy drinks have a greater effect on the cardiovascular system 
than caffeine itself.This begs the question of which ingredients in 
energy drinks could be causing these effects. 
Energy Drink Ingredients and Their Effects 
Energy drinks contain many ingredients that may be active, in-
cluding taurine, guarana, sugar, and caffeine, among others, as 
mentioned earlier. Some of these substances have not yet been 
widely researched, others have been researched but remain 
highly questionable, and a few seem to have a significant role in 








































Taurine is a naturally occurring nonessential amino acid. It has 
been studied numerous times, but with results that create a very 
wide spectrum of possible effects. Some studies do show am-
plified cardiovascular effects when caffeinated drinks containing 
taurine were compared with non-taurine-containing caffeinated 
drinks (Baum, et al., 2001; Doerner, et al., 2014). The validity 
of their conclusions is doubtful, though.  One study showed a 
subtle, yet significant increase in left ventricle contractility, but 
did not report the ingredients of the energy drink in question 
other than its taurine and caffeine content. Since it is possible 
that there were many other role-playing ingredients, this can-
not serve as a controlled study of taurine’s effects (Doerner, 
et al., 2014).Another study with a similar deficiency attributed 
an increase in stroke volume and contractility to taurine but 
did not account for the glucuronolactone present in the study 
drink that was not present in the control (Baum, et al., 2001). 
Glucuronolactone is an organic metabolite often used in energy 
drinks.Whether or not it has cardiovascular effects is unknown, 
but the fact that this study disregarded its presence in the drink 
in question weakens the conclusion that the augmented effects 
were due to the taurine.  Moreover, aside from the ambiguity of 
these results, many studies of taurine have shown that it does 
not have detrimental cardiovascular effects, but rather, it has 
cardioprotective effects. One such study showed that taurine 
had systolic and diastolic blood pressure-lowering effects and 
also led to a decrease in plasma catecholamine levels (Fujita, 
et al., 1987). These results suggest that not only does taurine 
not intensify caffeine’s negative hemodynamic effects, it atten-
uates them. It should be noted though, that this study tested 
taurine alone versus a placebo, as opposed to the above studies 
which investigated taurine in combination with caffeine. Thus, 
the prospect that the body reacts differently to taurine in these 
two circumstances cannot be discounted.As such, the discrep-
ancies throughout the research on taurine and the limitations of 
the studies make it hard to determine whether the compound 
contributes to energy drinks’ negative cardiovascular effects. 
Studies that are better controlled would have to be done in 
order to solidify any claims in this area. 
Guarana 
Guarana, also called zoom or Brazilian cocoa, is a seed orig-
inating from the Amazon basin and is present in many ener-
gy drinks. Guarana is known to be between 2-7.5% caffeine 
in composition (Beck, 2005), a concentration higher than any 
other known plant in the world, which contributes to its car-
diovascular effects. It also contains compounds such as theo-
bromine, theophylline, tannins, and saponins. Aside from these 
compounds, it is important to note that guarana is a fatty seed. 
Therefore, guarana is not as readily soluble as caffeine, a polar 
substance, and its components take longer to dissolve into the 
blood stream.Although the seed’s longer absorption period and 
strong effects have not been confirmed with certainty, a study 
that tested the effects of guarana versus a caffeine pill containing 
the same amounts of caffeine observed an increase in systolic 
blood pressure after ingestion of guarana that was not seen 
after the caffeine ingestion.This result was observed at the two-
and-a-half-hour mark, pointing to guarana’s slow dissolution 
span (Meyer, Ball, 2004).Thus, although the amount used in the 
study was greater in concentration than the guarana in energy 
drinks, it is possible that when guarana is combined with caffeine 
in energy drinks, its composition and solubility produce greater 
cardiovascular effects than caffeine alone. 
Sugar 
The sugar content in one serving of most energy drinks ranges 
from about 27 g - 37 g in smaller cans to about 57 g in larger 
drinks. In comparison to the American Heart Association’s rec-
ommendation for maximum added sugar intake per day, most 
of these measurements match or exceed the suggested maxi-
mum doses of 25 g and 37.5 g, for men and women respectively 
(AHA, 2018). It stands to reason that if energy drinks contain 
so much of this risky substance, sugar can play a role in the 
cardiovascular effects seen. 
A small, yet well-designed study tested the participants’ reac-
tions to four drinks on four separate days in order to test the 
effects of sugar, caffeine, and taurine. Subjects consumed Red Bull 
(containing sugar, caffeine, taurine, and other ingredients), sug-
ar-free Red Bull (identical to the first drink except for the sugar 
content), water with 120 mg of caffeine, or water itself, after 
which cardiovascular parameters were measured. Researchers 
found that all of the caffeinated drinks caused similar increases 
in systolic and diastolic blood pressure. They noted, however, 
that although the blood-pressure raising effect of all three bev-
erages seemed to be the same, the mechanisms raising the BP 
varied between the different drinks. While the two caffeinat-
ed, yet sugar-free drinks raised total peripheral resistance, the 
sugar drink raised many myocardial parameters such as stroke 
volume, cardiac output, and contractility.These increases were 
not seen after any other drink. Moreover, the sugar-containing 
drinks lowered total peripheral resistance.These results suggest 
that while caffeine alone might have a similar effect on blood 
pressure when compared to caffeine and sugar combined, the 
former seems to act through a vascular route, and the latter by 
a cardiac route (Miles-Chan, et al., 2015). 
The above effects seen after the sugar-sweetened, caffeinated 
Red Bull appear to be caused by an additive effect of the two 
active substances, as the sugar does not have these effects on its 
own. In a study of sugared drinks’ effects on the cardiovascular 
system, researchers showed that while fructose raised blood 
pressure, sucrose and glucose – the two sugars used in energy 
drinks – did not.These sugars did raise cardiac output and heart 
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rate, though (Grasser, et al., 2014b).Therefore, the effects of the 
Red Bull energy drink – to increase cardiac output, heart rate, 
and blood pressure – could not have been caused by sugar alone 
but must have been an additive result achieved by combining the 
two substances. 
This study further suggests that taurine’s affects are negligible, 
as the caffeinated drinks with and without taurine seemed to 
have the same cardiovascular effects. 
Caffeine - Mechanisms 
Aside from merely understanding that caffeine is the most ac-
tive  cardiovascular agent in energy drinks, we can also attempt 
to clarify the possible mechanisms by which it acts. Caffeine, a 
methylxanthine, is a stimulant known to work by the following 
three mechanisms: Firstly, caffeine competitively inhibits adenos-
ine receptors. Adenosine is a fundamental component in sleep 
regulation and plays a role in making a person tired. Secondly, 
caffeine stimulates catecholamine release¬, causing raised levels 
of epinephrine (adrenaline) and norepinephrine (noradrenaline), 
which stimulate the sympathetic nervous system and increase 
blood pressure. Lastly, caffeine increases the release of calcium 
from the sarcoplasmic reticulum, thereby stimulating muscle 
contractility (Rana, et al., 2010). All of these mechanisms can 
explain effects attributed to caffeine in energy drinks. 
Other Possible Mechanism by which Energy Drinks
Adversely Affect the Cardiovascular System
Endothelial Dysfunction 
Another explanation for energy drinks’ adverse effects on the 
cardiovascular system is that they have been shown to lead to 
endothelial dysfunction by increasing platelet aggregation and 
decreasing the reactive hyperemia index (Worthley, et al., 2010). 
Increased dysfunctional platelet aggregation can lead to throm-
bosis and cardiac arrest. Also, a reduced reactive hyperemia 
index indicates vessels that are not able to adapt to normal 
increases in blood pressure as well as they should be.This wear-
ing-down of the blood vessels makes the system more suscepti-
ble to adverse effects because it cannot adapt as well to changes 
in pressure and flow.
Biochemical Changes in Heart Muscle 
Long term energy drink consumption by male Wistar rats fol-
lowed by heavy exercise has been shown to increase glucose 
and glycogen concentration in their heart muscle.After feeding 
these rats energy drinks versus water for thirty days and then 
having them swim to exhaustion, researchers found increased 
levels of glucose and glycogen in the heart muscle of the rats 
exposed to energy drinks. Although the buildup of glycogen 
seems contradictory to caffeine’s usual effect of increasing glu-
cose concentration by activating AMPK (Amp activated protein 
kinase), it is possible that the when the compound is chronically 
activated, glycogen synthase is activated allosterically and over-
comes AMPK’s usual inhibition of glycogen formation.This is of 
concern due to glycogen’s association with incidents caused 
by the pre-excitation syndrome arrythmia. Glycogen has been 
found in increased concentrations in the heart after adverse 
events caused by pre-excitation syndrome (Munteanu, et al., 
2018).This suggest another possible mechanism by which ener-
gy drinks precipitate arrythmias. 
Conclusions 
There are two public health concerns. The first, is that while 
arrythmia-related deaths are rare and most patients with an 
increased risk of abnormal heart rhythms do not actually have 
fatal arrhythmias, the introduction of energy drinks will increase 
the frequency of fatal arrythmias in this population.The second 
and more troubling concern is the possibility that energy drinks 
are causing slight increases in blood pressure in habitual con-
sumers, who are generally young. Increased blood pressure by 
even small amounts has been convincingly shown to increase 
the risk for stroke and death due to cardiovascular events. On 
a public health level, if more and more adolescents and young 
adults use energy drinks and have increased blood pressure, the 
rate of hypertension-related deaths will rise in the foreseeable 
future.The benefits of these drinks must therefore be weighed 
against the adverse possibilities. 
Since many of the currently available studies used small sub-
ject groups, the need for larger studies to further clarify results 
cannot be overlooked.With time, the long-term effects of these 
relatively new substances can be studied. Population studies 
comparing those who consumed higher levels of energy drinks 
versus those who consumed caffeine through coffee and versus 
those who abstained from both should be conducted. 
As with most foods – especially those that contain active sub-
stances – energy drinks consumed occasionally and in moderation
seem to be reasonably safe for healthy people. Consumers should
be careful not to increase consumption to the point that it be-
comes habitual or reaches the unsafe levels discussed in this study.
Consumers should be warned not to overuse these substanc-
es and to avoid using them before strenuous activity, as many of 
the more serious adverse events mentioned above occurred 
after increased activity. Government authorities should consid-
er requiring manufacturers to warn buyers about the potential 
side effects mentioned in this review to prevent the occurrence 
of serious energy-drink related adverse events. 
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Abstract 
Subclinical Hypothyroidism, SCH, has been detected with increasing frequency in recent years and has brought about major 
controversies regarding management and treatment [Meier et al., 2001].The condition is characterized as having a high concen-
tration of thyroid stimulating hormone, yet normal thyroid hormone levels and is often asymptomatic. Scientific articles retrieved 
from various databases helped determine some of the long term risk factors associated with SCH, including progression to overt 
hypothyroidism, fatty liver disease, cardiovascular disease, neuropsychiatric complications and reproductive malfunctions. Studies 
determining the clinical and metabolic effects of L-thyroxine hormone replacement therapy on symptoms and potential risks of 
SCH on various patient populations were investigated and compared to controls that were not treated or were given a placebo 
drug. After considering both the arguments promoting treatment and others opposing it, conclusions were drawn regarding the 
promotion or discouragement of hormonal treatment for patients in different age brackets and stages of life.  In general, the 
greatest benefits of treatment are observed in patients with thyroid-stimulating hormone levels ranging over 10mIU/L, younger 
patients with slightly elevated thyroid-stimulating hormones who are at risk for cardiovascular disease and for pregnant women 
with gestational SCH. On the contrary, L-thyroxine treatment therapy is not as crucial for the elderly population or patients with 
slightly elevated thyroid-stimulating hormone values when there are no apparent symptoms of hypothyroidism being experienced. 
Introduction 
Describing a condition as ‘subclinical’ implies that it is asymptom-
atic, thereby suggesting that a less aggressive treatment plan is
needed and possibly rendering the condition unworthy of treat-
ment altogether. However, there is controversy regarding wheth-
er the condition is indeed ‘subclinical’ and if it is necessary or
beneficial to treat. Hypothyroidism is an endocrinological disor-
der in which there is inadequate production of thyroid hormones,
triiodothyronine (T3) and thyroxine (T4) by the thyroid gland.
These hormones strongly influence energy metabolism, digestion
and body heat production.Additionally, they play a key role in car-
diac contraction rate, memory, psychological health and sleep. In
the case where the gland itself fails to secrete sufficient hormone
concentrations, the disease is considered primary. However, if the
root of the problem is traced back to insufficient stimulation of
a structurally healthy gland due to decreased thyroid-stimulating
hormone (TSH) released from the adenohypophysis, then the
condition is regarded as secondary or central. Diminished secre-
tion of thyrotropin-releasing hormone (TRH) from the hypothal-
amus would cause the condition to be considered tertiary hypo-
thyroidism [Hadley & Levine, 2007;Wiersinga, 2010].  Subclinical
hypothyroidism (SCH)  ranks as a grade of primary hypothyroid-
ism and is characterized biochemically as an elevated serum TSH
concentration, with a normal serum-free T4 level, as well as T3
level [Meier et al.,2001].When a patient’s thyroid function is nor-
mal and hormone secretion is balanced according to homeostasis,
he/she is considered euthyroid. Euthyroid adults should exhibit
TSH levels within a range of 0.2-7.6 mIU/L, a T3 concentration
of 4.3-12.5 mcg/dL and a free T4 concentration of 0.7-1.7 ng/dL
[Robertson, Shilkofsky 2005]. Some experts have suggested that
the TSH upper limit should be only 2.5 or 3 mU/L, while others
argue that the serum TSH distribution gradually shifts towards
higher values with age and must be adjusted accordingly. Others
have proven through their studies that the accepted reference
range for serum TSH should be altered as patients age and that
maintaining a 4.5 mIU/L upper limit for TSH concentration results
in the prevalence of SCH to be significantly overestimated in the
elderly population. Nonetheless, while there is controversy over
the appropriate upper limit of normal serum TSH, most laborato-
ries agree that it is 4 to 5 mIU/L [Surks et al.,2007]. Biochemical
testing and laboratory test results alone are required in order
to diagnose SCH since patients often present with vague symp-
toms elevated TSH levels. Much research has been done regard-
ing whether to treat SCH in populations of various age brackets
and stages.A general consensus has been reached based on the
existing and potential risk factors involved and the success rates
of levothyroxine thyroid hormone replacement. 
Methods 
Relevant information was accumulated via original research 
literature obtained from databases such as Google Scholar, 
Proquest , Pubmed and Touro College’s Online Library . Medical 
journals, JCEM and JAMA, served as a source of information 
as well. Books, including a medical book and science textbook, 
were used to provide background information.All content was 
critically analyzed and compared to assure validity. 
Epidemiology 
Based on the results of population-based studies, the preva-
lence of SCH in adults ranges from 4 to 15 percent [Turnbridge 
et.al., 1977] and affects approximately 10 million people in the 
Unites States [Huber et al., 2002]. In one of the best longitudinal 
studies conducted,Turnbridge et al. (1977) found that 7.5% of 
women and 2.8% of men of all ages in Whickham, England have 
TSH levels exceeding 6 mlU/L.Twelve such studies done with-
in different cultures, similar to theirs, were reviewed, and they 
concluded that primary thyroid-gland malfunction occurs in 
approximately 5% of any population. Of the 16,533 participants 
in the Unites States Third National Health and Examination 
Survey (NHANES III), 4.3% had SCH [Hollowell et.al., 2002]. 
Of the 25,862 participants included in the Colorado Thyroid 
Disease Prevalence Study, an elevated TSH level was found in 
9.5% of the population [Canaris et. al., 2000]. Furthermore, the 
frequency of SCH is found to be higher in females than males, 
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rises with age and is less in blacks than in whites [Kanaya et 
al., 2002]. It is important to note that since thyroid hormones 
contain iodine, the inhabitants’ thyroid functioning is highly de-
pendent on the iodine reserve of their specific region. When 
analyzing population-based studies, it’s crucial to consider how 
the degree of iodine repletion or depletion in that geographical 
environment affects its populations intake and in turn, thyroi-
dal health [Laurberg et al., 1998]. For example, in Africa, lack 
of dietary iodine is the chief determinant of thyroid pathology, 
instigating a spectrum of iodine deficiency disorders, including 
hypothyroidism [Okosieme, 2006]. 
Clinical Findings 
While the clinical manifestations of SCH vary, patients some-
times report mild signs and symptoms similar to those experi-
enced due to overt hypothyroidism. However, these symptoms 
are characterized as neither sensitive nor specific [Meier et 
al., 2001]. Based on the Colorado Thyroid Disease Prevalence 
Study involving 2,336 participants with SCH, symptoms report-
ed by patients with SCH included dry skin (28%), poor mem-
ory (24%), slow thinking (22%), muscle weakness (22%), fatigue 
(18%), muscle cramps (17%), cold intolerance (15%), puffy eyes 
(12%), constipations (8%) and a hoarser voice(7%) [Canaris 
et al., 2000]. Conflicting data is seen from a community-based 
cross-sectional study where 1,423 participants, ranging from 
ages 18-75 years old, had TSH screenings and their symptoms 
were evaluated.The data collected indicated that subclinical thy-
roid disease is not associated with lower well-being or impaired 
health-related quality of life. Therefore, attempts to clinically 
identify SCH based on reported symptoms are unsuccessful 
[Bell et al., 2007]. However, significant evidence highlights nu-
merous long-term consequences of SCH, though they do not 
appear obvious from patients’ reports. 
Progression to Overt Hypothyroidism 
A significant number of patients with SCH eventually develop 
overt hypothyroidism. In a study done by Huber et al., after a 
mean observation period of 9.2 years, 23 out oof 82patients 
(28%) who entered the study with subclinical hypothyroidism 
developed overt hypothyroidism, as defined by low T4 concen-
tration and elevated TSH (>20 mU/L).The risk of progression to 
overt hypothyroidism was seen to correlate to the initial serum 
TSH level of the patient; the higher the concentration, the great-
er the risk. Of the 82 women with TSH concentration values 
ranging from 4-6 mIU/L, the frequency of progression to overt 
hypothyroidism was 0% after 9.2 years.When only the patients 
with a serum TSH concentration above 6 mIU/L were evaluat-
ed (n = 61), after 10 years, the cumulative incidence of overt 
hypothyroidism was 55.3% [Huber et al., 2002]. Overt hypo-
thyroidism is particularly common in older patients whose TSH 
levels exceed 10 mIU/L or those who have circulating thyroid 
antibodies [Ayala et al., 2000]. Obviously, overt hypothyroidism 
poses a greater threat to one’s overall health related quality of 
life as it presents with classical symptoms of fatigue, depression, 
weight gain, cold intolerance, bradycardia, constipation, dry skin, 
facial edema and loss of hair [Carle et al., 2014]. More severe 
dysfunction of the thyroid gland also stimulates a negative feed-
back mechanism in which more and more TSH is secreted, ulti-
mately causing the gland to swell, referred to as goiter. 
Fatty-liver Disease 
Since thyroid hormones play a fundamental role in lipid me-
tabolism, mild hypothyroidism may cause hypercholesterolemia 
and play an essential role in the pathogenesis of non-alcoholic 
fatty liver disease (NAFLD). Non-alcoholic fatty liver disease is 
defined as “extrahepatic accumulation of fat in the absence of 
excess alcohol consumption” [Liu et al., 2017].A cross-sectional 
study reported the prevalence of fatty-liver disease and abnor-
mal liver enzyme levels to increase progressively with rising TSH 
levels compared to patients with euthyroidism, suggesting asso-
ciations between the spectrum of SCH and liver malfunction. In 
one study population, the incidence of fatty-liver disease and ab-
normal liver enzyme level was 29.9% and 20.1%, respectively, for 
patients with SCH [Chung et al., 2012]. SCH patients experi-
ence higher amounts of liver aspartate aminotransferase  (AST) 
and alanine aminotransferase (ALT), an enzyme released into 
the bloodstream when the liver is damaged [Liu et al., 2017]. 
Cardiovascular Disease 
Thyroid hormones are known to affect the heart and vascu-
lature. As a result, the impact of SCH on the cardiovascular 
system has become an important subject of research [Liu et 
al., 2010]. While it is undisputed that overt hypothyroidism is 
linked to increased risk for cardiovascular diseases (CVD), con-
flicting data raises controversy whether SCH is also associated 
with heart disease.  Heterogeneity among individual studies can 
be explained by the different TSH cutoffs used, varying cardio-
vascular disease definitions or differences in participants’ age,
gender, or severity of SCH (as measured by TSH level) [Rodondi 
et al., 2010]. Clinical hypothyroidism has been known to cause 
an increase in blood pressure. Since thyroid hormone directly 
acts on arterial smooth muscle cells of blood vessels, causing 
vasodilation, when hypothyroidism occurs, a lower hormone 
level increases the vascular resistance and in turn the level of 
blood pressure. In a cross-sectional survey the incidence of high 
blood pressure, hypertension, in the SCH group was significant-
ly higher than the control, the euthyroid group.The conclusions 
drawn from this study coincide with previous data collected by 
Luboschitzky et al. in 2002 [cited in Liu et al., 2010]. 
Furthermore, since SCH has been linked with abnormal lipid 
metabolism, it is consequently related to increased risk for 









   
 
 



















and low density lipoprotein cholesterol (LDL-C) was detected 
as a feature of SCH in some of the literature, while contrast-
ing research found cholesterol levels to be in normal range. 
Nonetheless, several studies suggested a connection between 
SCH and development of atherosclerosis, and more recently 
published research established SCH as a risk factor for myo-
cardial infarction [Meier et al., 2001; Anderson et al. 2015]. A 
meta-analysis from 7 studies, including 2,020 patients with SCH, 
confirmed a substantial trend of increased risk of coronary 
heart disease by highlighting events like nonfatal myocardial 
infarction, angina and necessary coronary revascularizations 
common to patients with elevated serum TSH concentrations, 
especially of those that were 10 mIU/L or greater. Results from 
a meta-analysis of patient-level data from 11 prospective cohort 
studies showed greater risk for coronary heart disease mortal-
ity for patients suffering from SCH with serum TSH concentra-
tions above 10mIU/L. Rodoni et al. reported increased systemic 
vascular resistance, arterial stiffness, altered endothelial func-
tion, increased atherosclerosis and altered coagulability to be 
associated with SCH and the acceleration of development of 
coronary heart disorder. On the contrary, minimal TSH eleva-
tion (4.5-6.9 mIU/L) was not linked to cardiovascular disease or 
mortality [Rodoni et al., 2010]. 
Neuropsychiatric Symptoms 
While there is evidence that SCH is linked to neuropsychiatric 
complications, there has been conflicting research as well. One 
study assessed the history of major depression in subjects with 
SCH compared to euthyroid subjects.The frequency of depres-
sion was substantially higher in those who met the criteria for 
SCH (56%) than in those who did not (20%), suggesting that 
SCH may lower the threshold for the occurrence of depression 
[Haggerty et al., 1993]. Similar results were found in a later study 
where signs of neuropsychiatric dysfunction like somatization, 
cognitive impairment disturbances, psychomotor retardation 
and sleep disorders were seen in 63.5% of a population with 
mild thyroid failure [Demartini et al., 2010]. However, another 
study revealed opposite research as patients with SCH scored 
equally as well as the euthyroid control group on 14 cognitive 
function tests [Jorder et al., 2006]. 
Reproductive Malfunctions 
Alteration of the thyroid’s physiology under the impact of pla-
cental human chorionic gonadotropin (hCG) during the first 
trimester, results in adjustments to TSH levels. During the first 
trimester, a white woman maintains an upper limit TSH concen-
tration of 2.5 mIU/L and 3.0 mlU/L during her second and third 
trimester periods [Stagnaro-Green et al., 2011].  SCH during 
gestation poses fewer risks than overt hypothyroidism would, 
but still puts women at increased risk for preterm delivery at or 
before 34 weeks of gestation, placental abruption (3 times more 
likely to occur in women with SCH) and/or pregnancy loss 
compared to euthyroid women. Severe preeclampsia, defined as 
gestational hypertension is noted as a risk factor for pregnant 
women with SCH [Casey et al. 2005;Novakovic et al., 2018]. 
A meta-analysis of 15 cohort studies involving 1,896 pregnant 
women with SCH arrived at conclusions similar to Novakovik 
et al. and showed that SCH during gestation causes significant 
impairment to the intelligence and neurological development of 
the offspring [Liu et al., 2018]. 
It’s possible to acquire SCH as a result of pregnancy; an esti-
mated 15% of pregnancies in the U.S are affected by gestational 
SCH [Blatt et.al., 2012].  Over the gestational period, increased 
metabolic needs result in increased production of thyroid hor-
mones by approximately 50% compared to euthyroid, non-preg-
nant women. Consequently, necessary daily iodine intake levels 
rise by 50%. More renal blood flow and glomerular filtration 
results in an increase in iodide clearance from blood plasma. 
Thus, more iodine is necessary in the diet of a pregnant woman. 
The stress imposed on the thyroid gland during gestation re-
sults in SCH for many women with compromised dietary io-
dine levels. Clinical studies have proven that iodine deficiency 
during gestation causes impaired development of the brain and 
impedes mental function development of the fetus [Farebrother 
et al., 2015 ]. Measuring the IQ of children whose mothers had 
not been treated for SCH during pregnancy revealed mean IQ 
scores of 7 points lower than controls [Haddow et al., 1999]. 
Casey et al. (2005) proposed that preterm parturition results in 
prematurity which contributes to neurodevelopment delay and 
reduces intelligence quotient. 
Effects of Levothyroxine Hormone Replacement 
In general, the research showing correlation between T4 re-
placement and improvement of hypothyroid symptoms is con-
flicting and is probably due to differences in the populations 
studied, various TSH cut-off concentrations and age range. 
Levothyroxine, which is a synthetic form of T4, is usually ad-
ministered to patients suffering from overt hypothyroidism. 
Nevertheless, there is much controversy whether patients ex-
hibiting mild thyroid failure with similar symptoms should be 
prescribed levothyroxine as well [Meier et al., 2001]. Some, but 
not all, research conducted show how treatment facilitates im-
provement of hypothyroid symptoms experienced by patients 
with SCH. Subjects with mild thyroid failure who were treat-
ed with L-thyroxine showed significantly greater improvement 
in overall hypothyroid symptoms than did subjects who were 
given placebo [Cooper et al., 1984]. Nonetheless, in all the clini-
cal trials reviewed, with ongoing dosage monitoring, L-thyroxine 
succeeded in lowering previously elevated TSH concentrations 
to healthy levels. 
By decreasing TSH concentration to euthyroid levels, 
L-Thyroxine prevents the progression to overt hypothyroidism 
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[Ayala et al., 2000]. Following T4 treatment, ultrasound verified 
80% thyroid volume reduction in patients with goiter [Romaldini 
et al., 1996]. In one study, L- thyroxine and a placebo drug were 
randomly administered to 63 female patients over a span of 48 
weeks in order to achieve euthyroid TSH levels.  In the thyrox-
ine treated group, the mean serum TSH concentration was 12.8 
± 1.4 mIU/liter before and 3.1 ± 0.3 mIU/liter after treatment, 
whereas TSH levels remained unchanged in the control group. 
When lipid concentrations were measured after thyroxine 
treatment, it was observed that the total cholesterol and low 
density lipoprotein cholesterol decreased substantially, especial-
ly in those with TSH concentrations of 12 mIU/L and above. 
From the observed improvement, it is approximated that treat-
ment reduces the risk of cardiovascular disease and mortality by 
9-31%. In contrast, no change in any variable of thyroid function 
occurred in the placebo group (Meier et al., 2001).  Substantial 
improvement of cardiac function in treated patients was reflect-
ed by a sensitive measure of myocardial contractility [Cooper 
et al., 1984]. In a study done in Copenhagen, Denmark, the par-
ticipating cohort included patients over 18 years old with the 
mean age being 55.2 years. The total of 12,212 subjects were 
subdivided into 2 groups, one with TSH levels of 5-10 mIU/L and 
another with TSH levels above 10 mIU/L; some were treated 
from both groups. In this large cohort study no association be-
tween treatment and risk of myocardial infarction or mortality 
was revealed, besides in younger patients where it may seem 
that treatment had marginal protective advantage. However, 
limitations of the study such as no access to patients’ blood 
pressure or serum lipid levels and a relatively short follow-up 
period of 5 years cause it to have less credence since patients 
could have suffered from cardiac complication later on in time 
[Anderesen et al., 2015]. 
A study involving 415 patients with SCH (defined as TSH ≥ 
4.2 mlU/L) administered levothyroxine to measure its effect on 
non-alcoholic fatty liver disease and abnormal liver enzyme lev-
els.After treatment with LT4, the incidence of fatty liver disease 
in patients with more pronounced SCH (TSH concentration 
≥10 mlU/L) reduced from 48.5% to 24.2%, while in patients 
with milder SCH (TSH concentration 4.2-10 mlU/L), frequen-
cy of fatty liver disease and alanine aminotransferase was not 
significantly altered by LT4 supplementation. However, mild 
SCH patients with elevation of total cholesterol who received 
LT4 treatment showed decreases in the incidence of fatty liver 
disease and serum alanine aminotransferase levels. Those with 
higher TSH values experienced a decrease of 5.61 IU/L in serum 
aspartate aminotransferase and a small decrease in serum al-
anine aminotransferase. Patients with milder SCH showed a 
reduction in serum alanine aminotransferase from 19.09 IU/L 
to 17.95 IU/L, yet serum aspartate aminotransferase remained 
stable throughout the study in the untreated, mild SCH control 
group.  Observing how these parameters became less prevalent 
in patients who received treatment, but remained comparably 
stable in patients who weren’t treated, provides concrete evi-
dence of the success LT4 therapy has with prevention of non-al-
coholic fatty liver disease [Liu et al., 2017]. 
In another randomized double-blind, placebo-controlled trial,
TSH values decreased by 8.6 mIU/L. Patients treated with with
LT4 showed improved psychometric memory score involving
their thinking, memory and attention versus untreated control
patients [Jaeschke et al., 1996].  Unfortunately, in another study,
LT4 treatment was not enough to generate complete remission of
depressive symptoms, suggesting psychiatric evaluation in patients
affected in this way by SCH is needed [Demartini et al., 2010]. 
Regarding SCH during gestation, miscarriage was significantly 
less frequent among treated women compared to untreated 
women in a national U.S. cohort of 5,405 pregnant women. 
However, the treated group also had increased odds for 
preterm delivery, gestational diabetes and preeclampsia [Maraka 
et al., 2017]. Conflicting data claims LT4 decreased the rate of 
preterm delivery considerably in pregnant women who re-
ceived treatment compared to their control who did not (SCH 
defined as TSH ≥4 MIU/L; 5.3% incidence for treated women 
versus 29.4% in control group) [Nazarpour et al., 2017]. Further 
complicating the matter, another study revealed no difference 
in the prevalence of preterm delivery, gestational hypertension, 
miscarriage rates or adverse fetal outcomes between women 
who received LT4 treatment and those who got the placebo 
[Casey et al., 2017].  During pregnancy, beginning treatment for 
compensated maternal iodine status to ensure proper brain 
development in the fetus is extremely time-sensitive; until the 
end of the second trimester, iodine treatment protects the 
neurological system from consequences of iodine deficiency.
Since head circumference reflects brain mass, the head circum-
ference of an underdeveloped child will be significantly dimin-
ished. Microcephaly, where head circumference is more than 3 
standard deviations below the norm, was diagnosed in 27% of 
children of untreated mothers as opposed to 11% frequency in 
their treated control [Cao et al., 1994].Yet, opposing data says 
that no significant discrepancies are noted when comparing IQ 
scores and neurodevelopment of 5 year old children of mothers 
who received LT4 to those who took the placebo drug [Casey 
et al., 2017].Additional research trials are needed to determine 
whether LT4 therapy during gestation prevents adverse out-
comes, possibly induces some issues or simply doesn’t have any 
effect at all. 
In opposition to treating SCH, various studies, such as the 
meta-analysis of 12 clinical trials (9 of them with TSH concen-
tration cut-offs of less than 10,12 and 15 mU/L), show no chang-
es in hypothyroid symptoms or quality of life in the treated 













































drug [Villar et al., 2007].While SCH and cognitive dysfunction 
have been linked, T4 treatment in a population over 65 years 
of age proved it to be ineffective for aiding cognitive function 
[Parle et al., 2010]. Similarly, a double-blind, randomized, place-
bo-controlled, parallel-group trial involving 737 adults (65 years 
of age+,TSH levels ranging from 4.60-19.99 mIU/L with a mean 
TSH of 6.40±2.01 mIU/L) concluded that there are no apparent 
benefits to L-thyroxine treatment in the quality of life in older 
adults.There was no benefit observed in regard to hypothyroid 
symptoms, executive cognitive function as measured by the 
letter-digit coding test or degree of lethargy experienced by 
the group whom received treatment. However, after 12 months, 
the mean TSH level was 5.48±2.48 mIU/L in the placebo group, 
as compared with 3.63±2.11 mIU/L in the levothyroxine group; 
clearly, in terms of reaching healthy TSH levels, the treatment 
was successful [Stott et al., 2017]. 
While research supports that untreated SCH during preg-
nancy is linked to many adverse obstetric outcomes, many 
claim that insufficient evidence exists supporting the benefit 
of LT4 therapy on clinical improvement for women with SCH. 
Implementing guidelines to treat all pregnant women with SCH 
would lead to prescription of LT4 for up to 600,000 pregnant 
women in the U.S every year which would obviously have enor-
mous impact on the cost of healthcare [Maraka et al., 2017] 
Strengthening the argument that SCH should not be treated, 
there is potential danger for a patient to overdose on levothy-
roxine, causing TSH values to decrease abnormally. Statistical 
analysis claims that the incidence of this is as frequent as 10-
33% as treated SCH patients exhibit unusually low TSH levels. 
Overtreatment would completely reverse the original condition 
inducing symptoms of excess thyroid hormone. Many times, 
this is due to polypharmacy and drug interaction; research 
done reiterates the importance in monitoring TSH therapy in 
the older population, because of risk of over-replacement. In 
their trial with 339 thyroid hormone users, 41% had a low TSH, 
16% had a high TSH, and 43% were in the euthyroid range after 
treatment [Parle et al., 1993;Somwaru et al., 2009].Additionally, 
those against treatment resent the lifelong commitment to daily 
medication in asymptomatic patients, and the cost for both the 
hormone and for consistent monitoring of its efficacy.
Conclusion 
Based on the results of T4 replacement successfully reducing 
hypothyroid symptoms and potential risks associated with SCH 
in certain populations, it is recommended that LT4 replacement 
be given to those patients who present with abnormal thyroid 
function tests.The most obvious benefit appears to be limited 
to patients with baseline TSH levels of ≥10 mIU/L as they are 
most likely to experience progression to overt hypothyroidism, 
atherosclerosis, myocardial infarction and non-alcoholic fatty 
liver disease.The research regarding pregnant women with SCH 
poses no doubt to experts and healthcare providers in their 
unanimous decision to err on the side of caution and prescribe 
levothyroxine substitution for both the mother’s and fetus’s ad-
vantage.Adverse obstetric effects and risk factors far outweigh 
any arguments against treatment. However, treatment of patients 
with minimally elevated TSH values (between 4.5 and 10 mlU/L; 
differing depending on individual study TSH cut-off) demon-
strated minimal change in health related quality of life and only 
burdened patients with responsibilities to monitor treatment 
and cover its cost, suggesting that these patients not be treated. 
However, based on the increased protection against cardiovas-
cular disease and mortality in treated younger patients (<65 
years) with TSH ranging from 7 to 9.9 mIU/L, some recommend 
treatment. But in the elderly population where LT4 treatment 
exacerbates the issue of polypharmacy and may instigate harm-
ful drug-interactions, coupled with the fact that there is a lack of 
treatment trials showing benefit of treatment in this population,
only those who present with symptoms suggestive of hypothy-
roidism should be treated. Of course, long-term monitoring and 
annual clinical evaluation of TSH concentration should be im-
plemented to help ensure optimal dosage. Whether reference 
ranges should be adjusted for age, implementing a higher cutoff 
for starting treatment in older patients, awaits further research. 
Future research clarifying the reference ranges for thyroid func-
tion tests, specifically the upper limit for TSH, will help resolve 
conflicting data and enable researchers to easily compare data 
from different clinical trials in order to determine whether or 
not the condition requires levothyroxine treatment. 
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Abstract 
Stem cells seem to offer an alternative venue for treating many cell related diseases, such as age-related macular degeneration 
(ARMD). ARMD is a progressive neurodegenerative medical condition, which primarily affects the retinal pigmented epithelium 
(RPE), resulting in degeneration of photoreceptors. Scientists have been successful in implanting stem cells into the eyes of rats. 
These injected cells sustained visual function and photoreceptor integrity without any cancerous cell formation.There are numer-
ous treatments available to slow down the progression of ARMD. Depending on the type of ARMD, doctors may either recommend 
leading a healthier lifestyle or that one should undergo surgery. Numerous risk factors can increase one’s chances of getting 
ARMD depending on one’s age and race. Bad habits, such as cigarette smoking, can contribute to the progression of ARMD. It 
is important to get a comprehensive dilated eye exam periodically. Many eye diseases that don’t have any warning signs can be 
detected with such an eye exam. 
Introduction 
The most versatile cell types in the human body are embryonic 
stem cells. Stem cells have three unique general properties that 
distinguish them from other cells in the body. One is that these 
cells can replicate themselves even after long periods of inac-
tivity. Secondly, stem cells are unspecialized.These cells are not 
programed to become any specific tissue. For example, stem 
cells can’t work with other red blood cells to carry oxygen 
containing molecules through the blood stream.Thirdly, under 
certain physiologic or experimental conditions, stem cells can 
become the specialized cells that make up tissues and organs 
(National Institutes of Health 2016). 
When stem cells divide, they can make either more stem cells, 
or can differentiate into a specialized cell which is tasked with 
a specific function. For example, these stem cells can turn into 
motoneurons which are used for motor skill or into cardio-
myocytes to help pump blood through the arteries. However, 
Adult stem cells can only generate cells that are like the tissue 
in which they are located in (Tuch, 2006). For example, hemato-
poietic stem cells in the bone marrow form only cells that give 
rise to the different types of blood cells and cannot make nerve 
cells for the brain. 
Embryonic stem cells are made from oocytes that have been 
fertilized in vitro and not in a women’s body. The process of 
priming the cells in an in vitro fertilization clinic is known as cell 
culture. Human embryonic stem cells are primed by placing an 
embryo into a culture dish that contains a culture medium.With 
the right physiological conditions, these cells begin to divide 
and spread over the surface of the dish forming millions of un-
specialized stem cells.Although scientists have not agreed upon 
a battery of tests to ensure they are growing only unspecialized 
cells, there are some common tests performed to determine 
the cells fundamental properties. One technique used is by 
looking for particular cell surface markers, such as transcription 
factors, that are generally produced by undifferentiated cells. 
Stem cells in their culture dish can remain undifferentiated 
as long as they are under the appropriate conditions. However, 
cells automatically begin to differentiate once they are allowed 
to cluster together to form embryoid bodies. These cells can 
then begin to form tissue specific cells, such as muscle or nerve 
cells.Although differentiation is a sign of a healthy culture, this 
process is generally uncontrolled, and therefore an inefficient 
way to produce specialized cells. In order to create a more con-
trolled experiment, scientists change around the chemical com-
position of the culture medium or by inserting specific genes to 
specialize the cells in an organized fashion. 
Human embryonic stem cells have many applications in clin-
ical use and in research. One useful application is in cell-based 
therapies, situations where stem cells are induced to turn into 
specialized cells. Through this process, new cells which are 
needed to repair destroyed tissue can be formed. For exam-
ple, these specialized cells can replace bone marrow, muscle, 
and brain cells that are injured or malfunctioning. These cells 
form an internal repair system by cell mitosis for as long as the 
organism is alive. Due to their ability to replace damaged cells, 
stem cells seem to offer an alternative venue for treating many 
cell related diseases as well. If scientists can reliably find a way 
to differentiate the cells in an organized manner, then they may 
be able to cure many diseases in the future (Weiss,Troyer, 2006). 
One of the diseases that scientists believe embryonic stem 
cells can treat is age related macular degeneration (ARMD) 
(Shroff, 2015). Over 10 million Americans have vision loss re-
lated to Macular degeneration. Macular degeneration is the 
third most common pathological condition leading to vision 
impairment (Resnikoff, et. al., 2004).ARMD is a progressive neu-
rodegenerative medical condition, which primarily affects the 
retinal pigmented epithelium (RPE), resulting in degeneration 
of photoreceptors. This causes loss of vision in the center of 
the field of vision.The disease is caused by the deterioration of 
the macula, a region that is located at the center of the retina 
and is responsible for focusing central vision in the eye. This 
allows people to ride their bike or recognize a familiar face. 
Common symptoms include not being able to see in dim light, 
seeing spots, and distorted vision. 
There are two types of ARMD. There is the wet as well as 
the dry form. Most of the cases of ARMD are the dry form. 
Dry ARMD is also known as non-neovascular ARMD as well 
as non-exudative ARMD since there areno fluids that leak into 
the macula from blood vessels.Although people with this form 



















   





















































may have other functional limitations, such as fluctuating vision,
poor night vision, and pixelated vision. In this form of ARMD, 
the deterioration by the macula is linked with the appearance 
of drusen. Drusen are small yellow deposits that form under 
the macula. These deposits are buildups of shapeless acellular 
debris from the basement membrane of the RPE.This buildup 
of drusen causes the macula to thin and dry out, thereby causing 
the macula to lose its function.This process is known as atrophy. 
The amount of vision loss that occurs is directly proportional 
to the amount as well as the location of the drusen.Advanced 
cases of dry ARMD are also known as geographic atrophy (GA) 
since large areas of the retina stop functioning. Patients with GA 
usually see large blank spots in their central vision because their 
macula has deteriorated. Usually, most people over 50 years old 
have a drusen buildup in at least one of their eyes. Currently, 
there is no known cure for this form of the disease. 
However, some cases of dry ARMD progress into the wet 
form. In the wet form, there is an abnormal blood vessel growth 
under the macula. This type of growth is known as choroidal 
neovascularization (CNV). Once CNV has occurred in one eye, 
the patient has a higher risk that the other eye will get CNV 
as well. These new blood vessels are generally weak and can 
rupture easily.When they rupture, they leak fluids, such as blood 
and lipid containing solutions.This causes the macula to bulge, 
thereby causing a distorted central vision.These conditions can 
cause severe vision loss in a short amount of time. In this form 
of ARMD, patients may see spots because of the fluid buildup 
under the macula. Therefore, periodic eye exams are vital, es-
pecially if the patient is at a higher risk of contracting ARMD. 
There are three stages in ARMD.There is early, intermediate,
and late stage ARMD. During early stage, most people don’t re-
alize any of the symptoms.Therefore, it is crucial to have regular
eye exams. Early ARMD is diagnosed by the appearance of drusen
the size of 63 microns by the macula. In the intermediate ARMD,
there may be some vison blur in the central vision and by late
ARMD there is a noticeable vision loss in the central vision. 
Medical experts aren’t exactly sure what causes ARMD but
once present, many factors contribute to its progression.A per-
son’s age is by far the biggest factor for ARMD. Once one turns 50,
they should visit an optometrist for a comprehensive dilated eye
exam. Many eye diseases that don’t have any warning signs can be
detected with such an eye exam.This exam includes a visual acuity
test, a visual field test, dilation, and tonometry.Annual exams are
recommended once a year once one turns 60. However, if one
is African American, then they should get one when they turn 40
since they have a higher risk for glaucoma.Although there aren’t
any cures presently available, there are numerous treatments t for
ARMD. Many doctors may prescribe a strict diet and exercise to
slow down the progression. However, none of them can cure the
disease, except potentially stem cells. 
Although stem cells may offer new therapies, their use has 
been very controversial. People oppose stem cell research since 
one is harvesting a fertilized egg.They believe that this is wrong 
since this is tantamount to killing an unborn child, and therefore 
one should respect the value of a human life. However, others 
feel that morally it’s our duty to prevent or alleviate a person 
from suffering. 
Methods 
Literature for this article was obtained primarily using Touro 
College’s Online library. Other databases, such as PubMed, were 
used.Additionally, Google Scholar was valuable for finding nec-
essary and relevant articles. 
Discussion 
The retina of the eye is tasked with converting light into vision.At
the center of the retina is the macula. In the retina, there are the
rods and cones which process light into nerve impulses. Behind
the photoreceptor layer is the retinal pigmented epithelium (RPE).
The RPE is tasked with delivering nutrients and removing wastes
from the photoreceptor cells. In ARMD, RPE stops functioning,
causing the cones and rods to deteriorate. Today, scientists are
using stem cell research to understand how diverse cells in the
retina interact with one another.This has led to discovering new
ways of replacing photoreceptors and the underlying RPE. 
Generally, replacing dead cells with stem cells is very challeng-
ing since the stem cells would have to establish new connections
with the surrounding nerve fibers that ultimately relay the mes-
sage to the brain. However, the eye is a great target for stem cell
research since there are many barriers in the eye, such as tight
cell junctions, therefore making it relatively self-contained. This
prevents the migration of cells outside of the eye. Furthermore,
with the use of an ophthalmoscope it is easy to assess the ef-
fectiveness of the treatments. Doctors can also compare the
treated eye with the other eye to evaluate the effectiveness of
the treatments. 
RPE cells are easier to integrate with existing retinal cells since
they don’t need to connect with nerve fibers. With stem cells
research, one can use new RPE cells to replace dead RPE cells.
If the stem cells are replaced before the photoreceptors have
completely deteriorated, then the new RPE cells may be able to
prevent existing photoreceptors from dying, thereby preventing
the progression of the disease. Stem cells can also be used to
discover new therapies. When damaged RPE cells are stressed,
they produce characteristics of ARMD.These damaged cells can
then be studied to evaluate the different surface markers pres-
ent which can help in early intervention and in getting a better
diagnosis. 
Scientists have come up with different methods to replace the 
RPE layer. One method is using human embryonic stem cells. 
These cells are naturally pluripotent when harvested and can 
renew for long periods if properly maintained in vitro.They can 
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transform into the ectoderm, endoderm, and mesoderm.These 
three primary germ layers can differentiate into all the cells in 
the body. However, there are numerous obstacles raised with 
this method. One of the problems is whether it is ethical to 
harvest embryos since they can turn into a fetus (Narsinh, et. al., 
2011).Another challenge that must be overcome is the limited 
supply of human embryo donors. 
Another method researchers have used is induced pluripo-
tent stem cells 
(hiPSCs).These are usually epithelial cells that are reprogramed
to behave like embryonic stem cells. They can then be used to
grow rods and cones or RPE cells. The landmark discovery of
hiPSCs has been hailed as a significant advance in stem cell re-
search.This method circumvents the ethical debate with embry-
onic stem cells since no human embryo is destroyed ex utero.
However, there are numerous problems with this method as well.
Extensive research has shown that these cultures cells can turn
into benign or malignant tumors (Ho, et. al., 2012). Therefore,
these issues preclude clinical use of these cells for now. 
Another method which scientists are experimenting with is 
adult stem cells.This method entails growing RPE specific stem 
cells from adult stem cells. One source for such cells is from 
eyes donated to eye banks.These cells are less likely to be re-
jected if used in implants. However, there usually is a limited 
amount in each tissue, therefore making it harder to find and 
purify. Furthermore, these cells can’t be stored for any length of 
time before they turn cancerous (Reya, et. al., 2001). 
Delivery Method for Stem Cells 
Although there are no FDA approved cures for ARMD, implanta-
tion of healthy RPE into the macula may prove to be an effective
treatment.The following procedure was used to deliver RPE into
rats.After the rat was put under a general anesthetic, a hole was
created in the eye using a sharp needle.Then, a blunt needle was
inserted into the hole until it reached the RPE layer, into which
the stem cells were injected (Westenskow, et. al., 2015).
In one study, animal models, such as rats and mice with
macular degeneration, were treated with stem cells that be-
come RPE cells (Lu, et. al., 2009).To simulate real life condi-
tions, the rats were under a 12-hour light /dark cycle. One
day prior to their transplantation, all animals in the main ex-
periment were administered cyclosporine to prevent organ
rejection. Before the researchers administered the cells, they
washed the cells in balance salt solution.Two weeks after the
transplantation, the rats received an intraperitoneal injection
of dexamethasone.This steroid was injected to treat the re-
sulting inflammation.
These injected cells sustained visual function and photore-
ceptor integrity without any cancerous cell formation. Visual 
acuity increased when the models received a dose between 
5000-100,000 RPE cells. Following the procedure, the rats were 
monitored to check for any adverse reaction.They found that 
visual function was sustained for at least two months.The cells 
themselves survived for at least half a year before they started 
to deteriorate. However, this deterioration in visual acuity can 
be due to insufficient cyclosporine.Another hypothesis of why 
the cells deteriorated can be because the transplantation may 
need to be repeated several times in order to sustain their ther-
apeutic effect. 
ARMD Treatments 
For early dry ARMD, doctors recommend a diet that is high 
in antioxidants, such as strawberries and oranges. However, if 
the patient has an advanced stage of dry ARMD, such as GA, 
then the doctor may prescribe supplements that increase vital 
vitamins that support the cell. 
Until recently, the only treatment for wet ARMD was laser 
photocoagulation. This treatment by an ophthalmologist is a 
minimally invasive procedure which uses a laser to burn and 
destroy leaking blood vessels. However, this treatment cannot 
restore vision that has been lost already. One drawback to 
their use is that most CNV lesions are too big to be treated 
by laser coagulation.Another is that there is a high chance that 
the leakage will reoccur over time. Because of these limitations, 
scientists have been looking for alternative therapies that are 
safe and effective for a long period of time. 
One alternative treatment that is widely used today is Anti-
vascular endothelial growth factor (VEGF) therapy.This thera-
py includes periodic intraocular injections of a chemical called 
anti-VEGF. Normally,VEGF is beneficial for the circulatory sys-
tem since it helps promote the growth of new blood vessels. 
However, having too much by the macula can have deleterious 
effects on it since they promote the growth of weak new blood 
vessels. This intravitreal shot of anti VEGF stops the develop-
ment of new blood vessels by the macula, thereby preventing 
any further leaks. However, there are numerous side effects 
with this treatment. Patients have complained about vitreous 
floaters.This happens since the doctor punctures the vitreous 
layer of the eye.Another side effect observed was an elevated 
eye pressure.This can cause glaucoma if left untreated. 
Human Implant 
Although stem cells have been proposed as a potential treat-
ment in treating ARMD, there are still numerous drawbacks to 
their use. Safety concerns have been raised since there is a risk 
that these cells may turn into unwanted cell types which can lead 
to tumor formation in the eye and potential immune rejection. 
Although stem cells were discovered in the late 1990s, scientists 
did not know how to find a safe way of implanting them. The 
first reported transplanted hESC-derived cells into the macula 
was in 2012. hESC-derived retinal pigment epithelium cells were 




























   
 
    
  
 







   
 
 










dry ARMD patients (Schwartz, et. al., 2012). Ninety-nine percent 
of the stem cells differentiated into RPE cells.These differenti-
ated cells integrated into the host forming a homogenous RPE 
layer. Post-surgery, structural evidence showed that the cells had 
attached and continued to persist during the study. During the 
first four months, there were no signs of hyperproliferation, cell 
rejection, or abnormal growth. 
The scientists didn’t find any signs of adverse proliferation or
any other type of ocular disease. This method proved to be a
safer method for treating ARMD than other conventional meth-
ods, such as vitreoretinal surgery and immunosuppression. The
results of this study provide the first evidence for medium to
long term safety as well as graft efficacy.These results suggest that
stem cells can be a safe alternative for many medical diseases that
require tissue replacement.Therapeutic goals for the future will
be to treat the patient in the earlier stages of macular degenera-
tion, thereby preventing the photoreceptors from decaying. 
Risk Factor 
A study was conducted to evaluate the effects of antioxidants 
on AMRD. In this clinical experiment, they enrolled 3,640 partici-
pants who showed signs of ARMD.These participants had drusen 
buildup in at least one of their retinas.The size of drusen build-
up was between 63-150 microns. Participants were randomly 
assigned supplements that contained either 500 mg L-ascorbic 
acid, 400 IU tocopherols, or a placebo. The researchers found 
that compared to the placebo a high dose of L-ascorbic acid 
and various tocopherols may delay the progression of ARMD 
and other forms of vision loss.These supplements showed no 
adverse effects, proving their safety (Age-Related Eye Disease 
Study Research Group, 2001). 
A study was conducted to assess the risk of smoking in men. 
This study consisted of 21,157 US male physicians who did not 
have any known diagnosis of ARMD. Of them, 11% were current 
smokers, 39% were past smokers, and 50% that never smoked. 
Over the course of 12 years, they found 268 incidents of ARMD. 
Current smokers who smoked a pack a day had a 240 percent 
risk increase compared to nonsmokers. Past smokers had a 30 
percent increased risk of contracting ARMD. Current smokers 
who smoke less than 20 cigarettes had only a modest risk in-
crease of 26 percent (Christen, et. al., 1996). Unlike other risk 
factors, such as age, smoking is an avoidable risk factor. 
Since there aren’t any cures that are reliable for ARMD, it is 
therefore recommended to avoid smoking altogether. However, 
it could be that the study on smoking isn’t 100 percent accurate. 
It could be that the subjects who didn’t smoke had a slower 
progression since they ate foods rich in omega-3 fatty acid.This 
acid can be found in many common household products, such 
as fish and canola oil. In a study conducted with 681 twins, they 
found that having 2 or more servings of fish reduced the risk of 
ARMD by 45 percent (Seddon, et. al., 2006). 
Although some fruits and vegetables can slow down the pro-
gression of ARMD, such as those rich in L-ascorbic acid and 
tocopherols, other vegetables can be bad for ARMD. One study 
tried to find out if dietary nitrates can increase your chance 
of getting ARMD. These nitrates can be found in leafy vegeta-
bles, such as lettuce and spinach. In this study, there were 2,856 
participants.The scientists took numerous potential cofounders 
into account such as age, sex, smoking, energy intake, and fish 
consumption. The participants were monitored for 15 years. 
The scientists found that those who had a dietary nitrate intake 
had a 39 percent increase incidence of having ARMD (Gopinath, 
et. al., 2018). However, this percentage increase cannot be said 
to apply for all ethnic groups. 
A prospective cohort study of 6,176 participants between 
the ages of 45 to 85 was used to find the prevalence of ARMD 
between four racial groups. These groups were white, black, 
Hispanic, and Chinese.The method they used to test for ARMD 
was by taking a picture of the fundus through the dark-adapted 
pupils, whereupon they were able to measure the drusen size. 
What they found is that Hispanics had a 1.8 percent increase 
in prevalence compared to the black ethnic group.The Chinese 
had a 2.2 percent increase, and the white had a 3 percent in-
crease compared to the blacks. Differences in age, gender, 
pupil size, body mass index, smoking, alcohol drinking history, 
diabetes, and hypertension status did not explain the variability 
among the 4 racial/ethnic groups (Klein, et. al., 2006). 
A person’s age is by far the biggest factor for ARMD. In a 
population-based study, scientists tried to find the prevalence 
of ARMD in a sample of Hispanic individuals over the age of 
50.All 4,774 participants had an initial ophthalmic evaluation to 
determine a baseline for comparison. Over the course of the 
study, the scientists monitored drusen size, drusen type, and 
the area covered by drusen.They found that the prevalence of 
early and late ARMD increased with age.The prevalence of early 
ARMD varied with age as follows: people between 50 and 60 
had a 20 percent increase, while those aged 80 and older had a 
54 percent increase.The prevalence of late ARMD varied with 
age as well.Those in the age group of 50 to 60 had a .1 percent 
increase, while those 80 years and older had a 4.3 percent in-
crease (Muñoz, et. al., 2005). 
Conclusion 
Currently, there is no FDA approved cure for ARMD. However, 
one promising cure currently being researched is stem cell 
transplantation. However, there are numerous obstacles that 
still need to be overcome before they can be safely implanted 
into patients. Depending on the type of ARMD, doctors may ei-
ther recommend leading a healthier lifestyle or that one should 
undergo surgery. As one ages, one is more prone to getting 
ARMD.Therefore, it is important to get a comprehensive dilated 
eye exam periodically. 
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